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ABSTRACT
Fasciola hepatica (liver fluke), is a trematode parasite, particularly of
ruminants, that is found throughout the world. Sheep show no resistance to the
parasite, cattle may develop partial resistance and rats show complete resistance,
which is immune-mediated, to challenge infections. In rats, resistance occurs early
during infection, at the level of the gut and/or peritoneum. Little is known regarding
the natural immune responses in cattle that occur during this period.
This study was designed to investigate the effect that pre-exposure of cattle to
1-2 and 5-6 day old flukes had upon subsequent challenge infections, when
compared to naive and chronically infected animals. Infection parameters, together
with peripheral and local cellular and antibody responses to various F. hepatica
protein preparations were investigated.
A primary exposure to 5-6 day old flukes, terminated by triclabendazole
treatment, was found to reduce the degree of liver damage and eosinophilia
experienced after a challenge infection. Lower levels of the enzymes gamma-
glutamyl transferase and glutamate dehydrogenase were detected in sera, compared
to those in naive animals (P < 0.05). Eosinophilia was also reduced (P < 0.01), as
was egg output in the faeces during the early patent period (P < 0.05). Calves that
were pre-exposed to 1-2 day old flukes showed no significant differences in the
levels of these parameters, when compared to their nai've counterparts.
Sera taken prior to the secondary challenge from pre-exposed animals and
those receiving an unterminated primary infection recognised a variety of proteins in
Western blots of whole adult fluke somatic antigen (WFA) and excretory-secretory
(ES) preparations. The IgGl antibody response to protein bands of 96-82, 76-68 and
60-52 kDa predominated. After secondary challenge the response of the chronically
infected animals to these protein species was reduced and extremely strong
recognition of bands in the region 30-28 kDa was observed. Pre-exposed animals
maintained the response to the higher weight bands, showing a similar, but initially
stronger recognition pattern, to that of naive challenged animals. The lower weight
protein bands were not detected in these groups until much later.
The IgGl/IgG2 isotype antibody response to purified cathepsin and haem-
containing high molecular weight fractions were also examined by ELISA. A
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monophasic, IgGl response was seen to the cathepsin fraction, which occurred late
during the infection process and was not seen prior to secondary challenge in any of
the four groups. A mixed IgGl/IgG2 antibody response to the haem fraction was
seen within 14 days of primary infection. After secondary challenge, this response
was boosted in the pre-exposed, but not the chronically infected, animals. No
significant difference was noted in antibody titre to either protein fraction between
pre-exposed or nai've animals.
Peripheral blood mononuclear cells responded to stimulation with WFA and
ES preparations, giving a strong proliferative response as early as 7 days post¬
infection. This suggests the presence of common antigens between adult and very
early fluke stages. Proliferation was decreased after secondary challenge, particularly
in the chronically infected group.
In order to examine the local immune response in the 5-6 day pre-exposed
group, mesenteric and hepatic lymph nodes were removed 10 days after secondary
challenge. Substantial proliferation to WFA was seen with hepatic, but not
mesenteric derived lymph node cells, suggesting that the gut response to this antigen
preparation was not important. Pre-exposed animals showed a lower mean level of
IFN-y and IL2 cytokines in supernatant fluid. Both groups produced similar levels of
B cell stimulating factor. IgG antibody present in hepatic lymph node cell culture
supernatant fluid from pre-exposed animals recognised proteins on WFA and ES
Western blots of sizes 190-120, 96-82, 72-68 and 60-57.5 kDa. No such response
was seen with supernatant fluid from naive challenged animals.
These results suggest that pre-exposure to flukes of up to 5-6 days old
provides a degree of protection against secondary challenge infections in cattle.
Peripheral and local antibody is mainly directed against a series of proteins ranging
from 96-57.5 kDa in size and to particular bands in metacercarial preparations.
Although the main antibody response was IgGl dominated, the cellular response
showed a mixed cytokine pattern, suggesting an unrestricted T helper cell response.
Further investigation into the nature of immunoreactive bands identified, together
with examination of IgE antibody responses, will aid understanding of the naturally
occurring immune response during early infection.
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CHAPTER 1
GENERAL INTRODUCTION & LITERATURE REVIEW
1.1 General introduction
Fasciola hepatica, the common liver fluke, is an important trematode parasite
of mammals found in temperate and sub-tropical regions of the world. Distribution of
the parasite depends upon the presence or absence of the obligatory intermediate
host, snails of the Lymnaesidae family. The parasite is seen commonly in Western
Europe, particularly in areas with mild, damp climates favoured by the snail host. F.
hepatica is also widespread across much of Eastern Europe, Russia and associated
states, Asia, North and South America and Australasia (Torgerson and Claxton,
1998). Economically, the most important mammalian hosts are domestic ruminants,
mainly cattle and sheep. Prevalence rates in cattle in Britain have been estimated at
10% and in Ireland at up to 45% (Torgerson and Claxton, 1998). Fascioliasis
outbreaks have increased during the last few years in Scotland, and were particularly
bad during 1999 and in the first part of the year 2000 (SAC Veterinary Science
Division, 2000).
Infection can result in substantial animal morbidity and mortality, posing a
serious financial problem for both subsistence and commercial farmers alike.
Combined estimates of the worldwide cost of ruminant infections with F. hepatica,
F. gigantica (tropical liver fluke) and stomach flukes is approximately $3 billion per
year (Food and Agricultural Organisation of the United Nations, 1994). Economic
losses fall into three main categories: acute loss due to animal mortality; loss at the
abattoir, because of liver condemnation and finally, the less visible loss of poor
production. Chronic fascioliasis can reduce growth rates, feed conversion ratios
(Oakley et ai, 1979, Hope Cawdery et al., 1977) and wool production (Hawkins and
Morris, 1978).
In developing countries, poor animal productivity has a significant impact on
the income and subsequent well being of the farming population. In addition, more
direct effects on human health are seen in human cases of fascioliasis. Infection in
humans has been seen traditionally as a sporadic and atypical occurrence, however,
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the zoonotic potential of F. hepatica has recently become more evident (Chen and
Mott, 1990; Mas-Coma et al., 1999). Surveys of village populations in the
mountainous regions of Bolivia have demonstrated the magnitude of the problem,
recording infection prevalences of 23% (Bjorland et al., 1995), 27% (Esteban et al.,
1997) and 42% (Hillyer et al., 1992). Many of the infected individuals in these
surveys showed signs of acute liver disease. The World Health Organisation has now
recognised that F. hepatica is a serious zoonosis in certain regions of the world,
particularly in South America (WHO, 1995) and a new classification for the
epidemiology of fascioliasis in humans has recently been proposed (Mas-Coma et al.,
1999). The control of fascioliasis in domestic animals is therefore extremely
important from both a public health, as well as an economic, point of view.
Currently, the main method for controlling fascioliasis is by chemotherapy,
which eliminates the parasite from the ruminant host. Land management practices,
such as restricting grazing to snail free areas, are also employed where adequate
resources are available. However, both these methods are expensive and may require
repeated attention for effective control to be maintained throughout the year.
Consequently, interest in the development of a vaccine for fascioliasis has grown in
recent years. Several candidate fluke proteins have been isolated and used in vaccine
trials, with variable success (reviewed by Spithill and Dalton, 1998).
The development of effective vaccines against helminth parasites has been an
aim of researchers for many years. The discovery of efficacious vaccines protecting
against the cystic stages of the tapeworms Taenia ovis (Johnson et al., 1989) and
Echinocuccus granulosus (Lightowlers et al., 1996a; 1999) in sheep has at last
proven that the design of recombinant helminth vaccines is indeed possible. Much of
the research into helminth vaccines has been directed by the need to discover
protective vaccines against a variety of parasite diseases of humans, such as
schistosomiasis and onchocerciasis. A Fasciola vaccine would be of interest not only
because the parasite is of great economic importance to the farming community
across the world, but also due to its close relationship with the trematode parasite,
Schistosoma sp.. Antigens that may induce a protective response against Fasciola,
could have similar effects against Schistosoma. Studies with laboratory models have
demonstrated that a degree of cross-protection does occur between F. hepatica and
Schistosoma mansoni. Mice infected with one parasite show resistance to challenge
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with the other, and vice versa (reviewed by Hillyer, 1984). Vaccination ofmice with
a purified F. hepatica protein, now known as a fatty acid binding protein, induces a
degree of resistance to S. mansoni, S. bovis and F. hepatica infection (Hillyer, 1985;
Hillyer et al., 1988a; 1988b; Lopez Aban etal., 1999).
Ideally, vaccine design should be based upon a good understanding of the
natural immune processes occurring during the various phases of infection.
Unfortunately, to date, comparatively few studies have investigated immune
responses during infection with F. hepatica in the main target hosts, sheep and cattle.
The work described in this thesis investigates immune responses occurring
during F. hepatica infection in the natural bovine host.
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1.2 Literature Review
1.2.1 The lifecycle of F. hepatica
The discovery of the lifecycle of F. hepatica has formally been attributed to
two scientists working towards the end of the nineteenth century, Thomas and
Leuckart (reviewed by Andrews, 1988). The parasite has an indirect lifecycle
involving a snail intermediate host, within which asexual reproduction occurs and a
mammalian definitive host, the site of sexual reproduction (Figure 1.1).
Metacercarial cysts released by infected snails are ingested by mammals via
contaminated vegetation. Within the mammalian intestine they excyst and as newly
excysted juveniles penetrate the intestinal wall and migrate across the peritoneal
cavity to the liver, a process that can take as little as 48 hours to complete (Hayes,
1978). The juvenile flukes then migrate through the parenchyma of the liver over a
period of weeks, causing gross destruction of parenchymal cells and blood vessels,
until they eventually enter the bile ducts, where they reside as adults. The time from
ingestion to patency varies between different host species, but on average ranges
from eight to ten weeks in sheep and cattle (Boray, 1969). Fluke eggs produced by
the adults in the bile ducts are expelled into the gut with bile. They are then voided
with the faeces onto pasture-land.
Ambient temperature, moisture and oxygen tension levels all effect the
embryonation process within the fluke egg, (Andrews, 1988). When climatic
conditions are optimal, i.e. moist and warm (a minimum temperature of 10°C is
required for egg development), and in response to appropriate stimuli, particularly
light, the eggs hatch to release miracidia. The motile miracidia swim off in surface
films of water to find and penetrate the tissues of the snail host. Within the snail the
miracidia develop into sporocysts. Asexual multiplication occurs within the
sporocyst, with germinal cells forming many rediae. When these are mature the
sporocyst bursts, releasing the rediae which become cercariae. The cercariae are
subsequently shed from the snail into water and after finding a suitable site on
vegetation, they encyst, lose their tails and become metacercariae.
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Figure1.1:LifecyclofFas iolahepati
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1.2.2 Clinical disease in the ruminant host
The form of disease seen in an animal varies according to several factors,
including the host species, ingested metacercarial dose and current health status of
the animal (Boray, 1969). A spectrum of disease is seen ranging from a peracute
syndrome, with sudden death, to acute or chronic disease (Boray, 1969; Behm and
Sangster, 1998). Acute disease is seen more commonly in sheep and young calves,
which appear to be more susceptible to the effects of infection, perhaps due to their
small size. In the acute form, gross haemorrhage and acute liver failure are seen,
caused by the massive structural damage inflicted on blood vessels and the liver
parenchyma by migrating juveniles. Unless treated, the effects of circulatory collapse
and acute haemorrhagic anaemia often result in death. In comparison, chronic
fascioliasis is typified by lethargy, ascites and subcutaneous oedema and a low
liveweight gain. The symptoms of chronic disease are a result of impaired liver
function, hypoalbuminaemia and a low grade anaemia. In the subclinical form of the
disease, whilst no overt clinical signs are evident, reduced production may be noted
(section 1.1).
1.2.3 The control of fascioliasis
The efficient control of fascioliasis requires a multifactorial approach, aimed
at terminating infections in the ruminant host, reducing snail populations on pasture-
land and restricting grazing access of animals to contaminated areas and are
discussed below.
1.2.3.1 Elimination from the mammalian host
There are several drugs available which are effective at terminating fluke
infections in cattle and sheep. Some, such as nitroxynil and closantel, are only
effective against late juvenile and mature fluke stages, whilst others such as
albendazole, only kill the adult fluke (McKellar and Kinabo, 1991). However, one
drug is effective against very early juvenile and adult stages of the parasite,
triclabendazole (Boray et al., 1983; Richards et al., 1990). Triclabendazole is
preferred where there is significant risk of acute disease, because it can kill the early
migrating juvenile flukes, preventing liver damage. It is also useful in the treatment
of herds and flocks where individual animals may harbour differing ages of the
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parasite. Drug treatment only removes the current infection and except by possibly
reducing transmission levels, does not prevent re-infection. Where infective
metacercariae are present on pasture for several months, frequent dosing throughout
the grazing season may be required. Chemotherapy is therefore not the ideal means of
control, being expensive, manpower intensive and requiring constant access to
supplies of the drug. Additionally, the development of F. hepatica resistance to
triclabendazole has recently been reported in both Australia (Overend and Bowen,
1995) and the United Kingdom (Mitchell et al., 1998; Thomas et al., 2000).
Although triclabendazole resistance is not yet a widespread phenomenon, it is a cause
for concern and is further evidence for the need to develop alternative methods of
fascioliasis control.
1.2.3.2 Snail control
One of the most obvious targets for control is elimination of the snail
intermediate host. Chemical treatment of land with molluscides has been tried over
the years, but there are many problems associated with this approach (Wilson et al.,
1982). Molluscides must be applied on a regular basis for any consistent benefit to be
obtained, at least once annually, as snails can repopulate the cleared area rapidly. The
chemicals used are toxic and so concern over pollution and hazards to wildlife and
humans means this method is not desirable. Another method of control is drainage
(Roberts and Suhardono, 1996). The snail species involved in transmission live in
wet, mild habitats and are not found in well drained, dry areas. However, drainage
may not be beneficial for the local environment, and often acts in opposition to farm
irrigation schemes. On a smaller scale, antagonistic trematode schemes have been
tried. The snail can play host not only to F. hepatica, but also to other trematodes and
when infected with one species, it cannot host another (Lie et al., 1966). However,
such biological methods of control have not been successful when attempted on a
larger scale (Boray, 1969).
1.2.3.3 Grazing management
If the snail population cannot be removed, reducing exposure of stock to
snails should be attempted by restricting grazing to safe "snail free" areas. Fencing
off wet areas and ditches is simple and cost-effective, but if grazing land is scarce
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and much of it is suitable habitat for the snail, then this is not possible.
1.2.3.4 The use ofpredictive models in control
Various predictive models have been developed to aid in the control of
fascioliasis. These are based on climatic conditions, specifically rainfall, but
sometimes temperature and provide a measure of the risk of fascioliasis for the
following year (Ollerenshaw and Rowlands, 1959; reviewed by Torgerson and
Claxton, 1998). More advanced models include data on liver condemnation rates
from abattoirs, as well as climatic conditions and are more accurate (Goodall et al.,
1993). Sophisticated models, using geographical information systems (GIS), can
include data on soil type, hydrology, vegetation and climate (Malone et al., 1998).
The forecasting of the risk of fascioliasis, aids farmers in their decisions regarding
dosing and grazing strategies. Previously, these models were really only of value to
farmers in Western countries, where centralised veterinary support and finances
allowed their implementation. However, GIS models have been developed to predict
the risk of fascioliasis and in the design of chemotherapy strategies in Ethiopia
(Malone et al., 1998). With international support, there is potential for the use of
such models in the control of fascioliasis in developing countries.
In summary, the current methods of fascioliasis control are expensive, time
consuming and require considerable management. Immunological control in the form
of a vaccine on the other hand, could be a more efficient, simple and cost-effective
means of reducing disease.
1.2.4 Vaccine development strategies
In order to design an effective vaccine, the type and nature of the immune
response in the host to infection must be investigated. Several questions need to be
addressed before any significant progress can be made.
• Is there any evidence for the development of immunity during natural infections
in the field? Are infected animals able to rid themselves of infection and if so,
remain resistant to re-infection? If animals are not able to effectively eliminate
parasites and are not resistant to re-infection, how does the parasite evade the
hosts immune effector mechanisms? Knowledge of any such evasion tactics may
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allow the development of agents which can artificially inhibit or manipulate
evasion mechanisms to allow a suitable host-protective response to occur.
• Have cellular and humoral immune responses been investigated longitudinally
during the course of primary and secondary infections? This would give a picture
of the changing nature of any immune response during the different lifecycle
stages of the parasite within the host. The type of immune response occurring is
also important and so the contribution of humoral, cellular and accessory cell
components needs to be investigated.
• What stage of the parasite is potentially able to stimulate the most protective
response and where could this act? From the point of view of the host, killing a
small invading fluke is easier than killing a much larger adult. Removing the
flukes before they have caused significant structural damage to the liver would
also seem most logical. A vaccine that worked by stimulating responses against
the adult fluke stages only, would still result in the host being subjected to
considerable pathology. Whereas, if juveniles migrating through the gut and
peritoneum were targeted, elimination without any damage to the host could be
effected.
• The fluke parasite is composed of many thousands of proteins, some involved
with metabolism, others having structural roles. Have any of these antigens been
identified and how does the host respond to these antigens? Targeting an immune
response against proteins that are critical to the survival of the fluke, either for
general metabolic processes or for maintaining structural integrity, could result in
damage or death to the fluke.
• If any putatively protective responses are identified, how best could these be
harnessed to produce a suitable vaccine?
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1.2.5 The course of primary and secondary infections in different mammalian
hosts
Mammalian species exhibit varying degrees of susceptibility to disease and
resistance to re-infection. The majority of current knowledge concerning the nature of
fluke infection in the mammal has been derived from examination of the clinical and
pathological effects of infection in the two main economically important hosts, cattle
and sheep. This has been furthered by the use of experimental systems with
laboratory animals, particularly the rat.
1.2.5.1 Infections in sheep and cattle
Sheep and cattle show differing responses to infection with F. hepatica.
Sheep appear to be particularly susceptible to acute and chronic disease, especially
after heavy dose infections (Boray, 1969; Behm and Sangster, 1998). In comparison,
sheep that do not succumb to acute disease can remain chronically infected with a
primary infection for years (H. Urquhart, personal communication). Sheep show no
resistance, in terms of fluke burden, to secondary challenge infections, regardless of
dose or the interval between the primary and challenge infections (Sinclair, 1970;
1971; Haroun and Hillyer, 1986). However, flukes recovered from secondary
infections in sheep do show evidence of a temporary retardation in development.
Cattle are more resistant to fascioliasis than sheep. Experimentally, adult
flukes are lost from the bile ducts of cattle from 20-30 weeks after infection and
subsequently cattle show a degree of resistance to re-infection (Boray 1969; Doyle,
1971, Doyle, 1972). The timing of challenge appears critical: challenging animals
within 7 weeks of the primary infection does not result in resistance, whereas
challenge after 12 weeks does (Doyle, 1973). This suggests that the development of
resistance requires exposure of the host to the adult stage in the bile ducts. However,
mature, chronically infected cattle have been found in the field situation, suggesting
that during natural infections, cattle retain a degree of susceptibility to infection
(Clery et al., 1996). This could be due to the ingestion of smaller numbers of
metacercariae over a prolonged period.
Sheep and cattle could therefore be considered as representing two distinct
types or models of the disease, the susceptible and partially-resistant states,
respectively. Identifying the differences in the immune response between these two
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species and the reasons for such disparate reactions is important. If resistance in
cattle is partially determined by acquired immunological factors, the differences
between the two species may highlight the factors responsible for such resistance.
The gross pathology seen in chronically infected sheep and cattle also differs.
Cirrhosis and fibrosis of the liver parenchyma and bile ducts occur in both species,
but in cattle, unlike sheep, bile duct calcification is also seen (Dow et al., 1967,
Sinclair, 1971; Sinclair, 1973). It has been suggested that this calcification and other
fibrotic changes of the bile ducts is the reason for the partial resistance seen in cattle,
perhaps because it may physically impair fluke feeding (Boray, 1969). Goats, which
show similar pathology to sheep, and cattle also respond differently to direct
transplantation of adult flukes into the bile ducts (Hughes, 1987). In cattle, if the
ducts have been calcified, infections do not "take", whereas where the ducts show
less pathology, infection is always successful. However, it is unlikely that
calcification or physical impairment are the only factors involved in the partial
resistance seen in cattle.
The transfer of lymphoid cells between donor and naive calves has been
found to protect against challenge infection, provided the donor has been infected for
a minimum of eight weeks (Corba et al., 1971). Serum from infected cattle is also
able to protect against challenge infection in the rat (Haroun et al., 1981). These
observations suggest immunological factors are involved in resistance.
1.2.5.2 Infections in the rat
The rat, which has been used widely as an experimental model for
fascioliasis, shows a very different response to infection. Rats are susceptible to
primary infection but fully resist secondary challenge, although the primary infection
flukes remain unharmed (Hayes et al., 1973; Hayes et al., 1974a). Even minimal
primary infections prevent super-infection or challenge. No liver calcification is seen
and the contribution of physical components appears to be insignificant. Resistance
can also be transferred from infected donor rats to those that are nai've, using either
serum or lymphoid cell preparations (Hayes et al., 1974b; Hayes et al., 1974c; Corba
et al., 1971; Chapman and Mitchell, 1982a; Armour and Dargie, 1974; Rajasekariah
and Howell, 1979). Rat strain, dosages and timing of transfers in relation to both
donor and recipient primary and challenge infections are important in determining the
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outcome of infection.
Resistance in the rat therefore appears to be due, at least in part, to an
acquired immunological response. However, the possible incompatibility of the
parasite with an unnatural host may also be an important factor. The fact that the rat
is only a model must always be borne in mind when extrapolating results from the
known situation in the rat to that in the ruminant host.
1.2.6 Evasion of the immune response
Juvenile flukes migrate through the body cavity and liver for several weeks
before reaching the bile ducts. During this time they are in constant association with
host cells and blood. How is it, therefore, that they survive intact, apparently
unharmed by the immune defence mechanisms of the host? Several possible
mechanisms by which they may avoid recognition and elimination by the immune
system have been proposed.
1.2.6.1 Location ofadultflukes
The bile ducts, traditionally considered as being relatively inaccessible to
immune effector cells, may act as privileged sites. This would allow long term
survival of adult flukes without any risk from host damage. In rats, primary infection
flukes present in the bile ducts are not affected by host responses which prevent the
establishment of a secondary challenge infection (Hayes et al., 1973; Goose and
MacGregor, 1973). However, both cattle and rats eventually lose flukes from the bile
ducts (Hughes et al., 1976; Doyle, 1971), although sheep and goats do not. Is this
loss a natural physical process, perhaps nutritional, or are the flukes actively
removed? No firm evidence indicates which is the case.
1.2.6.2 Juvenile surface coat
Migrating juvenile flukes possess an outer glycocalyx coating (Hanna, 1980a)
which stimulates a strong antibody response (Hanna, 1980b; Duffus and Franks,
1981). In vitro studies have shown that immunoglobulin is able to adhere to the
glycocalyx, but after a period of time both antibody and glycocalyx are sloughed off
as a complex from the fluke surface (Hanna, 1980a; Duffus and Franks, 1981;
Burden et al., 1982). The sloughed glycocalyx is then replaced with one of similar
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antigenicity. Sloughing of this glycocalyx occurs both in vitro and in vivo and does
not require the presence of host antibody (Lammas and Duffus, 1983). Glycocalyx
turnover in this manner appears to be a natural process in the juvenile fluke and may
therefore act to prevent close association of host effector cells, such as eosinophils or
neutrophils, with the fluke surface, by removing opsonising antibody.
1.2.6.3 Cleavage of immunoglobulins
In vitro, flukes produce proteins termed excretory-secretory (ES) products.
These contain proteases that are able to cleave the immunoglobulin heavy chain in
the hinge region (Chapman and Mitchell, 1982b). Therefore, in addition to sloughing
the glycocalyx, flukes can potentially prevent opsonisation by antibodies and the
binding of host cells to their surface by cleaving immunoglobulin (Carmona et al.,
1993). However, immunoglobulin cleavage has not been demonstrated in vivo and
whether such activity is a prime function of the proteases within the host is not
known.
1.2.6.4 Can host effector cells damageflukes?
Eosinophilia has long been associated with helminth infections, although the
role of eosinophils in host protection is not clear. In vitro, several studies have
demonstrated the ability of eosinophils to damage juvenile and larval helminths in
the presence of specific antibody, notably with S. mansoni (Veith and Butterworth
1983; Butterworth, 1984) and Haemonchus contortus (Rainbird et al., 1998).
Electron microscope studies have shown that in vitro and in the presence of sera from
infected animals, eosinophils are able to bind to juvenile flukes and degranulate,
resulting in vacuolation of the fluke tegument (Glauert et al., 1985). After a period of
time, these cells and any bound antibody are subsequently shed along with the
secreted outer glycocalyx of the fluke, before the fluke can be destroyed by host cell
products. Major basic protein, isolated from eosinophils, is able to cause direct
damage to the tegument of juvenile flukes, upon co-culture (Duffus et al., 1980).
Demonstrating that host cells can kill or damage flukes, in vivo, is not as
simple and most evidence is circumstantial. Newly excysted juveniles, injected into
the peritoneum of sensitised rats and then recovered after a period of time, were
found to be coated in peritoneal cells, mainly eosinophils, but also macrophages and
13
neutrophils. The eosinophils appeared to adhere, degranulate and destroy the
tegument of the fluke, resulting in fluke death. (Davies and Goose, 1981). Adult
flukes implanted into the peritoneal cavity also experience similar damage (Bennett
et al., 1980). Further evidence for a protective role for eosinophils in Fasciola
infections in the rat has been obtained using an ex vivo gut-loop model, in which
protection against re-infection correlated positively with both local gut mucosal and
peripheral eosinophil levels (van Milligen et al., 1999).
Epidemiological studies investigating resistance to reinfection with
schistosomiasis in humans after chemotherapy, have also demonstrated the
importance of eosinophils during infection, with high peripheral eosinophil counts
being significantly associated with resistance to reinfection with both S.
haematobium (Hagan et al., 1987) and S. mansoni (Sturrock et al., 1983). However, a
further study found no association between eosinophilia and resistance, and it was
postulated that the functional activation state of the eosinophil may be more
significant that actual peripheral levels (Butterworth et al., 1985).
The importance of IL5-dependent eosinophil responses in protection against
infection has also been demonstrated for certain parasites in vivo by the ablation of
IL5 using anti-IL5 antibodies in mice, for example with Onchocerca lienalis (Folkard
et al., 1996) and Strongyloses ratti (Ovington and Behm, 1997). However, the
development of many other parasites, including S. mansoni, was unaffected by such
treatments (reviewed by Behm and Ovington, 2000). The role of eosinophils in
transgenic mice designed to overexpress IL5 has also been studied, again with
variable outcome: eosinophilia had no effect on the development of some parasites,
but with others burdens were decreased, whilst with S. mansoni burdens were
increased. F. hepatica infections are not affected in mice genetically deficient for IL5
(Ovington and Behm, 1998). The significance of these results with regard to natural
host-parasite systems is not clear: mice and humans react differently to infection, for
example, with S. mansoni infection (Brunet et al., 1998) and it may be that innate
immune responses, stimulated by the non-specific inflammation induced by the
parasite in the unnatural host, may alter the course and outcome of infection
(Meeusen and Balic, 2000).
Host macrophages are also able to damage or kill helminths in vitro.
Macrophage killing of schistosomula has been demonstrated in the presence of rat
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immune sera containing IgE, but not other antibody isotypes (reviewed by Capron et
al., 1982). Rat peritoneal cells from F. hepatica infected rats kill newly excysted
juvenile flukes in vitro when incubated with sera from infected animals (Spithill et
al., 1997). Killing efficacy correlated with the concentration of nitric oxide measured
in the vicinity of the fluke. Macrophage killing of filarial worms by the production of
nitric oxide has also been demonstrated with the filarial nematode parasites Brugia
malayi and Onchocerca lienalis (Taylor et al., 1996; Thomas et al., 1997).
From these studies it appears that host effector cells are able to damage
trematode parasites in vitro, including F. hepatica. If such cells are not removed from
the fluke surface, for example by glycocalyx shedding, then the toxic products that
they release, such as major basic protein and reactive oxygen species, may be
involved in parasite killing.
1.2.6.5 Speed ofmigration
During secondary challenge infections in sheep it has been observed that
fluke migration across the body cavity and liver to the bile ducts may be quicker than
during the primary infection (Meeusen et al., 1995). Although a good cellular
response to the secondary challenge infection was observed in the parenchyma, the
flukes left it behind. Empty fluke tracts were surrounded by inflammatory cells,
whilst flukes remained relatively clear of host cells. It is possible, therefore, that the
speed of migration may be too great for immune effector cells to efficiently bina the
flukes. A similar situation has also been seen in mice (Lang, 1967), but other studies
in sheep have been contradictory (Sinclair, 1970; 1971; 1973). This theory therefore
remains unproven.
1.2.6.6 Modulation ofhost effector cellfunction
Fluke products may also be able to modulate the activity of host effector cells
by reducing the activity of specifically-stimulated cells, such as lymphocytes, or of
general inflammatory cells. In vitro studies have shown that F. hepatica ES products
can modify host immune cell function. ES products can act as chemokines for normal
sheep and human neutrophils (Jefferies et al., 1996a) and are able to alter the
neutrophil metabolic burst in response to mitogen stimulation (Jefferies et al., 1997).
Sheep peripheral blood mononuclear cell responses to mitogens are also affected,
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being enhanced at low concentrations, but suppressed at higher concentrations upon
co-culture with ES (Jefferies et al., 1996b). ES products also suppress the rat spleen
cell response to the mitogen Con A in a dose-dependent manner (Cervi and Masih,
1997), whilst free radical generation and phagocytosis by naive bovine peripheral
blood mononuclear cells have been inhibited by co-culture with ES (Baeza et al.,
1993).
1.2.7 Site of resistance to challenge
Where does resistance to secondary challenge infections occur? This is an
essential question to address as the answer may indicate which fluke stage induces a
protective response and the antigens and immune mechanisms involved. In rats, fluke
burdens during early infection can be assessed by collecting flukes from livers and by
peritoneal washout techniques. Doy et al. (1978), found that after oral challenge with
F. hepatica, a significant reduction in the number of flukes recovered 48 hours later
was seen in sensitised compared to control rats. Resistance occurring so early may
therefore have been acting at the level of the gut or peritoneum. This idea was
supported by the appearance of gut tissue: the lamina propria of challenged sensitised
rats showed an increase in the number of eosinophils when compared to that of
control rats. Other studies using similar techniques saw resistance to challenge as
early as 24 hours post-challenge and concluded that immunity was effected either in
the gut lumen, gut wall or peritoneal wall (Hayes et al., 1977; Hayes, 1978). The
small intestinal mucosa of these rats was inflamed and hyperaemic, suggesting that a
strong reaction in this site of some sort had occurred. Furthermore, treatment with the
anti-inflammatory and immunosuppressive agent dexamethasone, removed the
protective effect. Dexamethasone treatment also results in higher fluke burdens in
singly infected rats (Baeza and Poitou, 1994).
Intraperitoneal implantation of newly excysted juveniles allows the gut stage
to be circumvented. In one such study, resistance was seen only in rats that received
oral challenge infections (Rajasekariah et al., 1977), although other evidence does
suggest that implanted juveniles can be killed in the peritoneal cavity (Doy et al.,
1982). Resistance in rats can be seen at the gut or peritoneal levels. Is this a specific
or non-specific effect? Athymic nude sensitised rats are equally resistant to oral
challenge as their heterozygous counterparts, but resistance is not seen when they are
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challenged intraperitoneally (Doy et al., 1982). Thus in rats, two distinct mechanisms
may be responsible for resistance to challenge infections, the first a gut level T cell
independent process, possibly eosinophilic and the second, a T cell dependent
process acting in the peritoneal cavity or at the liver capsule.
Rats demonstrate more complete resistance to challenge infections than cattle
or sheep. Is there any evidence for a similar mechanism of resistance in ruminants?
Only one study has been performed in cattle to investigate the site of resistance to re¬
infection, using a peritoneal wash-out technique (Doy et al., 1984). No reduction in
worm burden was found in sensitised calves at either 4 or 14 days after oral challenge
when compared to nai've animals, suggesting gut immunity was not significant.
Unfortunately, further exploration of this area has not been carried out.
1.2.8 Stage specific antigen expression
Surface expressed antigens alter in nature as the fluke migrates within the
host and matures. Cells within the tegument produce vesicles containing proteins that
are discharged onto the fluke surface to form the glycocalyx (Hanna, 1980b). The cell
types present and the granules they produce change as the fluke matures, with TO
cells and vesicles present in the newly excysted juvenile, T1 during liver migration
and T2 vesicles present, but not discharging onto the fluke surface until around the
time of entry into the bile ducts (Bennett and Threadgold, 1975; Hanna, 1980b;
Burden et al., 1983). Changes in expression of other surface glycoproteins have been
noted, particularly during the first 14 days of infection (Lammas and Duffus, 1985;
Dalton and Joyce, 1987). Differential expression of somatic and excretory-secretory
proteins has also been demonstrated in flukes of different ages (Dalton et al., 1985;
Tkalcevic et al., 1996; Oblitas, 1997).
Stage specific expression of antigens does occur and appears to be most
marked during the first few days of infection. The most obvious explanations for
changing antigen expression include the need for adaptation of the different fluke
stages to the different host environments they encounter as they migrate, together
with the possibility that antigen patterns change to aid immune evasion.
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1.2.9 Host immune responses to infection
1.2.9.1 T helper cells and cytokine production
Three populations of T lymphocyte have been defined in cattle, according to
cellular phenotype. CD4+ and CD8+ T cells, which express the ap T cell receptor,
recognise antigen in conjunction with MHC class II or I, respectively (Howard and
Morrison, 1994). CD4+ cells generate "help" for the immune response, whilst CD8+
cells have cytotoxic actions on host-infected or neoplastic cells. The third population
have a T cell receptor composed of y8 subunits and are thus termed y5+ T cells.
CD4+ T cells were originally classified in the murine system into T helper 1
(Thl) and T helper 2 (Th2) subsets by Mosmann et al. (1986). This distinction was
made on a functional basis according to the nature of cytokine production seen after
cell stimulation. The cytokines IFN-y, IL2 and TNFp were associated with the Thl
subset and IL4, IL5 and IL6 with the Th2 subset (Cherwinski et al., 1987). Thl cells
can induce a delayed type hypersensitivity response (Cher and Mosmann, 1987) and
are associated with cell mediated immunity, whilst Th2 cells provide help for
antibody production by B cells. However, Thl cells are also able to stimulate
antibody production, mainly that of the IgG2a isotype (Coffman et al., 1988, Stevens
et al., 1988). Both subsets also respond preferentially to different antigen presenting
cells, with macrophages stimulating Thl and B cells Th2 subsets (Gajewski et al.,
1991). Antibody production in response to Th2 help is mainly of the IgGl and IgE
isotypes, those typically seen in helminth infections.
Initially, T helper cells were viewed as belonging to one or other of these two
exclusive states, which appeared to reciprocally regulate one another. Further study
of Th subsets in the murine system and particularly in relation to Leishmania
infection, reinforced the idea of the polarised response and linked this with infection
outcome. With L. major infection in humans (Ajdary et al., 2000) and mice
(reviewed by Liew and O'Donnell, 1995), the Thl response is beneficial, resulting in
cure and resistance to challenge infections, whilst Th2 driven responses result in
pathology and disease exacerbation. Another example of a similar classification was
seen with murine Schistosoma mansoni infection. Studies suggested the presence of a
deleterious Th2 response leading to pathology, whilst an irradiated cercariae vaccine
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was found to induce a protective Thl response (reviewed by Coulson, 1997). More
recently, research has suggested that it is the balance of cytokines, rather than a
defined Thl/Th2 class of response, that is important in maintaining host resistance to
infection. Even in murine schistosomiasis, Th2 cytokines such as IL4 have some
beneficial effects and are necessary for host survival (Brunet et al., 1997; 1998).
In human schistosomiasis, field studies suggested that the opposite T helper
cell bias to that seen in the mouse was associated with resistance to infection. IgE and
IgGl antibody responses were found to correlate with protection (Hagan et al., 1991;
Rihet et al., 1991; Dunne et al., 1992; Demeure et al., 1993) and cellular cytokine
production also supported the importance of an IL4/IL5 type response (Roberts et al.,
1993; Couissinier and Dessein, 1995). A study investigating resistance to S. mansoni
in a Brazilian population has also identified the presence of a resistance gene for S.
mansoni which maps to chromosome 5, in close association with the genes encoding
the IL4 and IL5 cytokines (Marquet et al., 1996). These differences between infection
in the mouse model and the human highlight the necessity for caution when
extrapolating results between species.
Bovine T helper lymphocytes do not appear to segregate strictly into the
Thl/Th2 classification system. T cell clones obtained from cattle infected with the
parasites Babesia bovis, B. bigemina or F. hepatica showed an unrestricted cytokine
profile after stimulation with specific antigen or mitogen, in many cases co-
expressing IL4 and IFN-y (Brown et al., 1993; Brown et al., 1994a). Additionally
IL10, which is produced by Th2 cells in the mouse model and acts to downregulate
the Thl response, is produced by bovine T cells expressing IFN-y and IL4 and is able
to regulate proliferation and IFN-y production in all Th cell types (Brown et al.,
1994b; Chitko-McKown et al., 1995). Thus a spectrum of cytokine production, from
a ThO (unrestricted) phenotype, through to a bias towards the Thl/Th2 extremes is
seen in cattle. This is similar to the situation seen commonly in humans and with
some murine cell clones (Kelso et al., 1991; Kelso, 1995).
Attempts to 'pigeon-hole' immune responses in cattle, particularly those to
complex pathogens such as helminth parasites, do not help our understanding of the
host immune response to infection.
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1.2.9.2 Bovine immunoglobulin isotypes
Genes encoding bovine IgGl, IgG2 (of which two allotypes, A1 and A2
exist), IgG3 (originally termed IgG2b), IgA, IgM and IgE have been cloned (Knight
and Becker, 1987; Knight et al., 1988). B cell proliferation and immunoglobulin
production is stimulated by IL2 (Collins and Oldham, 1995). IL4 also stimulates B
cell activity and preferentially stimulates the production of IgGl and IgE isotypes,
whilst the classical Thl cytokine, IFN-y, regulates the production of IgG2 (Estes et
al., 1994; 1995; Estes, 1996).
1.2.9.3 Immune responses to F. hepatica in the rat
Although several fluke antigens have now been isolated and cloned very little
is known about the immune response that occurs in the ruminant host during
infection and whether it is beneficial, limiting damage, or tolerant, possibly
exacerbating infection. More is known regarding immune responses occurring in the
rat model, where animals exposed to a primary infection are able to completely
eliminate further challenges.
Keegan et al. (1992), found that during a primary infection, IgG antibodies to
whole fluke antigen appear early, within 7 days of infection and peaked within 3
weeks. No significant correlation was noted between antibody titre and the number of
flukes recovered at post-mortem during the primary infection, suggesting that the
measured antibody response was non-protective. Rats were resistant to secondary
challenge, but whether this was related to the action of antibody was not clear,
although the antibody response to challenge was rapid, peaking within 5 days.
Antibody was directed against juvenile tegumental and gut cell antigens and adult
gut, reproductive and excretory cell antigens. A circulating eosinophilia was seen
throughout infection and large numbers of neutrophils, macrophages, lymphocytes
and eosinophils were noted in liver sections surrounding flukes and fluke tracts.
Another study confirmed the early appearance of specific antibody to ES
proteins (Poitou et al., 1992). IgGl, IgG2a, IgM and IgE antibody isotypes were all
detected, but showed differing time-course response profiles throughout the infection
period (Poitou et al., 1993). IgM antibody was found throughout infection, not just
during the first few days, possibly suggesting the continual sequential release of new
antigens throughout fluke development. A total of eight protein fractions ranging in
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size from 115 to 22.5 kDa were recognised by antibody (Poitou et al., 1992).
Peripheral eosinophil and neutrophil numbers increased during infection and in the
spleen the proportion of B cells increased, whilst that of CD4+ and CD8+ T cells
decreased. Spleen cell proliferation was seen in response to both mitogen and antigen
stimulation, but thymic and peripheral blood mononuclear cells were unresponsive to
fluke antigen (Poitou et al., 1993).
Are the events noted in the periphery reflective of the responses occurring at
the actual sites of infection? Monoclonal antibodies derived from antibody producing
cells of hepatic, splenic and mesenteric lymph nodes of infected rats have been used
to examine the local immune response to fluke infection (Meeusen and Brandon,
1994). In chronic primary infections, only hepatic lymph nodes produce parasite
specific antibodies, whereas during secondary challenge mesenteric lymph nodes
produce antibodies specific to newly excysted juvenile proteins. By comparing
responses after oral and intraperitoneal challenge, protection against secondary
challenge was found to occur at both the gut and peritoneal levels. Circulating
antibody profiles did not always reflect the tissue specific responses seen, suggesting
that these may not be a reliable indicator of the immune responses actually occurring
at the site of infection. Results from a separate study, using the same monoclonal
antibodies to examine stage specific antigen expression and immunity, supported the
idea that immature flukes stimulate a more effective protective immune response
than adult flukes (Tkalcevic et al., 1996).
Recently, closer examination of the gut response to secondary challenge has
shown that resistance to re-infection is significantly correlated with tissue levels of
IgE, IgGl and the presence of eosinophils (van Milligen et al., 1998a). An ex vivo gut
loop model allowed the gut response to be examined during penetration (van
Milligen et al., 1998b). Juvenile flukes that penetrated the gut wall in sensitised rats
were covered in IgGl and IgG2a antibodies and eosinophils. Furthermore, serum
titres of IgGl antibody directed against newly excysted juvenile proteins were highly
correlated with protection (van Milligen et al., 1999). Thus, the same sort of response
that is seen during a primary infection, i.e. an IgGl, IgE, eosinophilic reaction, which
is not able to prevent primary invasion, is also noted during secondary challenge,
where it appears to be protective.
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1.2.9.4 Immune responses to F. hepatica in cattle and sheep
In both cattle and sheep, circulating antibodies to ES or somatic fluke
preparations are detected within 2 weeks of infection (Santiago and Hillyer, 1988;
Chauvin et al., 1995; Clery et al., 1996). IgGl appears to be the dominant IgG
antibody isotype in experimentally and naturally infected cattle (Clery et al., 1996;
Bossaert et al., 2000). Immune responses to the tegumental proteins present in the T1
and T2 vesicles have been examined in some detail in cattle. Serum IgG responses to
T1 and fluke gut antigens peak at 4-6 weeks post-infection, whilst that to T2 antigens
does not appear until week 6 (Hughes et al., 1981). IgG and IgA antibody to T1 and
gut antigens, but not to T2 antigens have also been detected in bile. Due to the lack of
an effective reagent for detecting bovine IgE, changes in parasite specific levels of
this antibody isotype have not been investigated.
Western blot analysis has been used to identify which proteins present in
crude fluke preparations are recognised by immune sera. Santiago and Hillyer (1988),
found that sheep and cattle recognised different somatic proteins. Cattle sera detected
a set of proteins of approximately 56, 64 and 69 kDa that were not present in sheep.
Both species recognised bands of 30-38 kDa, to which antibody appeared slightly
later than to the higher weight fractions recognised by cattle. Another study found
that the appearance of sheep antibody to certain ES proteins was time-dependent,
with that to bands of 69 and 51 kDa appearing within 3 weeks, whilst lower weight
bands of 20-30 kDa were not detected for a further two weeks (Chauvin et al., 1995).
Secondary challenge enhanced the response to the lower weight region only. A
similar change in the response pattern to different sized proteins has also been seen in
cattle (Itagaki et al., 1995).
The contribution of cell mediated immunity throughout infection is not easy
to assess. Peripheral blood lymphocyte responses to specific antigens or mitogens can
be investigated by lymphoproliferation and cytokine production assays. However, it
is important to realise that circulating lymphocyte reactions are not necessarily
reflective of those occurring locally. In cattle, specific lymphocyte proliferation in
response to whole fluke antigen is seen within 2-3 weeks of infection, but this effect
is transient and by 5-8 weeks cells become unresponsive (Oldham, 1985; Oldham
and Williams, 1985; McCole et al., 1999a). T cell sub-set depletion has shown that
both CD4+ and CD8+ T cells are responsible for the proliferation seen and y§+ T cells
22
do not appear to be involved (McCole et al., 1999b). Sheep peripheral blood
mononuclear cells also show a positive, but irregular proliferative response to fluke
proteins (Chauvin et al., 1995)
Cells extracted from the lymph nodes of cattle harbouring chronic primary
infections of Fasciola have been cloned (Brown et al., 1994a). These cloned cells
showed a spectrum of cytokine patterns in response to stimulation with adult fluke
extracts and mitogens. The majority of cells expressed IL2, IL4 and IFN-y cytokines
and were classified as ThO (unrestricted); some produced IL4 only and were
designated Th2 types. None were found to conform to the accepted murine Thl
pattern of IL2 and IFN-y production, with no IL4. It was suggested that this pattern of
cytokine production by the cells from infected cattle could indicate that a non-
protective Th2 like response dominated during chronic infection. However, as these
results were based on clones taken from just two animals at only one time-point
during infection, they should be interpreted with caution. IFN-y production has been
noted after stimulation of peripheral blood mononuclear cells from infected cattle
with fluke proteins (Clery and Mulcahy, 1998).
Histologically, macrophages, eosinophils, neutrophils and lymphocytes are
found in hepatic tissue during primary infections in sheep (Chauvin and Boulard,
1996). During secondary infection, the cellular reaction within the parenchyma
changes: the ratio of CD4+ to CD8+ cells increases and eosinophils are more
numerous than neutrophils, which predominate during primary infection (Meeusen et
al., 1995). B cell infiltrates were also greater in secondary infections.
In contrast to the situation in the rat, where the protective immune response
appears to be directed at gut penetrating fluke stages and is manifest by high levels of
IgGl, IgE and eosinophilia, immune responses in ruminants are very poorly
characterised. Cattle and sheep respond to infection by the early production of
antibody and peripheral lymphocytes are reactive to fluke proteins during the first
few weeks of infection, mainly throughout the migratory process. However, no
association has been noted between antibody levels and fluke burden and there is no
clear understanding of which responses may be beneficial to the host, which are
merely markers of infection and which may be detrimental, helping to prolong
infection.
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1.2.9.5 Genetic influence on susceptibility to infection
Studies with F. gigantica, the tropical liver fluke, have found that sheep breed
affects the outcome of infection. Indonesian Thin Tail sheep are comparatively
resistant to infection in comparison to western breeds of sheep (Roberts et al., 1997a)
and this is thought to be due to the presence of a major gene which exhibits
incomplete dominance (Roberts et al., 1997b). Further studies have shown that whilst
both the resistant and susceptible breeds show similar levels of IgGl and IgE
antibody to fluke proteins, levels of IgG2 are significantly lower in the resistant breed
(Hansen et al., 1999). It has been suggested that IgG2 acts as a blocking antibody,
preventing IgGl or IgE from promoting a protective response. Thus, an IgGl, IgE,
eosinophilic response may be able to induce protection in Fasciola infection.
Unfortunately, no difference in susceptibility to F. hepatica infection was noted
between Indonesian Thin Tail sheep and other breeds (Roberts et al., 1997a). As
mentioned previously, IgGl appears to be the dominant antibody present in F.
hepatica chronically infected cattle. The implications of the discovery of resistance in
Indonesian Thin Tail sheep to F. gigantica for the understanding of resistance to F.
hepatica infection therefore remains unclear. Variation in susceptibility to F.
hepatica infection in sheep has been demonstrated between other exotic and domestic
breeds (Boyce et al., 1987), although differences in the immune response were not
investigated.
1.2.10 Characterisation of F. hepatica antigens
Several antigens have been purified and isolated from crude fluke
preparations. The biochemical nature and possible functional role of many of these
proteins have been explored. Some have also been tested as potential vaccines with
variable success.
1.2.10.1 Glutathione S-transferase (GST)
GST is a member of a multifunctional family involved with the metabolism
of xenobiotics and the binding and transport of anionic compounds (Brophy et al.,
1990). The presence of GST in flukes was first discovered by biochemical and
enzymatic studies (Howell et al., 1988). Multiple isoenzymes were found in adult
fluke somatic extract, the two main components having molecular weights of
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approximately 25kDa. Immunohistochemistry showed that GST is widespread
throughout the tissues of the fluke. Vaccination of rats with purified GST did not
protect against challenge, although high antibody titres to GST were seen (Howell et
al., 1988).
GST was first used empirically in vaccine trials in sheep following the
successful use of GST in protection against S. japonicum (Smith et al., 1986) and S.
mansoni (Balloul et al., 1987) in mice and rats. Vaccination with F. hepatica GST
reduced fluke burdens in sheep by up to 57% and serum biochemistry showed that
establishment of flukes in the bile ducts had also been delayed (Sexton et al., 1990).
A degree of protection in cattle has also been demonstrated, although the efficacy of
vaccination varied according to the vaccine adjuvant used (Morrison et al., 1996).
Protection was also found to be very variable between individual animals and did not
correlate with antibody titre. GST isolated from flukes has now been sequenced and
cloned (Muro et al., 1993). Some similarity is seen with the GST of S. mansoni and
S. japonicum.
1.2.10.2 Fatty acid binding proteins
Experimentally, a degree of cross-reactivity is seen between the immune
response to schistosomiasis and fascioliasis. Mice infected with F. hepatica are
resistant to challenge with S. mansoni and vice versa (Hillyer, 1985). The protein
fraction thought to be responsible for this effect was isolated from F. hepatica
somatic adult extracts and designated FhSMIII(M). Specific antisera raised against
this fraction detected common determinants in S. mansoni extracts (Hillyer, 1984).
Vaccination of mice with purified FhSMIII(M) was found to protect against
challenge with both F. hepatica and S. mansoni (Hillyer, 1985). Cattle have also
shown some resistance to challenge with F. hepatica after immunisation, with worm
burdens reduced by up to 55% (Hillyer et al., 1987).
The active component of FhSMIII(M) is a 12 kDa polypeptide. Vaccination
of mice with this purified protein, called nFhl2, protects against S. mansoni
challenge by up to 77% (Hillyer et al., 1988a). During experimental infections with
F. hepatica, cattle and mice develop anti-Fhl2 IgG antibodies within two weeks of
infection. This suggests that Fhl2 is expressed early during infection of the host by
juvenile fluke stages. Mice also develop anti-Fhl2 antibodies in S. mansoni
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infections, albeit at a lower level and not until seven weeks post infection (Hillyer et
al., 1988b). Cloning and sequencing of the gene encoding Fhl2 has demonstrated
that the protein shows similarity to SMI4, a schistosome fatty acid binding protein
(Rodriguez-Perez et al., 1992). Fatty acid binding proteins are essential for the
survival of trematodes as they are unable to synthesise their own long chain fatty
acids and must use those of their hosts. Unfortunately immunisation of rabbits with
the cloned recombinant protein, rFhl5, did not elicit good protection (Muro et al.,
1997).
1.2.10.3 Cysteine proteinases
The presence of secreted proteases in the ES products were first noted in
experiments examining the action of ES products on immunoglobulins. Mouse, rat,
rabbit and sheep immunoglobulin were partially degraded by ES products in a papain
like manner (Chapman and Mitchell, 1982b). This proteolysis was enhanced in the
presence of cysteine and inhibitor studies suggested thiol or cathepsin like proteases
were responsible. The presence of thiol proteases in ES products from juvenile and
adult flukes was later confirmed by gelatine gel analysis (Dalton and Heffernan,
1989).
Several groups have now isolated and cloned these cysteine proteinases
(McGinty et al., 1993; Heussler and Dobbelaere, 1994; Dowd et al., 1997; Smith et
al., 1993; Roche et al., 1997). They appear to exist as a multiple enzyme gene family
in the fluke genome, possibly as multiple copies within the genome (Heussler and
Dobbelaere, 1994). Five different cathepsin L-like and two different cathepsin B-like
proteinases have been cloned and sequenced in one study (Heussler and Dobbelaere,
1994), and another two cathepsin L-like in another, termed CL1 (Roche et al., 1997)
and CL2 (Dowd et al., 1997).
What is the function of cysteine proteinases in the fluke? One common
method of attacking helminth parasites in mammalian hosts is by antibody-dependent
cell mediated cytotoxicity, usually involving eosinophils. Studies have shown that
eosinophils are able to bind or associate with flukes, but are often quickly shed. In
vitro experiments have demonstrated that crude ES and purified cathepsin L-like
proteinases from different fluke stages are able to cleave immunoglobulin G and so
prevent attachment of eosinophils to newly excysted juveniles (Carmona et al.,
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1993). This is reversed in the presence of cysteine proteinase inhibitors. Are
antibodies directed against cathepsin proteinases able to neutralise this
immunoglobulin-cleaving activity? In vitro incubation of purified cathepsin L in the
presence of polyclonal anti-cathepsin L antisera is able to reverse cleavage and
allows eosinophils to bind to newly excysted juveniles (Smith et al., 1994).
Purified CL2 is able to cleave fibrinogen in a non-thrombin like manner,
producing fibrin clots (Dowd et al., 1995). This clot formation may act either to
prevent excessive host bleeding around feeding adults or to protect the migrating
juveniles, acting as a physical barrier against immune attack. Cathepsins are able to
digest host tissues. Crude ES and CL1 and CL2 are able to degrade collagen types III
and IV, fibronectin and laminin (Berasain et al., 1997). These substances are present
in the liver capsule and parenchyma of the mammalian host and so this degradative
activity may be important for juvenile migration.
These studies show that the cysteine proteinases of F. hepatica appear to have
several functions during infection of the mammalian host, including penetration,
migration and feeding; possibly immune evasion and clot formation.
The cathepsin proteinases also stimulate some protective effect against fluke
infection in the host. Purified CL1, CL2 and a haem-containing protein have been
used both separately and combined in a vaccination trial (Dalton et al., 1996):
immunisation protected nai've cattle against challenge by reducing parasite burden
from between 42.5% (CL1 alone) to 72.4% (CL2 combined with haemoglobin).
Fluke egg viability was also substantially reduced, suggesting a possible anti-
fecundity effect. No correlation was noted between the circulating IgG antibody titre
and the protection seen. In this first vaccination study, Freund's complete adjuvant
was used as the adjuvant for the primary inoculative dose. However, a further
investigation, using the CL2 and haem fractions as a combined vaccine administered
in Freund's incomplete adjuvant, found that no significant protective effect was
induced (Mulcahy et al., 1998). Vaccination of sheep with purified cysteine
proteinases does not induce significant protection against challenge infection,
although a reduction in parasite fecundity does occur (Wijffels et al., 1994).
1.2.10.4 High molecular weightfractions
Two proteins greater than 200 kDa in size have been isolated from F. hepatica
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ES: one is a haem-containing protein isolated from ES products. In non-reducing
SDS PAGE, this fraction migrates as two bands, at a level distinct from bovine
haemoglobin, of approximately 200 kDa (McGonigle and Dalton, 1995). Also,
specific antisera can be raised by inoculation which does not recognise bovine
haemoglobin, indicating that it is indeed a genuine fluke-derived protein. This haem-
protein is thought to have a role in oxygen metabolism in the immature fluke, which
respires aerobically as it migrates through host tissue (Tielens et al., 1982). As the
haem-protein was isolated from adult fluke proteins, and respiration in adult flukes is
predominantly anaerobic, it is also thought to be involved in other, oxygen dependent
activities in the adult, such as egg production (Tielens et al., 1984). The haem
fraction has been used in combination with cathepsin in vaccine trials, where it
stimulated a reasonable degree of protection against challenge infection in cattle
(Dalton et al., 1996).
The other high molecular weight protein is a dipeptidylpetidase, present in the
ES of newly excysted juvenile, liver stage and mature flukes (Carmona et al., 1994).
Specific antibody is only detected late during infection, despite the presence of the
enzyme in the early juvenile stages. Dipeptidylpetidase is probably involved in the
digestion of host molecules, supplying nutrients to the fluke.
1.2.10.5 Leucine aminopeptidase
A membrane bound protein, leucine aminopeptidase, has been partially
purified from adult flukes (Acosta et al., 1998). SDS PAGE gel electrophoresis has
shown the fraction to be composed of a major 67 kDa product, with minor products
migrating in the 30-40 kDa region. Immunohistochemistry has localised the enzyme
to the gastrodermis of the fluke; it does not appear to be secreted in ES.
Aminopeptidase activity has also been found in S. mansoni (Cesari, 1983; Xu and
Dresden, 1986). The enzyme is involved in the final stages of protein degradation
and is thus thought to play a nutritional role in the fluke. Antibody responses to this
fraction during natural infections have not been studied. The results of the only
vaccine study conducted to date are so far unconvincing, due to the death of trial
stock and extreme differences in fluke burdens between animals within the same
group (Piacenza et al., 1999).
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1.2.10.6Antioxidants
Antioxidants have been found in many parasite species and are thought to
protect against the potentially damaging effects of reactive oxygen species (ROS).
ROS may be produced as a by-product of the parasite's own metabolic processes or
by host effector cells attempting to damage and eliminate the parasite. Catalase, one
of the more common anti-oxidant enzymes, has not been detected or isolated from
the fluke (Pritchard and Schofield, 1971). Alternative mechanisms must therefore be
in place to deal with such metabolites. In recent years various molecules showing
antioxidant properties have been isolated from F.hepatica. Given their essential role
in maintaining cellular integrity, antioxidants are an obvious target for vaccine
design.
A 21 kDa protein has been identified by screening an expression library with
sera from cattle vaccinated with the haem-containing high molecular weight fraction
(section 1.2.10.4). The protein is a member of the peroxiredoxin family and is
thought to be involved with the breakdown of hydrogen peroxide (McGonigle et al.,
1997). A smaller, 12 kDa thioredoxin has been isolated from the tegument of mature
flukes. Although humoral responses to thioredoxin have not been studied, T cells
from infected cattle are poorly reactive on culture with thioredoxin and so it has not
been studied further (Shoda et al., 1999).
Cytochrome c peroxidase activity was detected in crude ES products two
decades ago. However, it was only recently that the enzyme was partially purified
from ES products and specific activity investigated (Campos et al., 1999). The
isolated fraction displayed a major protein of 31 kDa and minor bands which run
between 41 and 45 kDa on SDS PAGE gel electrophoresis. Another antioxidant,
superoxide dismutase, has been detected in membrane, somatic and ES preparations
of juvenile and adult flukes (Piacenza et al., 1998). Enzyme activity is found to be
highest in juvenile flukes, reducing as the flukes mature. This reduction in activity
could be a reflection of the changes in metabolism that occur as the flukes age, or, if
the enzyme is able to protect against host ROS, perhaps indicative of the greater
exposure ofjuvenile flukes to such host products.
Currently, there is a noticeable lack of information regarding the host immune
responses to these antioxidants during natural infections. These need to be examined
before attempts are made to vaccinate animals experimentally.
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1.2.10.7 Other proteins
Screening of adult F.hepatica cDNA libraries with specific anti-sera is now
being used to identify and characterise further immunogenic fluke proteins. A
calcium binding protein of approximately 22 kDa has been identified by this method
(Ruiz de Eguina et al., 1999), as well as a protein belonging to the NK lysin family
(Reed et al., 2000). The latter is found particularly in immature, but not newly
excysted juvenile flukes and runs at 6-8 kDa on SDS PAGE gels. Further work needs
to be done to investigate the possible functions and immune responses to these newly
identified molecules.
Vaccine trials have been carried out with two other isolated fluke proteins.
Paramyosin, a sub-tegumental protein of approximately 94 kDa, has been used to
vaccinate sheep and cattle (Spithill et al., 1998). However, it was not protective in
sheep and conflicting results were obtained in two cattle trials. Another molecule that
was also found to be ineffective as a vaccine is a Kunitz type serine proteinase
inhibitor of 6 kDa (Bozas et al., 1995; Spithill et al., 1998). The failure of
vaccination using these proteins suggests that the approach of isolating proteins on
the basis merely that they are there and can be identified, rather than investigating
proteins detected by natural immune responses, may not be helpful.
1.2.10.8 Identifyingproteins in newly excystedjuveniles
As newly excysted juveniles are so small it is often difficult to obtain
adequate material for identifying component molecules. N-terminal sequence
analysis requires only a small amount of material and can give an indication of the
families to which proteins belong. Seven different proteins present in somatic
extracts have been identified by this method (Tkalcevic et al., 1995). Three of these
show no similarity to any known proteins, however, two are related to cathepsin B
protease, one to cathepsin L protease, another two show similarity with Schistosoma
haemaglobinases and one is related to a gluconeogenesis enzyme.
1.2.11 Summary
Rats develop immunity to re-infection and this may occur early in infection at
either the gut, peritoneal or liver capsule stages. Cattle appear to develop partial
resistance to re-infection and experimentally at least, may self-clear primary
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infections. It is not known where such immunity is effected in cattle and which
components of the immune system are responsible. Additionally, the information
about the immune processes occurring in ruminants both experimentally and in the
field situation is extremely limited. Those studies which have attempted to address
this area have also tended to look mainly at responses during the chronic state, and
not at those to the early invasive stages of F. hepatica.
Several fluke antigens have been isolated and used in vaccination trials, with
mixed success. The majority of these proteins have been isolated from adult fluke
protein preparations, often based on the presence of an antibody response found
during the later stages of infection. This "isolate and vaccinate" approach is relient
upon and dominated by the success of protein isolation methods, rather than being
based upon a better understanding of the natural immune responses occurring during
infection. Furthermore, although adult and juvenile flukes share many proteins,
concentrating on those abundant in the adult may result in a vaccine that is more
active in the rejection of more mature parasites. This is of particular significance
when considering the clinical implications of infection in the main target hosts.
Sheep in particular, are very sensitive to heavy infection, which can be fatal during
early fluke migration. Inducing an immune response which targets juvenile flukes, so
that they are attacked during early migration could greatly reduce the stress and
clinical illness experienced by infected animals. This is also of importance when
considering the production capabilities of sub-clinically affected animals.
There is therefore a need for re-examining the approach to fluke vaccine
development. Identifying immune responses occurring during the early migratory
stages of infection are crucial. Also, further investigation of the immune responses
induced by the various trial vaccines should be undertaken. Defining T cell subsets,
or rather the cytokines produced during infection, and the antibody isotypes involved,
may be necessary for deciding which antigens, adjuvants and inoculation routes
should be used for vaccination. Greater knowledge of host reactions to these antigens
will also allow optimisation of any protective responses stimulated by vaccination.
1.3 Objectives of the thesis
This study was therefore designed to investigate immune responses occurring
in cattle during early experimental infections with F. hepatica. In order to limit
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exposure to early juvenile stages of the parasite, animals were treated with the drug
triclabendazole to terminate infection. The response of such pre-exposed animals to
challenge infections was then investigated and compared with that of naive
challenged animals. In schistosomiasis, it has been found that by treating chronically
infected people to clear infection and then following the process of re-infection,
resistant and susceptible groups of individuals could be identified (Butterworth
1985). Differences in certain immune parameters, particularly levels of IgGl and IgE
antibodies and eosinophils were found between the two groups (Hagan et al., 1987;
1991; Roberts et al., 1993; Demeure et al., 1993). Although the aim of this study was
to examine experimental infections terminated during early infection, rather than
during a chronic infection state, it was anticipated that similar patterns of response
upon re-challenge might emerge.
The results of this study are based on the outcome and analysis of two main
experiments:
• In the first experiment, differences in the peripheral antibody and cellular
response to challenge infection were examined in naive, chronically infected and
drug-abbreviated pre-exposed animals, together with any alterations in
susceptibility to the challenge infection (Chapter 3).
• In the second experiment, local lymph node immune responses occurring shortly
after challenge infection were studied in pre-exposed and naive animals (Chapter
4).
• Antibody and cellular responses to crude fluke protein preparations and to
isolated cathepsin protease (Smith et al., 1993) and high molecular weight
(McGonigle et al., 1995) fractions were studied in both the experiments
(Chapters 5 and 6).
The aims of each experiment are described in more detail in the relevant chapter,
together with the rational for the methodology used.
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CHAPTER 2
GENERAL MATERIALS & METHODS
Recipes for all solutions and culture media are given in Appendix A.
2.1 Source and preparation of F. hepatica protein extracts
2.1.1 Excretory-secretory (ES) and whole adult fluke somatic antigen (WFA)
preparations
Live, adult flukes were obtained from the bile ducts of fresh sheep or bovine
livers and placed into warm (37°C) PBS, pH 7.4. The flukes were washed once in
PBS, then incubated at 37°C for 30 minutes to encourage regurgitation of sheep or
bovine blood from the gut into the media (10-15 flukes per 15 ml). Flukes that were
clean with little remaining visible gut contents were then selected and washed several
times in PBS until they were free from external debris and became pink-coloured.
Flukes were placed in 6-well tissue culture plates (Nunc®), with one fluke per 2-3 ml
of PBS and cultured for 3-4 hours at 37°C in 5% CO2 in air. The PBS, containing ES
proteins, was aspirated. Live flukes were snap frozen using a mixture of methanol
and dry ice and stored at - 70°C until required.
The PBS-ES preparation was centrifuged at lOOg for 10 minutes to pellet any
fluke eggs. The supernatant fluid was decanted, aliquotted into 1.5 ml volumes and
centrifuged at 13000g for 30 minutes at 4°C. Clarified fluid was then removed from
the pelleted cell debris by pipette, pooled, passed through a 0.22 pm syringe filter and
aliquotted. Aliquots were stored at -70°C.
WFA was prepared from the frozen flukes collected above. Flukes were
rapidly warmed to room temperature (RT) and then placed immediately into a small,
home-made "French press" that had been chilled in liquid nitrogen. The flukes were
shattered by hitting the rod of the press with a hammer. A 5-10% suspension of fluke
powder in ice-cold PBS was prepared and this was incubated on ice, with intermittent
vortexing, for 30-60 minutes. Large debris particles were removed by centrifugation
at 1200g for 10 minutes. The resulting supernatant fluid was then fully clarified by
centrifugation at 13000g for 30 minutes. Supernatant fluid was aspirated, pooled,
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filtered through a 0.22 pm membrane and stored at -70°C until required.
2.1.2 14 day oldjuvenilefluke somatic preparation
Juvenile flukes were prepared and isolated with the assistance of Dr Diana
Williams and Dr Atila Akca at the Liverpool School of Tropical Medicine,
University of Liverpool.
Female Wistar rats were dosed with 100 F. hepatica metacercariae (Compton
Paddock Laboratories, Newbury, Berkshire). On day 14 post-infection, rats were
euthanased, the livers removed and juvenile flukes isolated by dissection. The
juveniles were washed several times in warm PBS and then frozen at -70°C. Juvenile
flukes were defrosted on ice and homogenised with an Ultra-Turrax T8 homogeniser
(IKA Laboratories) in ice-cold PBS. The resulting suspension was incubated for 15-
30 minutes on ice with occasional vortexing. The mixture was clarified by
centrifugation at 13000g for 30 minutes at 4°C, however, to prevent unnecessary loss
it was not passed through a 0.22 pm filter. The preparation was then aliquotted and
stored at -70°C.
2.1.3 Metacercarial crush preparation
F.hepatica metacercarial cysts (Compton Paddock Laboratories) were
supplied encysted on cellophane film. Cysts were removed from the film with the
blunt edge of a scalpel blade, placed into microfuge tubes and washed 2-3 times with
PBS, removing excess fluid by pipette. The cysts were frozen on dry ice and then
ground, off ice, using a micropestle (eppendorf). This process was repeated several
times. The suspension obtained was made up to a larger volume with PBS and then
clarified by centrifugation at 13000g for 30 minutes. The supernatant fluid was
removed by pipette from pelleted debris, aliquotted and stored at -20°C.
2.1.4 Cathepsin-L protease and haem-containing high molecular weight fraction
(HMW)
The cathepsin and high molecular weight fractions used throughout the study
were kindly provided by Professor J. Dalton, Dublin City University, Glasnevin 9,
Dublin, Ireland. Both fractions were isolated from the excretory-secretory products of
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adult flukes (Smith et al., 1993; McGonigle et al., 1995).
It was not clear whether the cathepsin-L pool fraction was supplied in PBS
buffer and so buffer exchange was carried out using a PD-10 Sephadex® G-25M
column (Pharmacia Biotech) and PBS, pH 7.4. The high molecular weight fraction
was used as supplied, in PBS buffer.
2.1.5 Measurement ofprotein concentration
The protein content of the various preparations used was measured by the
bicinchoninic acid method using the BCA Protein Assay Kit (Pierce). The standard
microtitre assay was used for samples with expected concentrations above 0.25 pg/ml
and the enhanced protocol for those that were found to have concentrations lower
than 0.25 pg/ml. The assay was read at 570 nm on a Microplate Autoreader EL311
(BIO-TEK Instruments).
2.2 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE)
for separation of proteins
SDS PAGE electrophoresis was performed using the discontinuous method
according to Laemmli (1970). Gels were cast and run using both the Mini Protean II
and Protean® II xi gel apparatus (BioRad Laboratories). A 30% stock acrylamide/bis-
acrylamide solution (Sigma A-3699) was used to prepare the gel solutions. The
separating gel was either a 10 or 12% gel (mini-gels) or 10-15% gradient gel (large
gels) in 1.5M Tris pH 8.8 buffer with 0.1% w/v SDS, 0.05% w/v ammonium
persulphate and 0.005% v/v TEMED (Sigma T-9281). All stacking gels were 4%
acrylamide in 0.5M Tris pH 6.8 buffer with 0.1% w/v SDS, 0.05% w/v ammonium
persulphate and 0.005% v/v TEMED. 10-15% gradients were formed using a
385/395 Gradient Former (BioRad Laboratories) and a Micro-Tube Pump MP-3
(Tokyo Rikakika Co., Ltd.).
Samples were mixed with reducing loading buffer and heated to 95°C for 5
minutes prior to loading, or with non-reducing loading buffer (high molecular weight
fraction). Gels were run using SDS PAGE running buffer at 200V for 50 minutes
(mini-gels) or at 60V overnight (large gels). Broad range markers (BioRad
Laboratories) were run with each gel.
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2.3 Enzyme-linked immunosorbent assay (ELISA) for detecting IgGl antibody
to excretory-secretory proteins
The wells of a microtitre plate (Immulon-1, Dynex Technologies UK) were
coated in 100 pi of ES at 1.5 pg/ml diluted in carbonate-bicarbonate buffer, pH 9.6
(Sigma C-3041), covered in cling-film and incubated overnight at 4°C. The coating
solution was then shaken out and the plate was washed with an excess volume of
PBS-T buffer, 3 times, using a 3 minute incubation for each wash.
Any unbound sites in the wells were then blocked by adding 200 pi of 4%
normal sheep sera (Life Technologies) in PBS-T to each well and incubating for 1
hour at RT. The wash step was repeated.
Test sera was diluted in 1% normal sheep sera in PBS-T and 100 pi added to
the respective wells. The plate was shaken for 1 minute on a shaker and incubated for
1 hour at 37°C. The wash step was repeated.
A sheep polyclonal anti-bovine IgGl horseradish peroxidase conjugated
antibody (Bethyl Laboratories Inc., USA) was used to detect bound antibody, as a
1/8000 dilution in 1% normal sheep sera in PBS-T. The plate was shaken to mix and
incubated for 1 hour at 37°C. The wash step was repeated.
The reaction was developed using 3, 3', 5, 5'-tetramethylbenzidine, TMB
(one-component system, Kirkegaard and Perry Laboratories Inc.). 100 pi of TMB
was added to each well and mixed. The reaction was stopped with 0.2 M sulphuric
acid. The reaction was read at 450 nm on a Microplate Autoreader EL311 (BIO-TEK
Instruments).
This ELISA assay was used to screen stock animals for the presence of
antibody to F. hepatica, before inclusion in experimental groups. Optimal dilutions
of ES, test sera and secondary conjugate antibody were determined by titration in a
similar manner to the titrations described in section 5.2. Test, positive and negative
control samples were assayed in triplicate. The negative cut-off titre for the reaction
was taken as the mean of negative control samples plus 3 standard deviations of the
mean. Negative control samples were obtained from 3 uninfected Friesian-Holstein
calves and positive control sera from a F.hepatica chronically infected animal, calf
95.
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2.4 Tissue culture methods
All cell isolation and culture techniques were carried out in a tissue culture
facility using Class II vertical laminar flow hoods.
2.4.1 Isolation ofbovine peripheral blood mononuclear cells (PBMC)
Blood was taken from the jugular vein with an 18 gauge needle into 10 ml
vacutainers® (Beckton Dickinson) containing 2 ml of the anticoagulant acid citrate
dextrose (ACD) and processed within 1 hour of collection.
25 ml of the blood-ACD mixture was layered onto 15 ml of warm (37°C)
Lymphoprep™ (Nycomed Pharma AS) in a 50 ml centrifuge tube (Corning) and
centrifuged in a swing-out rotor at 1500g for 25 minutes at RT, without the use of a
brake. The interface was carefully collected using a sterile plastic Pasteur pipette and
placed into a new tube. The volume was taken to 50 ml with warm PBS and the cells
pelleted by centrifugation at 300g for 10 minutes. The supernatant fluid was
smoothly decanted and the cell pellet resuspended in PBS. The cells were again
pelleted by centrifugation at 120g for 10 minutes. This last wash and spin process
was repeated once more with PBS and once with warm RPMI 1640 media (Sigma R-
7388). After this final wash the cells were resuspended in complete media.
2.4.2 Isolation ofa single cell suspension from whole lymph node material
The method for isolating cells from bovine lymph nodes was adapted from
methods of Dr E. Innes (Moredun Research Institute, Pentlands Science Park,
Penicuik, Midlothian) and Gasbarre (1994).
Lymph nodes were taken from animals at post-mortem as soon as possible
after death and placed intact into ice-cold lymph node media. The lymph nodes were
transferred to a tissue culture facility and processed using aseptic techniques. Lymph
nodes were handled with sterile stainless steel forceps.
The lymph node was placed in a petri dish (Bibby Sterilin Ltd.) together with
approximately 30 ml of lymph node media and gross debris carefully dissected away.
The lymph node was then transferred into a fresh dish containing a similar volume of
fluid and chopped into tiny pieces with sterile scissors. The resulting suspension was
poured into a sterile bag (Seward Medical), sealed and homogenised for 60 seconds
in a Stomacher® 80 machine (Seward Medical). The cell suspension obtained was
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then separated from tissue fragments by filtering through a narrow gauge sterile
stainless steel sieve (tea-strainer).
The filtrate was transferred into a 50 ml tube and allowed to stand for 5-10
minutes to allow any remaining debris to sediment at the bottom of the tube. The
supernatant fluid was then aspirated by pipette, transferred to a fresh tube and
pipetted back and forth several times to break up any further cell clumps. The
suspension was centrifuged at 120g for 10 minutes to pellet cells, supernatant fluid
decanted and the pellet resuspended in 2-4 ml of lymph node media.
Red blood cells were lysed at this stage by the addition of 2-4 ml of a 0.83%
ammonium chloride solution for a 3 minute incubation period. The solution was then
made up to 50 ml with Hank's Buffered Saline Solution (Sigma H-6648). After red
cell lysis, the cells were washed twice in lymph node media and once in RPMI 1640
media, pelleting at lOOg for 10 minutes. Cells were finally resuspended in complete
media.
2.4.3 Cell counts using Trypan Blue and a haematocytometer
100 pi of cell suspension was mixed with 400 pi of RPMI 1640 media and
500 pi of Trypan Blue Solution 0.4% (Sigma T-8154) and allowed to stand for 5
minutes. The chamber of an Improved Neubauer haematocytometer (Weber) was
filled with the cell suspension and unstained cells counted at 100X magnification.
The number of cells per ml was calculated as:
cell count per square (1mm x 1mm) x dilution factor (10) x 104
2.4.4 Standard cell proliferation assay
Assays were performed in quadruplicate in 96 well tissue culture plates
(Falcon®) at a final cell concentration of 1 x 106 cells/ml, using 2 x 105 cells per well.
Cells were adjusted to 2 x 106 cells/ml in complete media. The protein
preparation used to stimulate the cells was prepared at double the required final
concentration in complete media and then mixed as a 1:1 ratio with the cell
suspension. 200 pi volumes of this mixture were then transferred to the relevant
wells. A positive control of cells with the mitogen Concanavalin A (Con A) at a final
concentration of 1 pg/ml and a negative control of cells in media alone, were
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included for each separate cell sample. Cells were incubated at 37°C in 5%C02 in air
for 5 days.
On the fifth day, 1 pCi (37 kBq) of 3H-labelled thymidine (Amersham) was
added to each well and the cells incubated for a further 6 hours. The cells were
harvested onto glass fibre filters (Wallac), using an automatic cell harvester
(Harvester 96®, TomTec), and the filters allowed to air dry. Filters were placed in
plastic pockets, 4 ml of scintillant fluid, OptiScint "Hisafe" (Wallac) added and the
pocket heat-sealed. The incorporation of 3H-thymidine into cellular DNA was then
measured using a 1450 Microbeta™ Plus scintillation counter (Wallac).
The arithmetic mean value of quadruplicate replicates was calculated and
used in the final analysis.
2.4.5 Cryopreservation ofmononuclear cells with dimethyl sulphoxide (DMSO)
Cells in a cell suspension were pelleted by centrifugation at 120g for 10
minutes. The pellet was resuspended in a mixture of 90% FCS (Life Technologies)
and 10% DMSO (Sigma D-2650) at a concentration of 1 x 107 cells/ml and
aliquotted into cryogenic vials (Nalgene®). Cells were cooled overnight in a Cryo
Freezing Container (Nalgene®) to -80°C and then placed in the vapour phase of a
liquid nitrogen cooling facility for long term storage.
2.4.6 Resuscitation ofcryopreserved cells
The cryovials were removed from the liquid nitrogen storage facility,
immediately placed on dry ice and transported to the tissue culture facility. The cells
were rapidly warmed to melting point in a 37°C waterbath and then the contents of
one vial (1.5-2 ml) added to 20 ml of complete media (at 37°C). The volume was
made up to 50 ml with further media and the cells pelleted by centrifugation at 120g
for 10 minutes. The cell pellet was resuspended in complete media and the
centrifugation step repeated. Care was taken to work rapidly throughout the process,
so that the cells could be placed in an incubator as quickly as possible, in order to
minimise cell death.
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2.5 Fluorescence activated cell sorter (FACS) analysis to characterise cells by
phenotype
2.5.1 Staining cells with monoclonal antibodies to cell surface markers
Cells were isolated as described above in section 2.4.1-2, however the final
wash step was performed using "cell wash" (FACSflow, Becton Dickinson) and cells
were resuspended in "cell wash" at a concentration of 1 x 107 cells per ml.
A round bottomed 96-well plate (Falcon®) was used for the staining and
washing steps. 5 x 105 cells/well were added to the plate and the cells pelleted by
centrifuging at lOOg for 5 minutes. The supernatant fluid was flicked out of the plate
and the cell pellet resuspended in 30-50 pi of the primary, anti-cell surface marker,
monoclonal antibody at the optimal dilution in cold "cell wash" (Table 2.1). A
negative control of mouse serum at a 1/500 dilution in "cell wash" was included for
each animal. The plate was incubated on ice for 30 minutes.
The cells were pelleted, as above. The supernatant fluid was flicked out and
the cell pellet resuspended in 200 pi of cold "cell wash". The spin step was repeated
and the cells washed twice more. After the final spin, the cells were resuspended in
25 pi of the secondary, FITC-labelled antibody conjugate at a 1/500 dilution (anti-
mouse polyvalent IgG/A/M, Sigma F1010). The cells were incubated with the
conjugate, on ice, in the dark, for another 20 minutes. The washing step was
repeated. After washing, the cells were resuspended in 200 pi of "cell wash" and run
through the FACScan cytometer within 2 hours.
2.5.2 Sample processing through the FACScan cytometer
Cells were run through a FACScan cytometer (Becton Dickinson). The
machine was calibrated using the negative control samples, adjusting forward scatter
(FSC) and side scatter (SSC) so that data points fell clearly within a dot-plot. Dead
cells and residual erythrocytes were gated out. Fluorescence was measured with the
FITC detector (FL1) set at around 620 meV. Settings and gates were optimised for
peripheral blood mononuclear cells and lymph node cells and kept constant between
samples. The cytometer acquired 10000 cells and results were displayed as frequency
histograms.
The proportion of cell staining positive for a particular cell type was
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calculated and displayed as a percentage. Results were compared over time or
between groups using the Mann-Whitney U test.
Table 2.1: Monoclonal antibodies to bovine cell surface markers used for FACS
analysis of cell phenotypes.
Antibody Specificity Cell type Dilution Reference
CC8a CD4 T helper 1/5 1
SBU-T8b CD8 T cytotoxic 1/1 2
86Db TCR1 y8+ T cell 1/1 3
VPM30b Not classified B cell 1/1 4









: a gift from Professor C. Howard, Institute of Animal Health, Compton,
Berkshire.
b
: gifts from Professor J. Hopkins, Faculty of Veterinary Medicine,
University of Edinburgh.
c:Sigma (M-5905)
1: Howard et ai, 1989.
2: Maddox etal., 1985.
3: Mackay et ah, 1989.
4: Naessens and Howard, 1991.
5: Gupta et al., 1996.
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CHAPTER 3
The effect of pre-exposure to restricted stages of juvenile F. hepatica on the
progression of a subsequent challenge infection in cattle (Experiment A).
3.1 INTRODUCTION
The immune response to the very early fluke stages present during the
migratory period from the gut, across the peritoneal cavity and to the liver has not
been examined in any detail in the ruminant host. A vaccine that stimulated a
protective host response against these early stages would be ideal, eliminating the
parasite whilst still small and before serious damage is inflicted upon the liver
parenchyma. In a natural infection, examining immune responses to these stages is
virtually impossible. No attempts have previously been made to measure specific
antibody to fluke proteins in cattle during the first week of infection. Antibody
present at later time-points will reflect the changing profile of protein expression as
the fluke matures and are necessarily not specific to an individual development stage.
Restricting exposure to early stages would require either physical removal,
which would be impossible unless flukes were implanted into the peritoneal cavity
within permeable sacks or removal by death of the parasite. Cattle vaccinated with
irradiated metacercariae have shown resistance to reinfection (Nansen, 1975) as have
rats (Corba et al., 1971). Irradiation is thought to alter parasites in a variety of ways.
These include changing the nature of expressed antigens and altering protein
synthesis (Wales and Krusel, 1992). Irradiation of F. hepatica metacercariae results
in the production of newly excysted juveniles with altered carbohydrate and
cathepsin-B expression (Creaney et al., 1996). These changes in protein synthesis
and antigenic nature may inhibit the natural development of the parasite, perhaps
arresting development such that it does not progress beyond a certain stage (Jarrett el
al., 1958). However, irradiation is not an exact method of terminating the stage to
which a fluke develops. The use of a drug that reliably kills early fluke stages is
therefore the best option currently available. In this study, exposure to early restricted
stages of the parasite was attempted by drug-abbreviated infections.
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The drug triclabendazole is the most effective fasciolicide available for
killing immature stages of the parasite. Studies in cattle have shown reductions in
fluke burden at 1 week post-infection of 85% (Fuhui et al., 1989), 88% (Richards et
al., 1990) and 95% (Boray, 1982) when used at a dose rate of 12 mg/kg and 98%
(Boray, 1982) when used at 15 mg/kg. The efficacy of killing earlier stages has only
been investigated in sheep, with a 98% reduction in burden found by treating at 1 day
post-infection, using a dose rate of 15 mg/kg (Boray, 1983). This and other studies
(Dorchies et al., 1983) have shown that killing efficacy is enhanced by increasing
triclabendazole dose. In the present study, triclabendazole was used at a high dose
rate of 36mg/kg, with the aim of achieving a high kill rate for flukes of less than 1
week of age.
The timing of fluke migration has only been studied in detail in experimental
animals such as the rat and mouse. In these species, gut penetration is immediate,
with flukes present in the gut mucosa within 2 hours of infection (van Milligen et al.,
1998) and present within the peritoneal cavity at 12-24 hours post-infection (Dawes,
1961; Bennett and Threadgold, 1975; Rajasekariah and Howell, 1977). Entry into the
liver is seen as early as 2-3 days post-infection in the mouse (Dawes and Hughes;
1964; Tkalcevic et al., 1996) and at 4 days in the rat (Hayes, 1978). There is little
data available describing the timing of migration within the ruminant, although
flukes have been found at 4 days post-infection in the peritoneal cavity of cattle (Doy
and Hughes, 1984). Kendall and Parfitt (1962) state that the time of entry into the
liver is approximately 90 hours, although it is not clear whether this relates to the
sheep, or another animal. However, given the more complex gut anatomy and larger
size of ruminants, it is to be expected that the migration of flukes might take longer
than that seen in rats and mice.
This study investigates the host response to two particular stages of fluke
migration through the host. The first, the migration of newly excysted juveniles
across the gut mucosa and into the peritoneal cavity. The second, the period of
migration from the gut, through the peritoneal cavity and into the liver parenchyma.
These two migration periods were estimated to last approximately 24 hours and 5
days in cattle, on the basis of the evidence given above. Juvenile flukes were
prevented from further migration by the administration of triclabendazole at these
two time-points. Animals that were pre-exposed to F. hepatica in this manner were
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then challenged several weeks later and the progression of infection examined until
patency was well established. Serum levels of the two liver enzymes gamma-
glutamyl transferase and glutamate dehydrogenase were followed, together with fluke
egg levels in the faeces and eosinophilia, in order to give an indication of the degree
and the rate of progression of infection. Any differences observed between these
parameters in pre-exposed animals, compared to that seen with na'ive challenged
animals, were investigated.
Experimental Aims
• To investigate the immune responses occurring in cattle to restricted life-cycle
stages of F. hepatica, specifically those exposed to the first 24 hours or to the
first 5 days of infection.
• To compare the immune responses occurring in animals exposed to restricted
stages with chronically infected or nai've animals, upon subsequent challenge
with the parasite.
• To determine whether exposure to restricted early stages of the parasite confers
any benefit to the animal in terms of reduced liver damage or fluke burden, when
subsequently challenged.
The immune responses examined included peripheral blood mononuclear cell
proliferative responses to crude fluke protein preparations and peripheral antibody
responses to crude and specific isolated proteins (antibody responses are examined in
Chapters 5 and 6).
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3.2 MATERIALS & METHODS
3.2.1 Experimental design
Four groups of ten calves were used in the experiment. Group A, the chronic
group, received a primary infection on day 0 and remained infected throughout the
experiment, with a superimposed secondary infection given on day 28. Group D, the
naive control group, did not receive a primary infection at day 0, but did receive the
day 28 challenge infection. Groups B and C received drug-abbreviated primary
infections and were then challenged on day 28. Group B had the primary infection
terminated by treatment with triclabendazole on day 5. Group C received three
exposures to metacercariae over the first 10 days of the experiment, with infection
being terminated by triclabendazole treatment 24 hours following each infection
dose. The experimental design is summarised in Figure 3.1 and Table 3.1.
The two control groups A and D were included in the experiment for different
reasons:
• Group A was used to compare the early immune response to F. hepatica infection
in chronically infected animals and in those that had received exposure to
restricted juvenile fluke stages during the primary phase of the experiment.
• Group D was used to assess the viability of the metacercariae used in the
secondary infection. More importantly, it also allowed a direct comparison of the
progression of a chronic infection in naive and pre-exposed animals, in terms of
the liver damage, egg production and immune responses induced.
45
Figure 3.1: Diagrammatic representation of the experimental design, showing the
different treatments that groups A, B, C and D received.
1 1
1 \ 1




I metacercariae \ triclabendazole
Time is shown along the upper line in days from days 0-120. Each group is illustrated
separately on the left hand side. The exposure period to flukes experienced by each
group is illustrated by a thick black line; metacercariae administration is shown by
vertical arrows and treatment with triclabendazole as jagged lines. Note that the
exposure period in groups B and C slightly overhangs the point of triclabendazole
treatment. This is to take into account the time needed for the drug, given orally, to
reach effective circulating blood levels. The secondary infections in all groups proceed
onwards from day 120, shown as arrowheads on the black exposure lines.
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Table 3.1: Summary of the primary and secondary infections and triclabendazole
doses received by the four groups A, B, C and D.
Group Primary exposure Secondary exposure
A Receive metacercariae on day 0 and
remain untreated with triclabendazole.
Receive challenge dose of
metacercariae on day 28.
B Receive metacercariae on day 0 and are
treated with triclabendazole on day 5.
Receive challenge dose of
metacercariae on day 28.
C Receive metacercariae on days 0, 5 and
10; and are treated with triclabendazole
on days 1, 6 and 11.
Receive challenge dose of
metacercariae on day 28.
D Receive blank filter paper boluses on
days 0, 5 and 10; and are treated with
triclabendazole on days 1, 6 and 11.
Receive challenge dose of
metacercariae on day 28.
3.2.2 Sampling timetable for sera and faeces collection
Routine samples were taken weekly, from day -14 to day 125-156, from all 40
animals in the study, as detailed below.
• Blood samples were taken into EDTA anti-coagulant for a haematological blood
screen, including a full differential white cell count.
• Serum from clotted blood was prepared and used for the measurement of levels
of the liver enzymes gamma-glutamyl transferase and glutamate dehydrogenase
and in studies to investigate antibody responses to fluke proteins (Chapters 5 and
6).
• Per-rectal faecal samples were collected for measurement of faecal egg counts.
These were stored at 4°C until processed.
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3.2.3 Stock
Castrated male Friesian-Holstein dairy calves, aged between 4-6 months old
at the start of the experiment, were used. Prior to the start of the study all animals
were screened three times for the presence of F. hepatica eggs in the faeces and twice
by ELISA, at an interval of three weeks, for IgGl antibodies to adult fluke excretory-
secretory antigens (section 2.3). The ELISA had previously been shown to detect a
positive serum response in cattle from as early as two weeks post-infection. One
animal appeared positive on the ELISA screen and was not included in the study.
Animals were randomly assigned to the four groups by stratifying all 40 in
order of weight and then allocating each to one of the groups in sets of four, using
random numbers. This method of allocation ensured that the animals in any particular
group were not biased in any way (such as weight or age) when compared to the
other groups. Group mean weights and weight ranges at the start of the experiment
are shown in Table 3.2.
Calves were penned in the allocated groups in an open-sided barn and were
fed a diet of calf rearing nuts with hay and water. One calf in group C failed to thrive
for unrelated reasons and was euthanased on humane grounds. All group C results
and analyses shown in section 3.3 were performed using the data of the remaining
nine animals only.
3.2.4 F. hepatica infection
British strain F. hepatica metacercariae were supplied encysted on cellulose
film by Compton Paddock Laboratories (PO Box 91 Newbury, Berks, RG20 7HB).
Metacercariae were counted under a dissecting microscope at 20X magnification and
the appropriate number (within +/- 10 cysts) cut from the film. The film, with cysts,
was then carefully wrapped within two layers of water-dampened Whatman number
1 filter paper. Cysts were counted within 24 hours of use and stored damp at 4°C. The
wrapped dose was placed in a balling gun and administered per os to the calves.
Animals were kept for several minutes after dosing in a concrete enclosure and fed a
small quantity of calf nuts to ensure that the dose had been swallowed.
A metacercarial dose per kg of bodyweight was given to each calf due to the
broad range in weight present within the four groups. This was chosen instead of flat
dosing, regardless of weight, to prevent the smaller animals being subject to a greater
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fluke dose per kg of liver. Flat dosing in this manner could have resulted in much
greater stress and interference in liver function in the smaller animals. The dose rate
used was 3.6 metacercariae per kg bodyweight, which was a moderate dose. Infection
was intended to stimulate an immune response and result in changes in the various
infection parameters, but not to produce clinical disease.
The primary dose given to groups A, B and C was calculated using individual
mean weights from two readings, taken 7 days apart. The second primary group C
dose given on day 5 was identical to the first. The third primary group C dose given
on day 10 was based on weights taken at day 7. Challenge secondary doses given on
day 28 were again given at a dose rate of 3.6 metacercariae per kg bodyweight, using
the mean of two weights taken during the preceding 7 days. The group mean weights
and infection doses are shown in Table 3.2.
3.2.5 Termination of parasite infection with the drug triclabendazole
Triclabendazole was used to terminate fluke infections in the two treatment
groups B and C (Fasinex™, Novartis Animal Health UK Ltd, Whittlesford,
Cambridge, CB2 4XW). Group B animals were treated per os with triclabendazole
on day 5 at a dose rate of 36 mg/kg. Group C animals were treated on day 1 and day
11 at a dose rate of 36 mg/kg and on day 6 at a dose rate of 24 mg/kg. The control
group, D, was also treated with triclabendazole at the same time points as group C.
The drug dose used was higher than the licensed dose rate for the product. It was
anticipated that this would improve the efficacy of killing juvenile flukes.
Triclabendazole has a very high safety index (Boray, 1983), so no problems were
envisaged by using the drug at this dose.
Triclabendazole is oxidised within the blood to two active metabolites, the
sulphoxide and sulphone, which do not attain peak concentrations until
approximately 18 and 36 hours, respectively, after drug administration. However,
detectable levels are present within 5 hours of dosing (Hennessy et al., 1987). Hence,
although groups B and C were treated at 5 days and 24 hours post-infection, a
window of several hours prior to any fasciolicide action must be taken into account.
Primary infection flukes in groups B and C may therefore have reached 6 and 2 days
old, respectively.
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Table 3.2: Group mean animal live-weights, showing weight ranges and the mean
metacercarial doses given, prior to the primary infection (day 0) and secondary
challenge infection (day 28).
Group





























3.2.6 Measurement of F. hepatica eggs in the faeces
Fluke burden was assessed by the use of faecal egg counts (FEC), measured
by a zinc sulphate flotation method. 3g of fresh faecal material were sieved into 45
ml of saturated salt solution until all but insoluble residue remained. The faecal
suspension was swirled well to mix and then 13 ml poured into a 15 ml centrifuge
tube, which was then centrifuged at 500g for 5 minutes. The supernatant was
discarded and the pellet resuspended in 13 ml of zinc sulphate solution (specific
gravity, 1.3). The tube was then centrifuged again for 3 minutes. The liquid was
brought to the brim of each tube without spillage, by adding zinc sulphate solution
drop-wise and then a coverslip was placed on the top of the tube. The coverslip was
left in place for 4 minutes and then removed, placed onto a glass slide and all fluke
eggs present counted under a microscope at 40X magnification. Egg counts per gram
were calculated as follows:
Count x 0.33 (scales to 1 g) / 0.28 (proportion of suspension used) x 20/V*
* ,V, volume of centrifuge tube: this terms adjusts for loss during the procedure
(M.Sc. Flandbook of Helminthological Techniques, Department of Tropical Animal
Health, University of Edinburgh 1997).
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3.2.7 Preparation of serum samples
Blood was collected into plain glass vacutainers™ (Becton Dickinson) from
the jugular vein using a 20 gauge needle. Samples were allowed to clot at room
temperature and then chilled for 2 to 4 hours at 4°C, before centrifuging at 1200g.
Serum was carefully removed from the pelleted clot by pipette and aliquotted into
micro-tubes. Serum samples were then stored at -70°C or -20°C for long and short
term storage respectively.
3.2.8 Measurement of gamma-glutamyl transferase (y-GT) and glutamate
dehydrogenase (GLDH) levels in serum
Damage to the liver was examined by measuring the serum levels of the two
enzymes y-GT (EC2.3.2.2) and glutamate dehydrogenase GLDH (EC 1.4.1.3). The
levels of these enzymes present in serum were measured using Technicon RA
chemistry kits (Miles Inc., Tarrytown, NY, USA) on a Bayer Opera Chemistry
System spectrophotometer, by Mr A. Dowell of the Dalghety Laboratory, Faculty of
Veterinary Medicine, University of Edinburgh. Levels are expressed as international
units per litre, IU/1.
3.2.9 Haematological screens
Blood was collected into vacutainers containing EDTA anticoagulant and
differential white cell counts (using blood smears) performed by the Clinical
Laboratory, Faculty of Veterinary Medicine, University of Edinburgh. The total
number of leucocytes were measured using a coulter counter (Baker); blood films
(stained with Modified Wright's stain) were examined microscopically to give the
differential cell count.
3.2.10 Peripheral blood mononuclear cell proliferative responses to whole fluke
antigen (WFA) and excretory-secretory (ES) preparations
Four animals from each group were selected for analysis of peripheral blood
mononuclear cell (PBMC) proliferative responses to the adult WFA and ES protein
preparations. The heaviest animals in each group were chosen as this allowed the
required volume of blood to be collected within the allowed limit dictated by Home
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Office regulations. Those used were as follows: group A, calves 45, 46, 55 and 65;
group B, calves 40, 71, 72 and 76; group C, calves 54, 57, 64 and 66 and group D
calves 43, 59, 69 and 73. PBMC were prepared as described in section 2.4.1.
It was not possible to perform assays with samples from all sixteen calves on
the same day. Eight animals were therefore sampled on one day and the remaining
eight on the following day. A negative, baseline assay was carried out on days -14/-
13. Those with high or irregular background responses were re-sampled on day -6.
Post-primary infection responses were investigated on days 7/8, 14/15 and 26/27. A
single secondary post-challenge assay was carried out on days 35/36.
The WFA and ES protein extracts were prepared as described in section 2.1.1
and proliferation assays were carried out according to the procedure outlined in
section 2.4.4. The cellular responses to these preparations were titrated for all
animals at days -14/-13, -6, 7/8 and 14/15, using WFA and ES concentrations of 1-30
and 1-20 jag/ml respectively. The optimum concentration for each preparation was
then selected and used throughout the remainder of the experiment. A positive
control of Con A at a concentration of 1 pg/ml and a negative control of culture
media alone, were used with all samples at each time-point.
3.2.11 Statistical analysis
The arithmetic group mean values for y-GT, GLDH, eosinophil and other
white cell parameters were used in the analysis. However, the geometric mean was
used for representing the group faecal egg output response.
All statistical analyses were performed using the Minitab® 12 software
package (Minitab Inc., USA). The non-parametric Mann-Whitney U test was used to
investigate group differences for all the parameters studied. The presence of any
possible correlation between dose and egg counts or enzyme levels was investigated
by the Spearman's rank correlation test.
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3.3 RESULTS
3.3.1. Detection of F. hepatica eggs in faeces
The pattern of egg production during the latter part of the time-course, from
day 105 (week 15) is illustrated in Figure 3.2.
Eggs first appeared in the faeces of animals from group A on day 70. Animals
in groups B and C started to produce eggs in the faeces from day 98 onwards, whilst
group D animals began to produce eggs slightly earlier, on day 84. Over the sampling
period, group A showed a biphasic egg output curve: a sharp peaked rise in egg
production between days 114 to 152 was super-imposed upon a lower egg output of
approximately 60 eggs per gram. From day 105 onwards, groups B, C and D began to
show an appreciable increase in the faecal egg count. The rise was slow and smooth
in all three groups, with group D showing the greatest egg output and group B the
least. Egg production peaked first in group D at day 138 and then started to drop,
whilst that in the two treatment groups, B and C, peaked during the final week of
sampling, at day 152. Egg production by the chronically infected group, A, decreased
from day 121, so that by the end of the sampling period, all groups showed similar
levels of egg production.
The difference in egg output between groups C and D was not significant at
any of the time-points examined. However, the clear difference in egg output
observed between groups B and D was significant at P < 0.05 on days 114-128
(Table 3.3).
Time averagedfaecal egg counts
Egg output can be intermittent, so the arithmetic mean faecal egg count for each
animal over a period of days was calculated at two points: during the early patent
period for groups B, C and D (days 121, 125 and 128) and towards the end of the
sampling period (days 138, 152, 154 and 156). Group means (geometric) were then
calculated for these two periods. Results are shown in Figure 3.3. The difference
between groups B and D for the period 121-128 was significant with P = 0.02 and
between group A and groups B, C and D for the same period with P < 0.002. No
significant differences were noted between any of the groups for the latter period
examined (days 138 to 156).
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Figure 3.2: Longitudinal profile of the geometric mean faecal egg count for groups
A, B, C and D from day 105 to day 156. Group mean geometric faecal egg counts
(FEC) are shown as eggs per gram (epg). A star marks the points where the
difference between groups B and D is significant at P < 0.05.
Day
— A - B - --A---C
Table 3.3: Results ofMann-Whitney U tests to examine group differences in faecal









* indicates a result that is statistically significant.
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Figure 3.3: Histogram illustrating group geometric mean faecal egg counts for time-
averaged counts during the early patent (days 121-128) and late patent (days 138-
156) periods. The star indicates that the difference between the group marked and
group A is significant at P < 0.002 and the circle that the difference between group B
and D is significant at P = 0.02.
180
FEC (121-128) FEC (138-156)
Time period
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3.3.2 Longitudinal serum profiles of the liver enzymes gamma-glutamyl
transferase (y-GT) and glutamate dehydrogenase (GLDH)
Figure 3.4 shows the profile of serum levels of the enzyme y-GT throughout
the course of the experiment. A sudden and rapid rise in the circulating levels of this
enzyme in group A animals was detected from day 49, which peaked at a level of
around 500 IU/1 at day 77 and remained relatively constant until day 125, when it
began to fall. A minor secondary peak was observed during the plateau period,
between days 98 and 125, which corresponds to the peak in the challenge control
group, D. Levels of y-GT in the groups B, C and D remained low until day 77, 28
days after the initial rise detected in group A. y-GT levels rose steeply in both groups
C and D from this point onwards, until day 98 in group C and day 119 in group D.
Group D reached a similar maximum level to that of group A, whereas levels in
group C peaked at around 350 IU/1, before beginning to fall. In contrast, the increase
observed in group B occurred about a week later, from day 84 and the rise was
slower, reaching a smaller, broader plateau at approximately 200 IU/1. Although there
was a striking difference between the enzyme profiles of the four groups, due to
within group variation, the differences between groups B and D were only significant
with P < 0.05 on days 84, 105 and 112 (Table 3.6). No statistically significant
differences were noted between the enzyme levels of groups C and D.
The profile of the enzyme GLDH was quite different (Figure 3.5). Resting
levels of the enzyme prior to infection fluctuated from week to week with many of
the animals. A true rise was detected in group A from day 28 onwards, initially of
shallow profile, but rising steeply from day 42 up to a maximum at day 56. A gradual
decline in GLDH levels until the end of the sampling period was then observed,
although a second minor rise occurred at day 112. Of the other three groups, D
started to show an increase in GLDH levels from day 42, with that of B and C
delayed by another 4 weeks, until day 70. Enzyme levels in group D rose rapidly up
to a peak at day 98, crossing the group A profile, which had started to decline. The
changes in GLDH levels in both groups B and C were very similar, although the level
in group B was always slightly lower than that of group C. The group C GLDH
profile also peaked sharply at day 91, reaching a similar value to that of group D. By
day 125, enzyme levels in groups B, C and D had declined significantly, levelling out
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to between 100 to 150 IU/1 by the end of the sampling period. Although the
difference between groups B and D was less marked with this enzyme than with y-
GT, it was significant through a greater part of the time-course (Table 3.6). This was
due to a greater consistency in enzyme levels between animals in the same group.
Comparison ofpeak enzyme levels
The longitudinal profiles of the liver enzyme response provide a useful
indication of the average progression of infection in the four groups. However, not all
animals reached peak values for the two enzymes at the same time. Peak values for
individual animals were therefore identified and group mean values calculated. Table
3.4 shows the mean peak values for both y-GT and GLDH enzymes for the four
groups. These results support the findings of the longitudinal group analysis, with the
difference between peak values in groups B and D remaining significant at P < 0.05
for both enzymes studied.
Table 3.4: Group mean peak values for the liver enzymes y-GT and GLDH, in
international units per litre (IU/1).
Parameter
Group
A B C D
y-GT 769 259a'b 390° 570
GLDH 411 327a'b 355c 393
Key:
a
. +u.a: the difference between groups B and D is significant with P <0.05
b: the difference between groups B and A is significant with P <0.01
c: the difference between groups C and A is significant with P <0.05
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Figure 3.4: Longitudinal profile of group mean serum levels of the enzyme gamma-
glutamyl transferase (y-GT) over the entire period of study, measured in international
units per litre (IU/1). Error bars are not shown to aid clarity, however the points where
the difference between groups B and D was significant at P < 0.05 are marked with a
star.
600 n
♦— A B A C --x--D
Note: a copy of this figure, including error bars, is given in Appendix B.l.
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Figure 3.5: Longitudinal profile of group mean serum levels of the enzyme glutamate
dehydrogenase (GLDH) over the entire period of study, measured in international
units per litre (IU/1). Error bars are not shown to aid clarity, however the points where
the difference between groups B and D was significant at P < 0.05 are marked by a
star.
450
Note: a copy of this figure, including error bars, is given in Appendix B.2.
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3.3.3 Peripheral blood eosinophil levels
Animals responded very rapidly to parasite infection by an increase in the
proportion of eosinophils in the peripheral circulation (Figure 3.6). Rises were
detected in all three groups 7 days after the primary challenge. The increase in both
groups B and C was small and transient, lasting only from days 7 to 28. The
chronically infected group, A, showed a sustained rise in eosinophil levels from days
7 to 35, reaching a peak of 1.5 x 109 cell/1. Eosinophil numbers then fluctuated
between 1.5-2.5 x 109 cell/1 throughout the rest of the sampling period, with a
pronounced peak between days 84 to 119 and no apparent tendency towards a decline
by the end of the sampling period.
Groups B and C responded within 7 days of the secondary challenge infection
(at day 35) with a substantial increase in peripheral eosinophil levels. Animals in
group D reacted more slowly to infection, with eosinophil levels rising from day 42,
but then increasing in close association with the other two groups. All three groups
showed similar peak levels of around 2.0 x 109 cell/1 at day 49 and then responses in
the three groups diverged. Group D maintained a high eosinophilia, not dropping
below a level of 1.5 x 109 cell/1 for the rest of the sampling period and with a peak
similar to that observed in group A between days 84 to 119. In contrast, eosinophil
counts in groups B and C decreased. Levels in group B dropped rapidly to less than
0.75 x 109 cell/1 by day 63 and then oscillated around 1.0 x 109 cell/1 for the
remainder of the experiment. The group C response was greater than that of B, but
again had dropped substantially by day 125. The difference noted between groups B
and D was significant with P < 0.05 on days 56, 63 and days 84 through to 112
(Table 3.6), and between groups C and D at days 56 and days 98 through to 125.
Individual animal eosinophil counts were averaged over the periods day 63-
125 and day 91-125 and the group means calculated (Table 3.5). For both periods,
counts in groups B and C were lower than those of group D and this difference was
significant for group B at P < 0.01 and for C at P < 0.05.
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Table 3.5: Time averaged peripheral eosinophil counts, shown as the group mean for
the periods days 91-125 and 63-125.
Period
Group mean eosinophil count, x 10 cells/1
A B C D
Days 91-125 2.12 0.97a'c 1.26b 2.21
Days 63-125 1.95 0.97a'c 1.28b 2.02
Key:
a: the difference between groups B and D is significant with P < 0.01
b
: the difference between groups C and D is significant with P < 0.05
L
: the difference between groups B and A is significant with P < 0.05
Table 3.6: Results of Mann-Whitney U tests comparing the difference in liver
enzyme and eosinophil levels between groups B and D throughout the later time-
course of the experiment (showing P values).
Time-point
Calculated P values for the given parameters; B
versus D
y-GT GLDH Eosinophils
Day 49 N/D 0.004** 0.850
Day 56 N/D 0.045* 0.011*
Day 63 N/D 0.0001*** 0.006**
Day 70 N/D 0.019* 0.391
Day 77 N/D 0.006** 0.076
Day 84 0.026* 0.014* 0.026*
Day 91 0.104 0.571 0.031*
Day 98 0.130 0.049* 0.001***
Day 105 0.021* 0.055 0.007**
Day 112 0.034* 0.037* 0.001***








Figure 3.6: Longitudinal profile of group mean peripheral eosinophil levels, from day
-21 to day 125. Error bars are not shown to aid clarity, however the points where the
difference between groups B and D was significant at P < 0.05 are marked by a star.
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3.3.4 Peripheral blood lymphocyte and neutrophil levels
There was no change in the group mean levels of peripheral lymphocytes and
neutrophils throughout the period of study.
3.3.5 Relationship between challenge dose and faecal egg output
Animals were dosed with a fixed number of metacercariae per kg liveweight.
As previously mentioned, this was carried out because the weight range within
groups was quite wide. In order to investigate the possibility that the differences in
faecal egg counts, eosinophil and enzyme levels were related to the initial dose given,
scatter plots and correlation analyses were performed.
Figures 3.7 shows scatter plots of the challenge dose of metacercariae against
faecal egg counts for individual animals in groups B, C and D, using the time-
averaged counts at days 121-128 and 138-156. The results of a Spearman's rank
correlation test for association between egg output and the secondary challenge dose
are shown in Table 3.7. No association was noted between administered dose and egg
output.
Table 3.7: Results of Spearman's rank correlation analysis, comparing the challenge
dose and faecal egg output at days 121-128 and 138-156, for groups B, C and D.
Time-point
Spearman's correlation coefficient, showing P-value
Shown as: coefficient (P-value)
Group B Group C Group D
Days 121-128 -0.285 (0.43) -0.500 (0.17) 0.261 (0.47)
Day 138-156 -0.103 (0.78) -0.183 (0.64) 0.321 (0.37)
3.3.6 Relationship between challenge dose and y-GT and GLDH levels
A similar analysis comparing the liver enzyme response and metacercarial
challenge dose was performed using peak y-GT and GLDH enzyme values. No
significant association was detected between peak y-GT values and metacercarial
dose for any of the groups, but there was a significant negative association between
peak GLDH levels and dose with group D (correlation coefficient -0.693, P = 0.03).
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3.3.7 Relationship between GLDH, y-GT and faecal egg counts
A significant correlation was found between peak y-GT and GLDH values for
groups A (coefficient 0.867, P = 0.001) and C (coefficient 0.833, P = 0.005), but not
for groups B and D. When the data was analysed as a single group, significant
correlation was also observed between the two enzyme peak values (coefficient
0.487, P = 0.002). Figure 3.8 shows a scatter plot of the data.
A moderate correlation was detected between both peak y-GT and GLDH
levels and early faecal egg counts (averaged over the period days 121-128) for groups
B, C and D analysed collectively (coefficient 0.44-0.45, P < 0.02).
3.3.8 Relationship between eosinophilia, challenge dose and faecal egg counts
No significant correlation was detected between the secondary challenge dose
and eosinophilia (averaged over the period days 63-125). A significant moderate
correlation was found between eosinophilia and early egg output for groups B, C and
D analysed as a whole (coefficient 0.582, P = 0.001), although when the groups were
analysed independently, the correlation was not significant. A scatter plot of
eosinophilia against early faecal egg count is shown in Figure 3.9. Analysing groups
B, C and D collectively, a moderate association was also detected between eosinophil
counts and peak enzyme levels for both y-GT (coefficient 0.407, P = 0.03) and
GLDH (coefficient 0.41, P = 0.03).
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Figures 3.7: Scatter plots ofmetacercarial challenge dose versus time-averaged faecal
egg counts (days 121-128 and 138-156) for individual animals in groups B, C and D.
Animals in group B are represented by squares, those in group C by triangles and in D
by crosses.
(a) Early patent period (days 121-128)
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Figure 3.8: Scatter plot of individual animal peak GLDH levels against peak y-GT
levels, for all animals in groups A, B, C and D. Animals in group A are represented by
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Figure 3.9: Scatter plot of individual animal eosinophil counts (averaged over days
63-125) against early faecal egg output (averaged over days 121-128), for all animals
in groups B, C and D. Animals in group B are represented by squares, those in group
C by triangles and in D by crosses.
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Eosinophilia x 109 /ml (averaged days 63-125)
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3.3.9 Proliferative responses of peripheral blood mononuclear cells to
stimulation with adult fluke protein preparations and Con A
3.3.9.1 Titration ofwhole adultfluke antigen and excretory-secretory preparations
Proliferative responses to WFA and ES protein preparations were titrated
with respect to antigen concentration at days 7 and 14 post-primary infection. The
day 14 proliferative responses, shown as group mean gross counts per minute, are
displayed in Figures 3.10 and 3.11. The optimum protein concentration that
stimulates maximum cell proliferation is likely to vary with each individual when
using an outbred population. In this experiment, a choice of optimum protein
concentration had to be made for the experiment as a whole. This choice was a
compromise between the best overall level of stimulation achieved and availability of
the protein preparations. Proliferative responses were vigorous and of similar
magnitudes with protein concentrations in the range of 10-30 pg/ml for the WFA
preparation and 10-20 pg/ml for the ES preparation. Optimum protein concentrations
were therefore taken as 15 pg/ml and 10 pg/ml for WFA and ES preparations,
respectively, for the remainder of the experiment.
3.3.9.2 Proliferative responses ofunstimulated cells throughout the study
The proliferative activity of negative control, unstimulated cells (background
response) altered over the study period (Figure 3.12). Some animals in each of groups
A and B showed extremely high background responses shortly after infection at days
7 and 14 (Figure 3.13). There were exceptions in both groups: calves 65 (group A)
and 76 (group B), which displayed responses similar to previous, pre-infection levels.
However, after secondary challenge at day 35, background responses in groups A and
B decreased substantially. Group C animals showed little change in control cell
proliferative levels during the experiment and the background response of group D
after challenge, at day 35, was also low.
The alteration in proliferative responses of control (unstimulated) cells after
infection in some, but not all, animals meant that displaying results of the test
(antigen stimulated) response as a ratio of the negative control response, i.e. the
stimulation index (SI), was not appropriate. Animals with similar test responses but
very different backgrounds responses, in counts per minute, showed widely differing
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stimulation indices. For this reason, the net response, calculated as the gross count of
test stimulated cells minus that of control (unstimulated) cells was used to display the
results. Use of the SI alone would be misleading, suggesting some animals responded
poorly to antigenic challenge, when in fact very strong responses were obtained.
3.3.9.3 Proliferative response to whole fluke antigen and excretory-secretory
preparations after primary and secondary infections
Figures 3.14 and 3.15 show individual net proliferative responses to WFA
and ES preparations at days 14/15, 26/27 and 35/36 for all animals. Considerable
variation in cellular responses within the four groups was observed. This is of
particular note with group C animals and the response to the WFA preparation: calf
54 showed a strong proliferative reaction at days 14/15 and 26/27, whereas that of
calves 57 and 64 was low. In group D, calf 43 also showed a greater response at day
35/36 than the other three animals in the group. In general, responses to the ES
preparation were poorer and more variable than those to the WFA preparation.
The group mean net proliferative responses are shown in Figures 3.16 and
3.17. Again, the degree of individual variation is illustrated by the magnitude of the
error bars displayed. However, some general comments can be made regarding the
overall group response to these proteins. Both groups A and B showed a strong
response to stimulation with WFA and ES proteins during the early period after
primary challenge at days 7/8 and 14/15. By day 26/27, the group A response was
much less prominent, whilst that of group B remained strong. The group C response
throughout this period was weaker, although the excessive response of calf 54 raised
the group mean value as a whole. After secondary challenge, groups A, B and C
showed only a weak proliferative response to stimulation with both WFA and ES
preparations, whilst that of group D, previously negative, was moderate. The
difference in response between group D and the other groups at day 35/36 was only
significant for the group A response to WFA (P = 0.03). Again, group variation,
particularly the excessive response of calf 43 in comparison to the other group
members, raised the mean value of group D. It should be noted that proliferative
responses of the other three individuals in the group were of a similar order of
magnitude to that observed with calves 40 and 71 of group B and calf 54 of group C.
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Figure 3.10: Proliferation of peripheral blood mononuclear cells at days 14/15 for
groups A, B and C; titration of whole fluke antigen (WFA) preparation. Cells were
cultured for a 5 day period either unstimulated (control) or with WFA (30-1 jig/ml).
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Figure 3.11: Proliferation of peripheral blood mononuclear cells at days 14/15 for
groups A, B and C; titration of excretory-secretory (ES) preparation. Cells were
cultured for a 5 day period either unstimulated (control) or with ES (20-1 pg/ml).
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Figure 3.12: Proliferation of unstimulated (control) peripheral blood mononuclear
cells after a 5 day culture period, shown as group means, for groups A, B, C and D at















Figure 3.13: Proliferation of unstimulated (control) peripheral blood mononuclear
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Figure 3.14: Individual peripheral blood mononuclear cell proliferative responses to
whole fluke antigen (15 pg/ml) at days 14/15, 26/27 and 35/36 for groups A, B, C
and D. Cells were cultured over a 5 day period and results are shown as the net
proliferative response (the difference between antigen-stimulated and unstimulated i.e
control cultures). Animals in group A are shown as solid bars, in group C as
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Figure 3.15: Individual peripheral blood mononuclear cell proliferative responses to
excretory-secretory preparation (10 pg/ml) at days 14/15, 26/27 and 35/36 for groups
A, B, C and D. Cells were cultured over a 5 day period and results are shown as the
net proliferative response (difference between antigen-stimulated and unstimulated i.e
control cultures). Animals in group A are shown as solid bars, in group C as
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Figure 3.16: Group mean peripheral blood mononuclear cell net proliferative
responses to whole fluke antigen (15 pg/ml) for groups A, B, C and D at all time-
points studied. Cells were cultured for a 5 day period. Error bars show the standard
error of the mean (n-4).
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Figure 3.17: Group mean peripheral blood mononuclear cell net proliferative
responses to excretory-secretory preparation (10 ug/ml) for groups A, B, C and D at
all time-points studied. Cells were cultured for a 5 day period. Error bars show the
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3.3.9.4 Proliferative responses to the mitogen Con A
The mitogen Con A was used as a positive control to check viability of cells.
All animals responded well, with strong proliferative responses. Proliferation was
relatively uniform within groups at all time-points studied, with the exception of
groups B and D on day 7/8 and group D on day 35/36 (Figure 3.18). Inter-group
variation was also low when compared to that observed with the WFA and ES
preparations. There were no significant changes in the proliferative response to Con
A over the study period with any of the groups (comparing pre- and post-infection
responses for each group), except for group B at day 35 and group C at day 7 (P =
0.03).
3.3.9.5 Comparison of individual proliferative responses with liver enzyme,
eosinophil andfaecal egg count levels
Proliferative responses to the WFA and ES preparations varied widely for
individual animals within the same group throughout the period of study (Figures
3.14 and 3.15). Individual peak enzyme levels and time-averaged eosinophil and
faecal egg counts were examined, in order to determine if extremes in these
parameters could account for the observed variation in the proliferative response.
Calf 54, of group C, showed a high proliferative response to both ES and WFA
preparations, but all infection parameters were of similar values to those of calf 57,
which had an extremely low proliferative response. Similarly, calf 43, of group D,
had a very high proliferative response to fluke proteins, although the peak GLDH
value and eosinophil level were similar to those of calves 69 and 73; calf 43 faecal
egg counts also fell in the midrange of the group. In group B, calf 76 had the lowest
peak enzyme levels, but the proliferative response was neither the highest nor the
lowest. Calf 71 (group B) was an exception to this, showing the greatest proliferation
as well as the highest group B GLDH and final egg count levels. These results
suggest that the wide range in proliferative responses within the groups cannot be
linked to particular trends in the other infection parameters measured.
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Figure 3.18: Group mean peripheral blood mononuclear cell net proliferative
responses to Con A (1 pg/ml) for groups A, B, C and D at all time-points studied.
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3.4 DISCUSSION
3.4.1 Pre-exposure alters the progression of a challenge infection
A clear difference in the blood and faecal infection parameters was observed
between the four groups. The chronically infected, group A, animals showed an early
increase in circulating levels of the two enzymes, y-GT and GLDH. Fasciola eggs
were detected in faeces from day 70 onwards and persistent eosinophilia of between
1.75-2.5 x 109 cells/ml was observed throughout the study. In contrast, the two
groups B and C, which received drug-abbreviated primary infections, reacted quite
differently. Patency was not established in any of the animals from either group until
day 98, 70 days after the secondary challenge infection. No change was detected in
the liver enzyme profiles during the primary phase of the study. However, both
groups B and C did show a small, but transient increase in the circulating eosinophil
count during the first three weeks following primary exposure. These observations
suggest that the abbreviated primary infections received by these groups had a
minimal damaging effect on the liver, did not reach patency within the expected time
period for a primary infection, but did stimulate an early circulating eosinophil
response.
The presence of the nai've group, D, that received only the secondary infection
at day 28, allowed direct comparison between the course of infection in previously
unexposed animals and in those that had been exposed to restricted early stages of the
parasite. Both the pre-exposed groups B and C had lower mean faecal egg counts
from day 112 onwards, when compared to that of group D. However, towards the end
of the sampling period egg output in all groups, including the chronic group A, in
which egg counts had been very high, converged.
Differences in the degree of liver damage experienced by groups B, C and D
were much more striking. The mean y-GT level in group B was approximately half
that of group D during the peak period (days 105-112), with the levels in group C
falling midway between the two. Due to the degree of individual variation within
groups, this difference between y-GT levels of groups B and D was only significant at
a few time-points. In contrast, GLDH levels in the three groups B, C and D were
more similar, although those of groups B and C were still lower than that of group D.
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Whilst this difference in group mean GLDH levels between groups B and D was less
marked than that for the enzyme y-GT, it was highly significant over much of the
time-course, due to minimal intra-group variation.
The eosinophilic response to the secondary challenge infection in groups B, C
and D was complex. All three groups showed an initial sharp rise in circulating
eosinophil counts during the first two weeks following secondary infection.
However, eosinophilia in group B then decreased rapidly and although elevated
above normal levels, remained lower than that of group D. As with all the parameters
examined, the group C eosinophilic response fell between that of groups B and D.
These results suggest that group B animals, which had received a 5-6 day
drug-abbreviated pre-exposure to juvenile flukes, experienced less liver damage, less
eosinophilia and showed a transiently lower faecal egg count than naive animals
upon challenge infection.
3.4.2 Problems associated with estimating fluke burdens
A major problem with both natural and experimental Fasciola infections is
the measurement of actual fluke burden. Faecal egg counts provide a useful guide to
the overall level of infection, but cannot be taken as a definitive measure of burden
for a number of reasons. Fasciola eggs may be released into the gut from the bile
ducts intermittently. Egg counts therefore vary from day to day for a particular
animal. The bulk of faecal material within the gut and gut passage time will also
affect egg density in the faeces. Although all calves were fed an identical diet,
variation in faecal consistency did occur; any transient looseness or diarrhoea will
have affected egg count values. The technique used to measure the faecal egg count
is another factor affecting the reliability of egg count data. In this experiment, the
zinc sulphate flotation technique was used. A sedimentation technique for measuring
fluke eggs is more reliable, because all eggs present in the sample are collected.
However, the sedimentation method is very time consuming and due to time
constraints, was not used in this experiment.
The use of weight dependent metacercarial dosing introduces a further
complication into the interpretation of the faecal egg count data, because animals did
not receive an identical dose. However, no linear association was detected between
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administered dose and egg output within groups. Representing egg counts as a linear
function of dose was not, therefore, considered appropriate and gross egg counts
were used in the analysis. This does not preclude a more complex relationship
between dose and egg output, which perhaps merits further investigation.
Furthermore, no association was detected between challenge dose and peak enzyme
levels or eosinophilia, excluding the negative correlation between dose and peak
GLDH levels in group D. This latter observation was unusual, but does support the
view that higher metacercarial doses did not automatically result in higher levels of
the various infection parameters.
The rise and subsequent fall in egg output in group A animals between days
112 to 125, eventually leading to a convergence in faecal egg counts between all four
groups towards the end of the sampling period, was interesting. This suggested that
either incoming secondary flukes began to produce eggs, boosting overall egg output,
or that those already resident had a period of increased fecundity. However, this
effect was short-lived; why did egg counts drop? The presence of density dependent
effects of worm numbers on fecundity has long been postulated in helminth systems
(Keymer, 1982, 1987). Evidence supporting the concept of density dependence has
been shown for a variety of nematode infections, including Ostertagia circumcincta
in sheep (Stear et al., 1999), Heterakis gallinarum in pheasant (Tompkins et ah,
1999) and Oesophagostomum dentatum in pigs (Roepstorff et al., 1996). The
presence of density dependence in fluke infections has not been investigated, but it is
reasonable to expect that within the limiting confines of the bile ducts, available
nutrients and space may affect parasite fecundity.
Alternatively, the reduction in group A egg counts could have been due to the
death of either the primary or incoming secondary parasites. This may have been a
result of natural ageing of the fluke, or indirectly, as a result of excessive host
reaction, such as fibrosis around the bile ducts, resulting in an unsuitable
environment for fluke survival. Host immune modulation of parasite fecundity is also
a possibility. It would have been useful to have continued egg output measurement
for a further few weeks in this study, to determine whether or not egg counts
stabilised or continued to drop in the chronic group A. Furthermore, any changes
seen in egg output in the other groups as infections matured may have provided some
indication as to whether the rise between days 112-125 observed in group A was due
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to a period of increased fecundity during the primary infection, or as a result of the
secondary challenge infection.
3.4.3 Changes in liver enzyme profiles
y-GT is a membrane bound enzyme; changes in serum levels are associated
with damage to the bile ducts, rather than to the liver parenchyma. GLDH, on the
other hand, is a cytosolic enzyme found in hepatocytes, which is released passively
when cells are damaged (Doxey, 1983). The longitudinal profiles of the two liver
enzymes y-GT and GLDH differed throughout the course of the experiment. GLDH
levels rose early, from day 28 onwards in group A and day 49 in group D. This
reflects the damage caused to the liver by migration of juvenile flukes during the
early stages of infection. Elevation in y-GT levels did not occur until much later,
from day 56 in group A and day 84 in the other groups. This elevation occurred
shortly after the expected time of arrival of maturing flukes into the bile ducts
(Kendall and Parfitt, 1962; Ross et al., 1966). The rise in y-GT levels was relatively
short-lived in groups B, C and D, but lasted twice as long in group A, probably as a
result of the two waves of flukes from both primary and secondary infections
reaching the bile ducts. GLDH levels also showed a prolonged elevation in group A,
compared to that in the other groups, again indicating that the secondary flukes were
actively causing parenchymal damage.
The drop in y-GT enzyme levels towards the end of the experiment suggests
that either the more mature flukes caused less bile duct damage, the bile duct
epithelia became unresponsive to damage and enzyme production was reduced or,
that flukes were being lost from the ducts. In contrast, GLDH levels were still
relatively high at the end of sampling. It is possible that the damage inflicted upon
the liver parenchyma by migrating juvenile flukes and the mechanisms involved in
healing, such as fibrosis, took longer to resolve than the changes in the bile duct
epithelium.
The magnitude of the difference in enzyme levels between groups B and D
was much smaller for GLDH than for y-GT. This difference could be an indication
that whilst the damage in the bile ducts in group B, and therefore perhaps the number
of flukes, was substantially less than in group D, considerable damage in the
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parenchyma still occurred. Host factors, possibly immune-mediated, may have
restricted progression of flukes from the parenchyma into the bile ducts. However,
the fact that enzyme levels may not be in linear association to the parasite burden
must also be considered.
In the present study no correlation was found between peak enzyme levels
and faecal egg counts for any of the calves. Fluke burden did not, therefore, appear to
be related to the degree of liver damage seen. A moderate positive correlation was
noted between peak GLDH and y-GT levels when the data was examined as a single
group, but not with groups B and D when examined individually. Other studies of F.
hepatica infection in cattle have also demonstrated the lack of correlation between y-
GT levels and fluke burden (Bulgin et al., 1984), although a positive correlation
between the number of juvenile flukes recovered from the parenchyma and GLDH
levels has been established (Leclipteux et al., 1998).
3.4.4 Eosinophils and F. hepatica infections
The early and sudden rise in the number of circulating eosinophils that
occurred in group A after primary infection and in groups B, C and D after secondary
challenge is typical for F. hepatica infections, having been noted previously in rats
and sheep (Poitou et al., 1993, Chauvin et al., 1995). The pre-exposed groups B and
C also showed a mild, transient eosinophilia shortly after primary infection, in
response to exposure to very early fluke stages prior to drug abbreviation. Eosinophil
numbers therefore rise rapidly after fluke invasion and this rise may be stimulated by
fluke migration across the gut, peritoneal cavity or liver capsule. The high peak level
of eosinophilia observed in groups B, C and D after secondary challenge was not
maintained in group B, in which a rapid drop to approximately half the peak value
occurred. This lower level was maintained until the end of the experiment.
Group B, which experienced the least amount of liver damage and showed
transiently lower egg counts, also had a lower final eosinophil count. This could be
reflective of a lower overall worm burden. The moderate positive correlation between
eosinophilia and early faecal egg counts support this theory. A weak correlation was
also detected between eosinophilia and peak enzyme levels.
The reason for the presence of a high peak eosinophilia in group B similar to,
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but no greater than that in the other groups shortly after secondary challenge is not
clear. The fluke burden during the first days after challenge in groups B, C and D
may be no different, thus initial eosinophil counts are similar. The absence of a
greater eosinophilia could be taken as an indication of the insignificance of this cell
type in protection to infection. However, tissue specific eosinophil counts may be
more significant than peripheral eosinophil levels in parasite infections, and these
were not evaluated in this study. The functional activation state of the eosinophil may
also be more relevant than total cell numbers, in situations where eosinophils are
thought to be protective. The importance of the activation state of eosinophils in
parasite killing has been shown in vitro with schistosomula and human eosinophils
(Veith and Butterworth, 1983) and with Haemonchus contortus in sheep (Rainbird et
al., 1998). The absence of a distinction in peripheral eosinophil levels between
groups B, C and D during the early secondary phase of the experiment, therefore,
may not accurately reflect possible differences in eosinophil activity between the
groups.
3.4.5 The use of chemotherapy to terminate infection
Two disadvantages in the use of drug treatment to terminate infections are
firstly confirming that complete clearance of the parasite has occurred and secondly,
the possibility that drug treatment per se may alter the immune response and thus
response to re-infection.
As mentioned in section 3.1, triclabendazole is the most effective fasciolicide
available for killing early stages of F. hepatica. Confirmation that all primary
infections in animals of groups B and C were terminated could only be obtained by
liver dissection, which was not carried out. Examination of individual enzyme
profiles of the animals in groups B and C gave no indication of an early rise in y-GT
or GLDH levels, although the escape of a small number of flukes may not have
resulted in a detectable change in enzyme levels. Sub-optimal doses of
triclabendazole in sheep are also able to lengthen the prepatent period (Biischer et al.,
1987), so the absence of eggs prior to the time when they first appeared in group D is
not conclusive proof that primary infection flukes had not established. However, the
evidence given here does support the view that the majority of primary infection
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flukes in groups B and C were killed by drug treatment.
In schistosomiasis, praziquantel treatment of chronic infections in humans
results in an enhanced humoral and cellular response to specific parasite antigens
(Roberts et al., 1993; Grogan et al., 1996a; 1996b; Satti et al., 1996; Mutapi et al.,
1998). Drug treatment appears to alter the immune response in a manner not seen in
natural infections. Praziquantel acts by both damaging the tegument and paralysing
the worm (Harnett, 1988). The former is likely to increase the release of antigens,
possibly exposing the host to antigens that may have been previously hidden. The
mode of action of triclabendazole on the fluke is not well understood, although the
main activity appears to be inhibition of mobility and secretory functions, probably
by interference with the microtubule system (Bennett and Kohler, 1987). Integrity of
the fluke tegument depends upon continual renewal of surface components, because
the glycocalyx is continually shed. Renewal is carried out by the secretory bodies,
which carry components from the TO, T1 or T2 cells in the syncitium to the fluke
surface. Triclabendazole alters secretory body function, possibly as a result of
interference with the microtubule system, leading to loss of the tegument within 24
hours in vitro (Stitt and Fairweather, 1993). Tegumental loss, resulting in parasite
disintegration, may expose the host to antigens quantitatively or qualitatively
different to those seen during live infections. This may have been a factor altering the
natural exposure and therefore immune responses to, early infective stages in this
experiment.
3.4.6 Peripheral cellular responses during infection
At day 7 post-infection, all three infected groups, A, B and C showed
extremely strong proliferative responses to both the WFA and ES preparations. This
indicates that early infection rapidly primed lymphocytes, even when the infection
had been terminated by drug treatment. Furthermore, even though all three groups
had only experienced invasion by juvenile flukes of up to a week old, cells were able
to respond to adult derived proteins. This suggests the presence of common antigens
between adult and the very early juvenile fluke stages which are recognised by
lymphocytes. As the primary infection progressed, the group A response decreased
substantially, whilst that of groups B and C remained relatively high (day 26). A
reduction in antigen specific cellular proliferation has been previously documented
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with chronic F. hepatica infections in cattle (Oldham and Williams, 1985; McCole et
al., 1999a); the response of group A was consistent with such findings. Groups B and
C may have been able to maintain a good proliferative reaction at this stage due to
the absence of maturing flukes. In addition, terminating infection by drug treatment
may have enhanced responsiveness by making more antigen available for lymphocyte
priming.
However, groups B and C did show a reduction in cellular responsiveness to
fluke proteins after the secondary challenge infection. Whilst both groups showed
similar levels of response to the WFA preparation, group B had a slightly greater
response to the ES preparation. The ability of the secondary infection to stimulate a
proliferative response was confirmed by the positive reaction obtained with group D
animals. One group D animal, calf 43, showed a much greater response than other
animals in the group. If the response of this animal is excluded, it can be seen that
both group B and D animals showed similar responsiveness to ES proteins after
secondary challenge, at day 35. The secondary challenge infection therefore reduced
group A and C proliferative responses to fluke antigen considerably and those of
group B to a lesser extent.
3.4.7 Parasites and modulation of host cellular responses
There are several possible reasons for the reduction in peripheral cell
reactivity observed during the course of the experiment. As the fluke migrates
through the different organs and tissues of the host, it matures through stages, until it
reaches the bile ducts. Mature flukes within the duct may be less "visible" to the host
immune system, and so provide less antigenic stimulation. Zimmerman et al. (1983)
suggested that differing stage-specific fluke products might alter cell responses and
the presence of a specific "suppressant" factor released by flukes has also been
postulated (Oldham and Williams, 1985). However, if the migratory phase in the
parenchyma is the main stage stimulating cell proliferation, high responses after
secondary challenge should have been observed in group A, when the secondary
wave of flukes entered the liver. Thus, the simple movement of primary flukes into
the bile ducts, supposedly becoming "less visible", cannot account for the depression
in the cellular response of group A. Flukes may release products which are able to
alter immune cell function, particularly if present locally in adequate concentrations.
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These may affect the interaction between lymphocytes and corresponding antigen
presenting cells. Alternatively, the presence ofmature flukes may have resulted in an
immune response which did not promote a positive cellular response to juvenile
migratory stages, perhaps by altering the cytokine environment or activation states of
host cells.
ES products have varying effects on host immune cells in vitro (section
1.2.6.6). Whether ES products are able to alter immune cell function in vivo, and
whether this action can persist in cells removed from an infected host and
subsequently cultured is not clear. In this experiment the alteration in proliferative
activity was noted over time, particularly after challenge infections. It follows that an
independent action of the ES or WFA preparations on cell function within the in vitro
culture system, per se, was not responsible. Any change effected by expression of
modulating factors by the flukes must therefore have occurred within the host and
been maintained after cells were removed for culture. A possible mechanism
whereby parasite products could exert such an effect is the down regulation of
signalling pathways within the cell.
Parasite-induced modulation of immune cell function has been observed with
other helminth parasites. Echinococcus multilocularis protoscoleces depress mitogen
stimulated proliferation of normal mouse spleen cells in an IL2 dependent fashion
(Kizaki et al., 1993). Glycophospholipids isolated from the metacestode may be
wholly or partly responsible for this action. Co-culture of healthy peripheral blood
mononuclear cells with mitogens and glycophospholipids was found to result in a
dose-dependent reduction in cellular proliferation (Persat et al., 1996). This was due
to a decrease in IL2 production by the cells, although IL2 receptor expression
remained normal. Another cestode, Taenia multiceps, produces two factors which
have opposing effects in vitro on mouse macrophage and T cells (Rakha et al., 1991).
One factor enhances stimulation of T cells by macrophages, whilst pre-treatment of
macrophages with the second factor results in a reduction in T cell responsiveness
after macrophage-T cell interaction. In mice, infection with the filarial parasite,
Brugia malayi, results in the generation of an IL4-dependent macrophage or
eoinophil population present within the peritoneal cavity, which is able to depress
lymphocyte proliferative responses to specific antigen (MacDonald et al., 1999). B
cells can also be affected by parasite products: the rodent filarial nematode
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Acanthocheilonena viteae is thought to depress B cell responses directly by
interfering with the protein kinase signalling pathway within the cell (Deehan et al.,
1998).
Changes in cell viability did not appear to be responsible for the reduction in
proliferative responses detected during this experiment. Cellular proliferation in
response to culture with the mitogen Con A remained unchanged throughout the
study period. This is in contrast to other ruminant studies: in sheep a reduction in
mitogen induced proliferation was noted as infection progressed (Zimmerman et al.,
1983), whilst a recent study in cattle observed a transient enhancement of cell
responses to Con A during the early infection period (McCole et al., 1999b). In this
experiment, F. hepatica infection did not modify the host cell response to the
mitogen Con A.
The reason for the variable change in background proliferative responses of
unstimulated (control) cells in groups A and B after primary infection is not clear,
although this phenomenon has been noted previously in F.hepatica infection
(McCole et al., 1999a). It is possible that early stage fluke infection resulted in non¬
specific cell activation within the host, and that these cells continued to proliferate
once in culture. Nonspecific polyclonal activation of normal lymphocytes has been
demonstrated with several helminth parasites, usually through the release of a
parasite factor with mitogenic properties. In vitro studies examining the effect of
antigen stimulation on cell proliferation have found that Toxocara canis is able to
stimulate macrophages and B cells (Wang et al., 1995), Heligmosomoides polygyrus
stimulates lymphocytes (Robinson and Gustad, 1997) and Ascaris products can act as
B cell mitogens (Lee and Xie, 1995). Furthermore, experimental infection of mice
with S. mansoni can result in B cell activation much greater than would be expected
by specific antigen alone (Lopes et al., 1990). In this study a specific mitogenic
action of the protein preparations themselves on cells did not appear to be
responsible, because group D cellular responses remained at background levels prior
to the secondary challenge infection.
An alternative explanation for the enhanced background response could be
that activated cells responding to a concurrent, unrelated infection, were included in
culture, for example, those responding to a respiratory viral infection. Animals were
housed in adjacent pens sharing the same air-space, so all groups would have been
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equally affected by a respiratory infection and therefore, it would be expected that
cells from all groups would respond in culture in a similar manner. This was not the
case, with all group C and D animals showing low background responses, except for
calves 66 and 69 at day 7, which had moderately raised background levels.
Examining the nature of the cell phenotypes present in control cultures before
and after growth and determining the cytokines released during culture with fluke
products, could be useful in the further investigation of the changes observed during
this experiment.
3.4.8 Conclusions
Cattle pre-exposed to 5-6 day old fluke infections experienced lower levels of
liver damage, eosinophilia and early faecal egg counts after secondary challenge
infection, when compared with nai've animals. These results suggest that the actual
fluke burden in 5-6 day pre-exposed calves was lower than in nai've animals and that
pre-exposure therefore resulted in a degree of resistance to secondary challenge
infection.
The results of proliferation studies using peripheral blood mononuclear cells
and crude fluke protein preparations indicated that 5-6 day pre-exposed calves were
as responsive as chronically infected animals to stimulation with fluke proteins
during the primary phase of the experiment. The adult fluke must therefore share
antigens which are common to early fluke stages of less than 7 days old. Animals in
the 5-6 day pre-exposure group were also able to maintain cellular proliferative
response to fluke proteins that was greater than that of chronically infected animals
during the 4th and 5th weeks of the study. No significant changes were observed in
cellular responses to the mitogen Con A throughout the course of the experiment.
86
CHAPTER 4
Cellular and cytokine responses of hepatic and mesenteric lymph node cells
from F. hepatica infected calves (Experiment B).
4.1 INTRODUCTION
Peripheral blood mononuclear cells provide a useful means of examining
time-course cellular responses to specific antigens during infection. With localised or
compartmentalised infections, however, peripheral cellular responses may be an
incomplete reflection of the immune response occurring at the infection site.
Furthermore, concurrent unrelated infections, for example subclinical respiratory
disease, may influence some of the responses shown by peripheral cells. Respiratory
disease is common in young cattle stock housed in a traditional manner and may well
have been present in the cattle used in Experiment A (Chapter 3). This problem of
concurrent infection becomes more significant when trying to examine the cytokine
responses of cells during culture. A low level respiratory viral infection could lead to
an enhanced IFN-y response if virus-activated cells are included in culture. The
cytokine response obtained in both unstimulated and antigen stimulated cultures
might therefore be distorted.
An alternative, measuring site specific responses, provides a more accurate
reflection of the in vivo cellular response present during infection. This can be
achieved by extracting mononuclear cells from lymph nodes and examining the
response to stimulation with specific antigen, as with peripheral cells. There is
currently no published working describing local lymph node derived mononuclear
cell responses to fluke proteins during the early stages of F. hepatica infection in
cattle. As juvenile flukes penetrate the gut mucosa prior to migration through the
liver parenchyma, the cellular responses at both these sites was investigated in this
experiment.
Cytokine production by lymph node cells after stimulation with F. hepatica
proteins was investigated, as well as cellular proliferative responses. The nature of
the cytokines released by lymphocytes indicates the general nature of the effector
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immune response (section 1.2.9.1). In the past, much emphasis has been placed on
attempting to classify the exact nature of the T cell response, as either Thl or Th2.
This approach detracts from one of the prime reasons for examining the nature of
cytokine production, specifically vaccine design. Vaccine adjuvants and antigen dose
have a profound influence on the nature of the cytokine response induced to a
specific antigen after vaccination (Grun and Maurer, 1989; Constant and Bottomly,
1997). The route of inoculation may also influence the nature of the cytokine
response and is illustrated by a recent study in which mice were vaccinated against F.
hepatica using DNA encoding the glutathione S-transferase protein (Smooker et al.,
1999). Intradermal vaccination using a secretory type DNA construct induced an
IgGl and IgE antibody response, whilst intramuscular vaccination with a construct
favouring cytoplasmic expression resulted in the production of IgG2a. The recent
move towards the use of recombinant cytokines as adjuvants in bovine vaccines also
requires knowledge of the type of response to be boosted (Lofthouse et al., 1996).
Parasites are complex organisms composed of many antigens able to stimulate
differing and possibly opposing immune responses. Recently, attention has turned
towards the development ofmultivalent vaccines, either using various proteins of the
same parasite to protect against one infection, or of different parasites to protect
against several. Including proteins that are incompatible, and which may stimulate
opposing immune responses, could substantially reduce vaccine efficacy.
In the previous experiment (A), it was shown that calves pre-exposed to a 5-6
day period of F. hepatica infection showed signs of reduced liver damage and
eosinophilia upon subsequent challenge. The peripheral cellular response to fluke
proteins in these animals was highly variable. This experiment was therefore
designed to examine local, hepatic and mesenteric lymph node responses in
equivalent pre-exposed calves and in naive calves, shortly after a challenge infection.
It was anticipated that the study would provide an indication as to which of the two
locations, gut or liver, was the main immunoreactive site during challenge infection.
A more uniform response between animals in the same group was also anticipated,
because fluke infection would be the predominant stimulant of the immune response
at both these sites. As hepatic and mesenteric lymph nodes are not easily accessible,
this necessitates extraction at post-mortem. The responses at only one time-point
could therefore be examined for an individual animal.
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ExperimentalAims
• To examine proliferative responses of mesenteric and hepatic lymph node cells to
a crude F. hepatica protein preparation.
• To investigate cytokine production by hepatic lymph node cells after culture with
various F.hepatica preparations.
• To determine the cell phenotypes present in hepatic lymph nodes after challenge.
• To investigate the antigen recognition profile, if any, of cell culture supernatant
from hepatic lymph node cell cultures, by Western blots using various fluke
preparations (section 6.3.3).
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4.2 MATERIALS & METHODS
4.2.1 Experimental design
Preliminary trial
A preliminary trial was performed prior to the start of the main study, to
allow optimisation of the timing and methodology for lymph node extraction. Two
female Friesian-Holstein calves, aged 3 months, were given 450 F. hepatica
metacercariae per os and then treated 5 days later with triclabendazole at a dose rate
of 36mg/kg. On day 30, both calves were challenged with 500 metacercariae. Hepatic
and mesenteric lymph nodes were removed at post-mortem on day 11 (calf 827) and
day 14 (calf 813) after the secondary challenge infection.
Cell suspensions were prepared from lymph node material as explained in
section 2.4.2. A standard proliferation assay was carried out using whole fluke
antigen (WFA) at 15 pg/ml (concentration previously optimised by titration with
peripheral blood mononuclear cells taken during the first two weeks of the
experiment, data not shown) and Con A at 1 pg/ml. Cells were also cultured
unstimulated at a concentration of 2 x 106/ml and supernatant fluid collected after a
five day period, for later use (section 6.3.3). Proliferation was observed in hepatic
node derived cells at both of the time points studied.
Main study
Two groups of four calves were set up: a naive control group and a 5-6 day
exposure group, equivalent to groups D and B of Experiment A, respectively (the
groups in this study are therefore also termed D and B). Group B was dosed on day 0
with metacercariae, whilst group D received blank pellets; both groups were then
treated on day 5 with triclabendazole at a dose rate of 36 mg/kg (Table 4.1). Both
groups B and D were challenged with metacercariae on day 30. On each of days 40
and 41, 10 and 11 days post-secondary challenge, two calves from each group were
humanely slaughtered and the liver, hepatic lymph nodes and samples of mesenteric
lymph node collected.
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Table 4.1: An outline of the experimental design for the main study, showing the





Day 0 600 metacercariae per os Blank pellet per os
Day 5 Triclabendazole at 36mg/kg Triclabendazole at 36mg/kg




Day 40 Collect lymph nodes from two
animals (calves 9, 13)
Collect lymph nodes from two
animals (calves 16, 17)
Day 41 Collect lymph nodes from two
animals (calves 1, 2)
Collect lymph nodes from two
animals (calves 6, 12)
4.2.2 Stock
The animals used in the main study were intact, male Friesian-Holstein bull
calves aged between 4-6 months at the start of the experiment. Animals were
obtained from farms of the University of Edinburgh and had been reared indoors
from birth. Prior to the study, all animals were screened by ELISA to test the IgGl
antibody response to fluke excretory-secretory proteins (section 2.3). Animals were
screened twice, four weeks apart; all those used were negative.
Animals were allocated into two groups by stratifying for weight and then
using random numbers to place weight pairs into either group. The Student's t-test
showed no significant difference in the weight distributions between the two groups:
means 155 kg and 146 kg, P = 0.53. The two groups were then randomly classified as
either pre-exposure (B) or control (D).
4.2.3 F. hepatica infection
In this experiment a flat dose rate of a given number of metacercarial cysts
per animal was used, for two reasons. Firstly, the weight range of the calves was
moderate: prior to the start of the experiment, the weight range in group B was 135-
170 kg and before secondary challenge the range was 172-210 kg (group B) and 152-
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200 kg (group D). Secondly, the main point of interest in this experiment was the
immunological response to infection and not the relative levels of the various
infection parameters. A primary dose of 600 metacercariae per calf was used, but the
secondary challenge dose was reduced to 375 metacercariae per calf, because of
limited availability of the parasite. Metacercariae were counted and prepared for
dosing as in section 3.2.4.
4.2.4. F. hepatica protein preparations
Whole fluke antigen (WFA) and excretory-secretory (ES) protein fractions
were prepared as described in section 2.1.1. High molecular weight and cathepsin-L
pool fractions (section 2.1.4) were also used in the study.
4.2.5 Sample collection
Sera
Blood was collected weekly from each animal from day -21 until the end of
the experiment; sera was prepared (section 3.2.7), aliquotted and stored at -80°C for
later analysis of antibody responses (section 6.3.3).
Peripheral blood mononuclear cells (PBMC)
PBMC were isolated from blood as described previously (section 2.4.1) and
used in proliferation assays and for fluorescence activated cell sorting (FACS)
analysis of cell phenotypes (section 2.5). Proliferation assays were set up at three pre-
infection time-points (negative) and on days 7, 14 and 37 post-infection. FACS
analysis was carried out once prior to the start of the experiment and on days 7, 20
and 37.
Post-mortem samples
Animals were humanely slaughtered on days 40 and 41. Blood was collected
for sera preparation and was aliquotted and stored at -80°C. The livers, including
hepatic lymph nodes, and intestines with mesentery were removed from the carcass
and samples taken as quickly as possible. Whole mesenteric lymph nodes and half
portions of hepatic lymph nodes were placed into ice cold lymph node media and
removed to a tissue culture facility, where cells were extracted from the nodes as
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described in section 2.4.2. The following assays were carried out with the lymph
node derived cells:
• FACS analysis to determine cell phenotype of hepatic lymph node cells (section
2.5).
• Proliferation assays to examine hepatic and mesenteric lymph node cell responses
to stimulation with WFA and Con A preparations.
• Cell culture assay to investigate cytokine production by hepatic lymph node cells
after stimulation with WFA preparation.
• Unstimulated hepatic lymph node cells were grown over a 4 day period for
collection of supernatant fluid to be used in Western blot assays (section 6.3.3).
Excess cells were cryopreserved in 10% dimethyl sulphoxide (DMSO), 90% foetal
calf serum (FCS) (section 2.4.5) and stored under vapour phase nitrogen until
required.
4.2.6 Cell proliferation assay
PBMC and hepatic and mesenteric lymph node cells were cultured
unstimulated and with WFA at 15 pg/ml or Con A at 1 pg/ml in quadruplicate wells,
using the standard method (section 2.4.4). The optimum protein concentration for
cell stimulation had been chosen from previous titration studies (section 3.3.9.1).
Cryopreserved hepatic lymph node cells that had been in storage for 12
months were defrosted (section 2.4.6) and tested for proliferative responses to high
molecular weight, cathepsin-L pool, ES and WFA preparations. As the quantity of
high molecular weight and cathepsin preparations was extremely limited, titration for
optimisation of cell proliferation could not be done. Proliferation responses to the
high molecular weight fraction at 1 pg/ml and 0.2 pg/ml and to the cathepsin-L pool
fraction at 10pg/ml were therefore examined (hepatic node cells were found to be
unreactive to lower concentrations of the cathepsin fraction in a trial assay).
Proliferation assays were also set up using WFA at 15 pg/ml, ES at 10 pg/ml and
Con A at 1 pg/ml.
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4.2.7. Cytokine production after stimulation of hepatic lymph node cells with
fluke proteins
Cytokines produced by fresh hepatic lymph node cells after stimulation with
WFA were examined over a 96 hour period. Cells from all animals were cultured in
flat-bottomed 6 well plates (Nunc®) at a concentration of 1 x 106 cells/ml, either
unstimulated (control) or with WFA at 15 pg/ml, under standard conditions. Cells
and supernatant fluid from control and antigen stimulated cultures were then
harvested 24, 48, 72 and 96 hours later. Cytokine production by cryopreserved cells
was also examined in response to culture with the high molecular weight and
cathepsin-L pool fractions and the ES and WFA preparations. Cell cultures were set
up as for the proliferation assay above. Cell culture supernatant fluid only, was then
harvested at 72 hours.
Cells and culture fluid were harvested from the culture plates and the cells
pelleted by centrifugation at 120g for 10 minutes. The supernatant fluid was
smoothly decanted, aliquotted and stored at -20°C. The cell pellets from fresh hepatic
node cell WFA-stimulated and control cultures were resuspended and washed in a
large volume of cold (4°C) PBS. by repeating the centrifugation step. These cell
pellets were then lysed using lysis buffer from either the "Qiagen RNeasy Mini"
(Qiagen) or the "SV Total RNA System" (Promega) RNA isolation kits. RNA was
extracted from the lysates according to manufacturers' instructions and stored at -
20°C. Unfortunately, due to lack of time, it was not possible to investigate the RNA
response. Cell culture supernatant fluid was tested by ELISA or bioassay for the
presence of the cytokines IFN-y, IL2 and IL4.
4.2.8 Bovigam1*1 ELISA assay to measure bovine IFN-y in cell culture
supernatant fluid
The presence of IFN-y in supernatant fluid was measured using the
BovigamrM ELISA assay system (CSL Limited, Poplar Road, Parkville, Victoria,
Australia). Samples were tested in duplicate following the manufacturer's
instructions. Recombinant bovine IFN-y (gift, from the Institute of Animal Health,
Compton, Berkshire) was used as the standard for a titration curve, to allow
quantification of any IFN-y present.
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4.2.9 Measurement of IL2 by bioassay with an IL2-dependent cell line
The presence of IL2 in supernatant fluid was measured by means of a
bioassay, using the bovine IL2-dependent cell line (4325), by Dr R. Collins at the
Institute of Animal Health, Compton, Berkshire, according to the method of Ktihnle
et al (1996). Results are presented here as the stimulation index: this was taken as the
response ratio between control and antigen stimulated cultures.
4.2.10 Measurement of IL4 by B cell bioassay
The presence of B cell growth factors in hepatic node cell culture fluid was
analysed by bioassay using B cells freshly harvested from an uninfected cow. This
assay was performed by the author, in conjunction with Dr R. Collins (section 4.2.9),
according to the method of Kiihnle et al (1996). Briefly, B cells were isolated from
PBMC obtained from a mature cow, using magnetic bead extraction with the
monoclonal antibody ILA58. Purified B cells (1 x 105 per well) were then cultured
with 33 pi of supernatant fluid in culture media for 24 hours under standard
i
... ,
conditions. Cells were labelled with H-labelled thymidine during the last six hours
of culture, harvested onto glass fibre filters and the amount of thymidine incorporated
into the cells measured by scintillation counter. Results are expressed as the
stimulation index. In order to examine whether the observed response is due entirely
to IL4, ablation of responses can be attempted using an anti-IL4 antibody. Complete
ablation of growth would suggest that the factor within supernatant fluid responsible
for growth was indeed IL4. Unfortunately, it was not possible to carry out this assay
due to a lack of time and materials.
4.2.11 Production of antibody by unstimulated lymph node cells
Lymph node derived mononuclear cells were incubated at a concentration of
2 x 106 cells/ml in complete media alone for 4-5 days under standard conditions. The
supernatant fluid was collected by harvesting the cell suspension and centrifuging at
120g for 10 minutes. Supernatant fluid was decanted without disturbing the cell
pellet and stored at -20°C. This was used neat as an antibody probe on Western blots
of fluke proteins (section 6.3.3).
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4.3 RESULTS
4.3.1. Peripheral blood mononuclear cell proliferative responses to culture with
whole fluke antigen
All group B peripheral blood mononuclear cell samples showed substantial
proliferative responses to WFA at both days 7 and 14 (Figure 4.1). The response of
individual animals was in many cases greater than or of a similar magnitude to that
obtained by culture with the mitogen Con A.
PBMC collected on day 37 from both groups B and D were tested for
proliferative responses to WFA after they had been in cryopreservation for several
months. Cells were responsive to WFA antigen, with no significant difference in the
magnitude of the response between groups B and D (Figure 4.2). This is in contrast
to the proliferation results of Experiment A, where the 7 day post-challenge response
was lower in the pre-exposed group, B, than in the naive control group, D (section
3.3.10). It is worth noting that the variability between responses of animals within the
same group was reduced in comparison to those obtained in Experiment A. This
could be due to the fact that all animals were obtained from a single, closed farm.
The response of the cryopreserved cells to the WFA preparation at day 37 was lower
than that to the mitogen Con A, unlike the day 14 response obtained with fresh group
B cells, where the reverse was seen. Group B cell proliferation to WFA was also
reduced after challenge, compared to the day 14 response. This reduction could be
due either to altered reactivity or viability of the cells as a result of cryopreservation
or as a direct result of the secondary challenge infection.
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Figure 4.1: Longitudinal profile of group B peripheral blood mononuclear cell
responses to whole fluke antigen (WFA) and Con A at days 7, 14 and 37, shown as



















Day 7 □ Day 14 0 Day 37
Proliferative responses ofPBMC after a 5 day culture either unstimulated (control) or
with WFA (15 pg/ml) and Con A (1 pg/ml). Error bars indicate the standard error of
the mean, where n=4.
Figure 4.2: Group mean proliferative responses of groups B and D peripheral blood
mononuclear cells to whole fluke antigen (WFA) and Con A after the secondary
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Proliferative responses ofPBMC after a 5 day culture either unstimulated (control) or
with WFA (15 pg/ml) and Con A (1 pg/ml). Error bars indicate the standard error of
the mean, where n=4 for both groups.
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4.3.2 Peripheral blood mononuclear and hepatic lymph node cell phenotypes,
measured by FACS analysis
Group B longitudinalprofile ofperipheral bloodmononuclear cell phenotypes
There was no change in the proportion of CD4+, CD8+, CD14+ or yS+ T cells
present in the blood of animals in group B throughout the period of study (Figure
4.3). However, the proportion of B cells was significantly lower at day 37 than at any
of the other time-points. Group D cells were also examined on day 37 and no
difference was detected in cell phenotype proportions between this group and group
B for any cell type. It was expected that the proportion of B cells present in group D
at day 37 would have been similar to the level in group B prior to secondary
challenge i.e. at day 7. Also, as all other cell types were present at stable levels in
group B throughout the study, it is probable that the low percentage of B cells
obtained at day 37 was the result of a technical error and was not due to a genuine
decrease in the levels of peripheral B cells.
Hepatic lymph node cell phenotypes in groups B and D at day 40/41
The group mean cell phenotypes present in hepatic lymph nodes are shown in
Table 4.2. Results of Mann-Whitney U tests showed no significant difference
between the two groups for any of the cell types studied. A CD 14 positive cell
population was not detected in either group. Variability within the two groups was
low.
Table 4.2: Proportion of hepatic lymph node cells staining positive for the given cell
types, shown as the group mean and giving the standard error of the mean (SEM),




Group B Group D
CD4+ IAH-CC8 42.4 (4.1) 39.2 (5.6)
CD8+ SBU-T8 12.7(0.9) 16.4(1.7)
B cells VPM30 24.1 (3.7) 20.0(2.1)
y8+ T cells 86D 2.0(1.0) 0.5 (0.5)
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Figure 4.3: Proportion of peripheral blood mononuclear cells staining positive for the
given cell populations in group B at days 7, 20 and 37, shown as the group mean.
■ Negative 0 Day 7 H Day 20 □ Day 37
Cells were taken at a negative time-point (pre-infection) and on days 7, 20 and 37
post-infection. The proportions of cells staining positive for the cell types are shown:
CD4, CD8, GD (yd T cells), B cells and CD14. The group mean is shown and error
bars denote the standard error of the mean (n=4).
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4.3.3 Lymph node cell proliferative responses to whole fluke antigen and Con A
Preliminary trial
Both trial animals, 813 and 827, showed lymph node proliferative responses
of a similar magnitude to one another, despite the three day interval between the two
harvests. Hepatic lymph node cell responses to culture with the WFA preparation
were much greater than those of mesenteric node derived cells for both animals
(Figure 4.4). The response of hepatic node cells to WFA was greater than that to the
mitogen Con A, whereas mesenteric node cell responses to WFA were much lower
than those stimulated by Con A.
A hepatic lymph node cell response to the adult fluke protein WFA was
present 10 days after the secondary challenge infection. A final time-point of days 10
and 11 post-secondary challenge was therefore decided upon for lymph node
collection in the main study.
Main Study
Hepatic lymph node cells from all animals in groups B and D showed a
substantial proliferative response to stimulation with the WFA preparation (Figure
4.5). Responses were, in all but one case (calf 6), comparable to or greater than the
response obtained by Con A stimulation (Table 4.3). There was no difference in the
magnitude of the response between the two groups. In contrast, the mesenteric
response to the WFA preparation was low. Mesenteric cells from three of the calves
in group D (calves 12, 16 and 17) showed slightly greater proliferation than those
from group B animals. Mesenteric cells from calf 9 were contaminated by fungus and
the results are not included.
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Figure 4.4: Proliferative responses of hepatic and mesenteric lymph node cells of the



















Cells were cultured unstimulated (control) or with WFA (15pg/ml) and Con A (1
pg/ml) preparations over a 5 day period. Mean gross counts per minute of
quadruplicate cultures for individual samples are displayed, with error bars showing
the standard error of the mean.
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Figure 4.5: Hepatic and mesenteric lymph node cell proliferative responses to whole











































Individual proliferation results for hepatic and mesenteric lymph node cells from
group B and D animals after a 5 day culture with WFA (15pg/ml). Results shown are
the difference (net counts per minute) between WFA-stimulated and unstimulated
(control) cells. Group D (naive control) animals are marked *. Note that there was no
mesenteric sample for calf 9 of group B.
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Table 4.3: Hepatic and mesenteric lymph node cell proliferative responses for
individual animals, shown as the stimulation index, for whole fluke antigen (WFA,
15 pg/ml) and Con A (1 pg/ml) stimulated cultures.
Animal Hepatic Mesenteric
Group Identity WFA Con A WFA Con A
B 1 152 197 3 629
2 63 68 3 664
9 101 102 N/D N/D
13 138 79 3 656
D 6 44 383 4 832
12 94 113 39 322
16 22 13 176 720
17 48 39 51 489
Key: N/D = not done
Response to stimulation with Con A
The stimulation indices obtained for mesenteric lymph node cells stimulated with
Con A were considerably greater than those of hepatic node cells (Table 4.3).
Analysing group B and D responses collectively, the hepatic response to stimulation
with Con A was greater than the mesenteric response (215,478 and 176,011 counts
per minute, respectively). However, background control counts from unstimulated
cell cultures were much lower with mesenteric node cell cultures: a mean of 297
counts per minute was obtained for mesenteric cells, compared to 3692 for hepatic
node cells. This difference in the background response accounts for the large
discrepancy in Con A stimulation indices between hepatic and mesenteric lymph
node preparations.
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4.3.4 Cytokine production by fresh hepatic lymph node cells after stimulation
with whole fluke antigen
IFN-y
Optical density values obtained in the BovigamIM ELISA assay for cell
culture supernatant fluid harvested between 24 and 96 hours are shown in Figure 4.6.
IFN-y production by all samples was low at 24 hours; differences between animals
became apparent at 48 hours, but by 96 hours all cultures were producing substantial
amounts. The amount of IFN-y present in the day 3 culture supernatant fluid was
quantified by titration with recombinant bovine IFN-y and is shown in Figure 4.7.
Overall, three out of the four calves from group B showed low IFN-y production in
WFA stimulated cultures (calves 1, 2 and 9), whereas three out of the four from
group D showed high production (calves 12, 16 and 17). Calves 6 and 13 were
anomalies in their respective groups. The difference in IFN-y production between
groups B and D was not statistically significant, however, due to the small number of
animals involved.
IL2 and B cell growth factor
The group mean stimulation indices over the 96 hour period for the IF2 and B
cell bioassays after culture with primary cell culture supernatant fluid are shown in
Figures 4.8 and 4.9. Stimulation of cell growth by supernatant fluid in both assays
was only moderate, although distinct from background responses. Supernatant fluid
collected from all WFA-stimulated cultures produced positive responses; there was
little difference between the two groups B and D. Cytokine production peaked at 72
hours for both IF2 and B cell growth factor. Supernatant fluid from group D cell
cultures resulted in the greatest variation in bioassay responses, particularly with the
IF2 bioassay. Samples from calves 16 and 17 showed the earliest production of both
cytokines and had the greatest IF2 production. Supernatant fluid collected from
lymph node cultures of calf 13 on day 3 and calf 6 on day 4 resulted in the greatest
responses in the B cell bioassay.
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Figure 4.6: IFN-y levels in whole fluke antigen stimulated cell cultures, during a 24 to





Hepatic lymph node cells were cultured with WFA (15 pg/ml) and cell culture
supernatant fluid collected at 24, 48, 72 and 96 hours. This was then tested for the
presence of IFN-y using the Bovigam1M assay. Net optical density values were
measured at 450 nm, and results are given as the difference between the value
recorded for antigen-stimulated and unstimulated cultures for each animal. Group D
animals (naive control) are marked *. There was no 96 hour sample for calf 9. Bars
denote 24 hour (speckled pink), 48 hour (black), 72 hour (dark red) and 96 hour
(speckled black) responses.
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Figure 4.7: IFN-y production in ng/ml by whole fluke antigen stimulated hepatic




1 2 9 13 6* 12* 16* 17*
Animal identity
The amount of IFN-y present in the 72 hour culture supernatant fluid was quantified
in the Bovigam™ assay using recombinant bovine IFN-y as a standard. Net
production (difference between antigen-stimulated and unstimulated cultures) is
shown in ng/ml. Group B animals are shown as speckled bars and group D as hashed
bars, together with an asterisk *.
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Figure 4.8: IL2 production by whole fluke antigen stimulated hepatic lymph node
cells, during a 24 to 96 hour culture period.
Supernatant fluid harvested from fresh hepatic lymph node cells cultures stimulated
with WFA (15pg/ml) was tested for the presence of IL2 using the IL2-dependent cell
line 4325. Proliferation of the cell line in response to addition of the primary culture
fluid, over a 24 hour culture period, is shown as the stimulation index with n=4 for
both groups at 24, 48 and 72 hours and n=3 for group B and n=4 for group D at 96
hours. Error bars show the standard error of the mean.
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Figure 4.9: B cell growth factor production by whole fluke antigen stimulated hepatic
lymph node cells, during a 24 to 96 hour culture period.
The presence of B cell growth factors present in cell culture fluid between 24 and 96
hours after stimulation with WFA (15 jag/ml). Culture fluid was added to purified
bovine B cells and proliferation measured after a 24 hour culture period. Results
represent the group mean stimulation index, with n=4 for group D and n=3 for group
B (calf 9 not tested). Error bars show the standard error of the mean.
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4.3.5 Proliferative responses of cryopreserved hepatic lymph node cells to
various F. hepatica protein preparations
Hepatic lymph node cells which had been stored under vapour phase nitrogen
were revived after several months of storage and tested for proliferative responses to
culture with the following antigen preparations: high molecular weight fraction,
cathepsin-L pool fraction, ES and WFA preparations. Cell loss during the defrosting
process was approximately 50%. Although the responses of defrosted cells may not
accurately reflect that seen with fresh cells, they were useful in indicating any major
trends in the cells response to the various fluke preparations. Figure 4.10 shows the
group mean net proliferative response to all the preparations studied. Individual
responses to the high molecular weight and cathepsin-L pool fractions are shown in
more detail in Figure 4.12.
All cells responded well to culture with the WFA and ES preparations. The
response to WFA was slightly lower than that obtained with fresh hepatic node cells,
but was of a similar magnitude to the Con A response. The response to high
molecular weight and cathepsin-L pool fractions varied more widely between
animals than those to the WFA and ES preparations.
All animals showed moderate proliferation in response to stimulation with the
high molecular weight fraction at 1 pg/ml, with calf 2 showing an excessively high
response. The lower concentration of 0.2 pg/ml elicited a much lower response in all
calves, except for calf 2, with which the response was similar to that seen with the
higher concentration. There was no obvious difference in proliferative responses to
the high molecular weight fraction between groups B and D.
In contrast, proliferation in response to the cathepsin fraction was much
poorer overall. Cathepsin at a concentration of 1 pg/ml did not elicit a significant
response in a trial assay. Due to lack of material, it was not possible to try
concentrations above 10 pg/ml. A general trend of slightly lower responses to the
cathepsin fraction in group B, compared to group D, animals was evident, but this
was not statistically significant. Unlike the response to the high molecular weight
fraction, that of calf 2 to the cathepsin fraction was much closer to that of other
animals in the group.
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4.3.6 Production of IFN-y by cryopreserved hepatic lymph node cells after
culture with various F. hepatica protein preparations
Group mean IFN-y production at 72 hours for the various fractions tested is
shown in Figure 4.11 and individual IFN-y production to the high molecular weight
and cathepsin fractions in Figure 4.13.
The IFN-y response to the high molecular weight fraction at a concentration
of 1 pg/ml was very high for both calves 1 and 2 (group B). The latter animal also
had a high proliferative response, whereas that of calf 1 had been average.
Stimulation with the high molecular weight fraction at 0.2 pg/ml resulted in a more
uniform response with all eight animals, although little IFN-y was produced by the
cells from calf 9 in response to any of the proteins studied.
Cathepsin-stimulated production of IFN-y by cells from calves 1 and 2 was
much lower than that produced in response to the high molecular weight fraction,
similar to the pattern seen with the proliferative response. In contrast, all group D
samples and calf 13 from group B produced more IFN-y after stimulation with
cathepsin, when compared to that obtained with the high molecular weight fraction.
This was despite the fact that in all animals the proliferative responses to the
cathepsin fraction were lower than with the high molecular weight fraction. It would
therefore appear that although cathepsin did not stimulate a strong proliferative
response, cathepsin was a more potent stimulant of IFN-y production than the high
molecular weight fraction.
IFN-y production by fresh and cryopreserved cells after WFA stimulation was
compared and is shown in Table 4.4. Calves 2, 13 and 17 showed very similar
responses with both fresh and cryopreserved cells, however cryopreserved cells of
calves 1, 6 and 12 produced more, and those of calves 9 and 16 less, IFN-y than the
equivalent fresh cells. Despite these differences in the individual IFN-y response, the
overall pattern of low IFN-y production by group B animals, versus high IFN-y
production by group D animals was maintained. IFN-y production in response to
stimulation with the ES preparation had not been tested previously with fresh hepatic
lymph node cells. Flowever, responses of cryopreserved cells were very similar to
those seen with the WFA preparation.
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Figure 4.10: Proliferative responses of cryopreserved hepatic lymph node cells to
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Group mean net proliferative responses after a 5 day culture period with the
following: high molecular weight fraction at 1 pg/ml, HMW (H); high molecular
weight fraction at 0.2 pg/ml, HMW (L); cathepsin-L pool at 10 pg/ml; excretory-
secretory antigen at 10 pg/ml, ES, and whole fluke antigen at 15 pg/ml, WFA. Con A
was also used at 1 pg/ml. Error bars indicate the standard error of the mean, where
n=4 for both groups.
Figure 4.11: Production of IFN-y by cryopreserved hepatic lymph node cells in
response to a 72 hour culture period with various fluke protein preparations (as




















Figure 4.12: Proliferative responses of cryopreserved hepatic lymph node cells to the
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Individual net proliferative responses after a 5 day culture period with the following:
high molecular weight fraction at 1 pg/ml, HMW (H); high molecular weight fraction
at 0.2 (ig/ml, HMW (L); cathepsin-L pool at 10 pg/ml. Group D animals are marked
by an asterisk *.
Figure 4.13: Production of IFN-y by cryopreserved hepatic lymph node cells in
response to a 72 hour culture period with high molecular weight and cathepsin
fractions (as for Figure 4.12), shown as the net response (difference between antigen-
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Table 4.4: Comparison of IFN-y production by fresh and cryopreserved hepatic
lymph node cells after a 72 hour culture with whole fluke antigen at 15 pg/ml (group
D animals are marked *). Net IFN-y production (difference between antigen-
stimulated and unstimulated cultures) is shown.
Cell
source
Animal identity, giving net IFN-y (ng/ml) in culture fluid
1 2 9 13 6* 12* 16* 17*
Fresh 10.4 13.7 12.3 40.6 8 40 57.7 31.9
Cryo¬
preserved
18.5 13.9 3.4 38.8 25 63 36.6 26.1
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4.4 DISCUSSION
4.4.1 Distinct differences between hepatic and mesenteric lymph node responses
In this study a clear difference was observed between the local lymphocyte
response of hepatic and mesenteric lymph node derived cells to stimulation with the
WFA preparation. Hepatic node cells from both pre-exposed (group B) and naive
animals (group D) responded vigorously to antigen stimulation, and in many cases
this response exceeded or was of similar magnitude to the mitogen induced
proliferative response. It can therefore be concluded that within 10 days of infection,
juvenile flukes reached the liver and were present for long enough to stimulate an
effective lymphocyte response. Proliferative responses were similar in both groups,
with the exception of calf 6 (group D), so pre-exposure did not have any modulating
effect on the magnitude of the hepatic lymph node cellular response to a secondary
infection. This observation is supported by the results of peripheral blood
mononuclear cell proliferation assays, in which both groups B and D showed similar
proliferative responses to stimulation with WFA at day 37. In contrast, mesenteric
node derived cells responded weakly to stimulation with the WFA preparation,
although nai've animals showed a slightly greater response than pre-exposed animals.
The local response to adult derived F. hepatica proteins in this experiment was
therefore greatest at the level of the liver and not the gut.
As flukes mature and migrate through the host, their antigenic profiles
change, with some proteins being lost and others gained (Lammas and Duffus, 1985;
Dalton and Joyce, 1987; Tkalcevic et al., 1996). In this experiment, responses to
mature fluke preparations, only, were examined. Ideally, mesenteric cells should have
been stimulated with a metacercarial or a newly excysted juvenile preparation, as
these are the stages that gut associated mononuclear cells will have been exposed to.
Unfortunately, due to cost and the difficulties of supply at the time of the experiment,
sufficient parasites were not available to make these preparations. However, distinct
hypersensitivity reactions in colonic mucosae from infected rats have been noted in
vitro in response to specific stimulation with adult-derived antigens (O'Malley et al.,
1993). Gut responses in the rat are therefore not entirely specific to early juvenile
fluke antigens. The absence of a significant mesenteric response to juvenile antigens
in this study would have allowed more definite conclusions to be drawn regarding the
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inactivity of mesenteric lymphocytes to fluke proteins after Fasciola infection.
4.4.2 Species differences in the gut response
The results of this experiment suggest that the gut response to challenge
infection in the pre-exposed group was not significant. The lack of a gut-level
response is in agreement with the results of a previous study, in which no difference
was found between the number of flukes present in the peritoneal cavity of nai've and
sensitised calves after secondary challenge (Doy and Hughes, 1984). However,
eosinophilia and an increase in the number of mucosal mast cells have been detected
in ileal epithelium after secondary challenge infections in cattle, suggesting the
presence of a local cellular reaction in the gut (Wicki et al., 1991). Furthermore, in
vitro challenge of colonic mucosae, obtained from chronically infected cattle, with F.
hepatica proteins results in mucosal ion transport, again suggesting specific gut
reactivity to adult fluke proteins (McCole et al., 1998). The gut mucosa is therefore
reactive during fluke infection; whether a local lymphocyte response is involved and
whether the observed mucosal changes are beneficial to the host, is not known.
In contrast, the situation in the rat is quite different. Resistance to challenge
infections occurs at both the level of the gut and peritoneum or liver capsule (Doy
and Hughes, 1982). Immunohistochemical studies and experiments using ex vivo gut
loops, have demonstrated that resistance to challenge infection in sensitised rats is
associated with an increased number of eosinophils, mast cells and IgE-positive cells
in the gut mucosa (van Milligen et al., 1998a; 1999). Mesenteric node cells from
mice infected with F. hepatica produce cytokines after stimulation with fluke
proteins (O'Neill et al., 2000) and mesenteric nodes from infected rats are able to
produce fluke-specific antibody in cell culture (Meeusen and Brandon, 1994). These
studies show that specific mesenteric node responses to fluke proteins can be elicited
during infection in experimental models.
In this experiment, cytokine levels in bovine mesenteric lymph node cell
culture fluid were not measured, due partly to the absence of a significant response in
the proliferation assay, but also because the assays were very costly. It may be that
mice and rats, being inappropriate hosts for Fasciola, due to differences in the size
ratio between parasite and host, experienced greater gut pathology than would
normally be seen in the natural ruminant host. This could account for differences in
115
the immune responses and specifically in the gut response, between rodents and the
natural ruminant host.
4.4.3 Factors affecting the mesenteric lymph node response
One problem with interpreting the mesenteric response is the possibility that
responsive cells are not evenly distributed throughout the mesenteric lymph nodes. In
this experiment, samples of only one or two nodes were taken. The small intestine is
very long and as sampling had to be rapid to preserve the viability of cells and reduce
the chances of contamination, node selection was random. Ideally, the intestine
should have been unravelled and samples taken from nodes draining equivalent
stretches of the intestine. If flukes had penetrated the gut at some distance from the
sampling point and reactive cells were few and unevenly distributed, these reactive
cells could have been missed by sampling the wrong node.
The location of gut penetration by newly excysted juveniles (NEJs) in the
intestine has only been examined in experimental animal models. The results of these
studies suggest that the majority ofmigration occurs through the mucosa of the small
intestine, particularly the jejunum (Kawano et al., 1992; van Milligen et al., 1998c).
NEJs do reach the colon in challenged rats, but significant penetration here is thought
to be unlikely. Gut passage in simple stomached animals with a short intestinal
length will be quicker than in ruminant animals. Flukes may therefore be able to
penetrate the intestine over a greater part of its length in rats, than in cattle. Whether
migration is site restricted and the importance, therefore, of sampling particular
regions of mesenteric node tissue in cattle, is not known. It should be noted,
however, that in the rat ex vivo model, intestinal mucosal responses were not
restricted to the site of challenge in the small intestine, but could also be found in
large intestinal tissue some distance from the site ofNEJ penetration (van Milligen et
al., 1998a).
4.4.4 Cytokine production by hepatic lymph node cells
The analysis of cytokine production by bovine cell cultures is severely
hampered by the lack of reliable assays for quick, reproducible and accurate
quantification. Consequently, full use of the material obtained in this experiment
could not be made and only tentative conclusions about cell responses to various
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protein fractions could be drawn. The proliferation obtained in the bioassays used to
detect the presence of IL2 and B cell growth factor, was only moderate, even with
positive control samples. To support the bioassay results, the presence of mRNA in
stimulated cells, encoding the various cytokines, should have been examined.
Unfortunately, although RNA was prepared, further assays could not be performed
due to lack of time.
Hepatic lymph node cells from all animals produced IFN-y in response to
WFA stimulation. Overall, naive animals (group D) produced more IFN-y than pre-
exposed animals (group B). This pattern was also reflected in the results of the IL2
bioassay: animals producing high levels of IFN-y, had a high IL2 stimulation index.
Little difference was seen in the ability of supernatant fluid from the two groups to
stimulate B cell growth. Due to lack of materials, an inhibition study using an anti-
bovine IL4 monoclonal antibody was not carried out. If addition of the antibody to
bioassay cultures had completely ablated growth of cells, it would be reasonable to
assume that the factor in culture supernatant causing B cell growth was indeed IL4.
Only two other studies examining local lymph node cytokine production in
responses to F. hepatica have been published to date. In a study of sheep, hepatic
lymph node cells obtained during early primary infection showed moderate
proliferation in response to stimulation with excretory-secretory (ES) preparation,
although activity varied considerably between individuals (Moreau et al., 1998). IFN-
y production was detected in only half of the animals sampled at day 10 post¬
infection, but was not found at any later time-points. F. hepatica infected mice
respond more consistently, with both hepatic and mesenteric lymph node cell cultures
producing cytokines after stimulation with crude adult homogenate at 3 weeks post¬
infection (O'Neill et cil., 2000). Cytokine profiles varied with mouse strain, infective
dose and the concentration of antigen used to stimulate cells, however overall, an
IL4/IL5 type response appeared to predominate. High dose infections were shown to
reduce mitogen-induced production of IFN-y and IL2 by spleen cells, compared to
low dose infections, suggesting some modulation of the lymphocyte response
occurred. Whereas in this study, cell responses to stimulation with Con A were
strong in both groups of animals.
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The results shown here are consistent with the view that during F. hepatica
infection, bovine T helper cells are able to produce mixed cytokine responses (Brown
et al., 1994a): hepatic node cells from groups B and D produced IFN-y, IL2 and B
cell growth factor after stimulation with fluke proteins. This is in contrast to the
situation in the mouse, where infection resulted in a predominantly Th2 like response
in both hepatic and mesenteric lymph nodes. The slightly lower production of IFN-y
by pre-exposed calves may suggest the presence of a more refined recall response. It
must be remembered that the WFA and ES preparations used here for cell stimulation
were crude, containing various antigens and therefore probably capable of
stimulating a heterogeneous T cell population with opposing effects.
4.4.5 Cellular responses to isolated F. hepatica proteins
Cathepsin-L pool and high molecular weight (HMW) fractions became
available in limited quantities for testing cellular responses some time after the initial
experiment was carried out. Cells used were therefore those that had been
cryopreserved in vapour phase nitrogen. Due to lack of antigen material, the assays
were not well optimised. Flowever, the results provide a general indication of the
local hepatic node responses to these two antigens in infected cattle, which has not
been previously examined. Given the interest in these two preparations as potential
vaccine candidates (Dalton et al., 1996), understanding lymphocyte responses to
these proteins during natural infection is critical.
Cell proliferative responses to the FIMW fraction were much greater than to
the cathepsin fraction at the concentrations used, with both pre-exposed and naive
animals giving a good proliferative response. With the exception of calf 2, nai've
animals (group D) showed a stronger response than those that were pre-exposed
(group B) with both protein fractions. IFN-y production at 72 hours was very
variable: high levels were present in culture fluid from calves 1 and 2 (group B) after
HMW stimulation, whereas that in all other animals was much lower. Cathepsin
induced IFN-y production was similar to that induced by the HMW fraction, despite
the fact that cellular proliferation was lower. It is a possibility that the peak
proliferative response to the cathepsin fraction occurred at an earlier time-point than
with the HMW fraction and was missed by examining the 5-day response. The timing
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of the proliferative response, together with the use of a wider range of cathepsin
concentrations, should be further investigated. Individual cathepsin induced IFN-y
production appeared to follow the pattern observed with the WFA and ES
preparations, with group D animals producing more IFN-y than those of group B
(excluding calf 13). Unfortunately, it was not possible to measure the levels of IL2
and IL4 in the supernatant fluid by bioassay. Conclusions regarding the overall
cytokine profiles induced by these proteins cannot, therefore, be made.
In summary, the high molecular weight fraction induced a moderate to high
proliferative response with the majority of samples, whilst stimulation with the
cathepsin fraction only resulted in a weak response. In contrast, IFN-y production
was high after stimulation with the cathepsin fraction, but variable in response to the
high molecular weight fraction. Both fractions were recognised by host cells during
the early stages of F. hepatica infection, suggesting that they were either produced
by, or cross reactive with proteins of, the early juvenile fluke.
4.4.6 Further limitations in the experimental method
The variability in the response of cryopreserved cells to the isolated fluke
proteins between animals of the same group may have been due partly to poor
optimisation of the assay, but also to alterations in cell viability after defrosting.
Cryopreserved cells did grow well in response to mitogen, WFA and ES stimulation
and responses within groups were more consistent with these preparations than with
the HMW fraction. However, mitogenic and WFA responses were reduced in
comparison to those obtained from cultures set up with equivalent fresh cells. In
addition, IFN-y production by fresh and cryopreserved cells in response to WFA
stimulation varied. Survival of cells during resuscitation was approximately 50%.
Further losses may have occurred after cell counting, during the plating procedure
and during the early hours of culture, which may have introduced further
inconsistency into the experiment. Any possible changes in cell phenotype
proportions after cryopreservation should have been examined, to determine whether
specific cell populations were lost during the preservation process. Ideally, all culture
assays should have been performed with fresh cells.
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4.4.7 Conclusions
The dominant cellular response at 10 days post-infection to F. hepatica whole
fluke antigen occurred in hepatic and not mesenteric lymph nodes. There was no
difference between the level of the proliferative response of peripheral and hepatic
lymph node mononuclear cells from 5-6 day pre-exposed or naive animals. However,
naive animals did display a weak mesenteric response, which was not detected in the
pre-exposed animals. Hepatic lymph node cells stimulated with whole fluke antigen
produced IFN-y, IL2 and B cell growth factor: an unrestricted T helper cell cytokine
profile. Cells from naive animals tended to produce a greater amount of IFN-y than
those from pre-exposed animals.
The phenotypes of peripheral blood mononuclear cells from pre-exposed
animals did not change over the period of study. There was also no significant
difference in the cell phenotypes present within the hepatic lymph nodes of naive and
pre-exposed animals.
The high molecular weight fraction induced a moderate proliferative response
in hepatic node-derived cells, whilst the cathepsin fraction resulted in a poor
response. Both fractions stimulated the production of IFN-y.
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CHAPTER 5
IgGl and IgG2 antibody responses of F. hepatica infected calves to purified
cathepsin-Ll and L2 pool and high molecular weight fractions.
5.1 INTRODUCTION
Juvenile and adult flukes secrete a variety of proteins in vitro culture which
are also thought to be released in vivo. A number of these proteins have been isolated
and characterised, including the cathepsin proteases and a haem-containing high
molecular weight fraction.
As discussed previously (section 1.2.10.3), the cathepsin proteases are able to
cleave immunoglobulin and prevent eosinophil attachment to newly excysted
juveniles in vitro (Smith et al., 1993b; Carmona et al., 1993). Although it has not
been demonstrated that this is a major activity of the protease within the mammalian
host, it is possible that immunoglobulin cleavage is an active immune evasion
mechanism. Vaccination of laboratory animals with purified cathepsin proteases
results in the production of neutralising antibody (Smith et al., 1994). Cathepsin
proteases may therefore be good candidate antigens for use in vaccination against
fascioliasis. Antibody to cathepsin stimulated by vaccination could prevent the
destruction of antibodies directed against other targets, possibly allowing host-
mediated fluke damage and subsequent elimination.
Vaccine trials, using cathepsin protease in conjunction with the haem-
containing high molecular weight fraction have had variable results (Dalton et al.,
1996; Mulcahy et al., 1998). One characteristic of vaccination was the induction of a
strong IgG2 antibody response to fluke products, not an isotype seen typically during
natural infections (Clery et al., 1996; Bossaert et al., 2000). This was noted when the
vaccine was administered in both Freund's complete and Freund's incomplete
adjuvant. However, administration of the vaccine in the latter adjuvant did not elicit
significant protection to challenge infections. Furthermore, animals vaccinated with
cathepsin/haem fractions in Freund's incomplete adjuvant showed similar
correlations between IgGl/IgG2 antibody titres and fluke burden to animals
receiving adjuvant alone. Thus vaccination and more specifically the adjuvant used,
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appeared to have a strong influence on the isotype pattern observed after challenge
infection.
Given the intense interest in these preparations as vaccine antigens,
examining antibody responses to these proteins during the early infection period is
important. In this experiment, sera from the four groups of calves of Experiment A
were tested for antibody responses to purified cathepsin-Ll/L2 pool and high
molecular weight fractions throughout the course of the study. Both IgGl and IgG2
isotype responses were examined, in order to determine whether a typical IgGl
response occurred, or an IgG2 response, as for vaccinated animals. Another reason
for examining the antibody isotype pattern is that different cytokines preferentially
stimulate the IgGl/G2 isotypes (section 1.2.9.2). By determining the IgG isotype
response, an indication of the nature of the T helper response can also be obtained.
Antibody responses were measured by indirect enzyme-linked
immunosorbent assay (ELISA). A simple analysis, examining optical density values
for the two antibody isotypes at selected time-points pre- and post-secondary
challenge infection was carried out initially. From these profiles, the time-points
where peak reactions occurred were selected and individual sera samples were then
fully titrated and group cut-off titre values calculated. A basic analysis was
performed, comparing titre values and the various infection parameters measured
previously (Chapter 3).
ExperimentalAims:
• To investigate the IgGl/G2 antibody isotype responses to cathepsin-L pool and
high molecular weight fractions, in the four groups of calves of Experiment A.
• To examine any differences between the responses of pre-exposed and
chronically infected animals during the first four weeks of infection and between
all groups of animals after secondary challenge.
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5.2 MATERIALS & METHODS
5.2.1 Antigen preparations
The high molecular weight and cathepsin-Ll/L2 pool fractions, prepared
from adult fluke excretory-secretory products, were gifts provided by Professor J.
Dalton, Dublin City University, Glasnevin 9, Dublin, Ireland (section 2.1.4).
5.2.2 Sera samples
Sera from all four groups of calves used in Experiment A (Chapter 3) were
examined for antibody responses to both fractions. The groups consisted of a chronic
infection group, A; a 5 day pre-exposure group, B; a 24 hour pre-exposure group, C
and a naive group, D, which had all then received a secondary challenge infection.
The longitudinal antibody response to the high molecular weight fraction
between days 0-98 and to the cathepsin-Ll/L2 pool fraction between days 0-112 was
investigated. This was performed by examining the group mean optical density
values obtained with test sera fixed at an optimised dilution. Individual sera were
also titrated out fully for each fraction: at days 28 and 56 with the high molecular
weight fraction and at day 105 for the cathepsin-L pool fraction. All samples were
assayed in triplicate for the longitudinal screens and in duplicate for the titration
series. Known positive and negative control sera was used as the plate standards and
for optimising the ELISA systems, which were obtained from a F.hepatica
chronically infected animal (calf 95).
5.2.3 Secondary and tertiary antibodies
Mouse anti-bovine IgGl and IgG2 monoclonal antibodies, obtained from the
hybridoma clones CVI.BoIgG1.15.8.1a and CVI.BoIgG2.12.5.4c, respectively (ID-
DLO, Edelhertweg 15, 8219 PH Lelystad, The Netherlands; Van Zaane and
Ijzerman, 1984), were used to detect bovine IgGl and IgG2 antibody isotypes. A
working stock at a concentration of 2 mg/ml was prepared in PBS. Bound
monoclonal antibodies were detected using a polyclonal rabbit anti-mouse IgG
horseradish peroxidase conjugate (Sigma A-9044).
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5.2.4 ELISA optimisation
Optimal concentrations of antigen, test sera and anti-bovine IgGl/G2
monoclonal antibodies were determined by sequential titration, using calf 95 positive
and negative sera. The tertiary conjugate antibody was used within the recommended
range, at a 1/5000 dilution.
5.2.5 ELISA protocol
Immulon-1 (Dynex Technologies, UK), 96 well microtitre plates were coated
with the antigen fraction at the relevant concentration prepared in carbonate buffer,
pH 9.6 (Sigma C-3041). The plates were covered with cling-film and left overnight
at 4°C. Plates were washed three times with PBS-T (Appendix A), then blocked with
2% normal horse sera in PBS-T for 1 hour at room temperature. Plates were washed
twice in PBS-T and then incubated with test sera, at the appropriate dilution in 1%
normal horse sera in PBS-T (ELISA diluent) for 1 hour at 37°C. Plates were again
washed three times and then incubated with the secondary monoclonal antibody,
prepared in ELISA diluent, for 1 hour at 37°C. Plates were washed a further three
times with PBS-T. The tertiary polyclonal anti-mouse-Ig horseradish peroxidase
conjugate was then used to detect any bound mouse monoclonal; again, a 1 hour,
37°C incubation step was used. After a final three-wash step, bound conjugate was
detected with the substrate 3,3',5,5'- tetramethylybenzidine, TMB (two component
system, Kirkegaard and Perry Laboratories Inc.). The reaction was stopped with 2M
sulphuric acid. All well volumes throughout were 100 pi, except for the blocking
step, which was 180 pi per well. Plates were read immediately at 450 nm on a ICN
Titertek Multiscan Plus (MK11) for the high molecular weight time-series and on a
BIO-TEK Microplate Autoreader (EL311) for all other ELISAs.
5.2.6 Statistical analysis
Statistical analysis was performed using the Minitab 12® software package
(Minitab Inc., USA). Group differences for the longitudinal analysis were
investigated by the Mann-Whitney U test. Differences in cut-off titre values were
examined by the Student's t-test. Any possible association between antibody





A summary of the reagent dilutions used for both the high molecular weight
and cathepsin-L pool fraction longitudinal ELISAs are shown in Table 5.1. Results
of the titration of the high molecular weight fraction are given in the following
section to demonstrate the method used for assay optimisation.
Table 5.1: Summary of optimised antigen, sera, monoclonal (secondary) antibody












0.5 pg/ml 1/300 1/2000 1/5000
Cathepsin-
L1/L2 pool
2.5 pg/ml 1/150 1/2000 1/5000
5.3.2 Titration results for the high molecular weight fraction
Antigen titration
The protein fraction was titrated downwards from a concentration of 4 pg/ml
in a doubling dilution series, with sera at 1/200, secondary monoclonal antibodies at
1/2000 and the tertiary conjugate antibody fixed at 1/5000 dilutions. Calf 95 pre-
infection and days 20, 48 and 88 post-infection sera were used. The titration curve
for the IgGl isotype is shown in Figure 5.1 and the binding ratios of positive to
negative sera at each dilution point for the IgGl response in Table 5.2. A final
concentration of 0.5 pg/ml was chosen for use; this was slightly lower than the
optimum determined by binding ratio, but was midway down the linear phase of the
titration curve. This offered a good distinction between positive and negative sera
whilst conserving the limited amount ofmaterial available.
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Sera titration
Using a coating antigen concentration of 0.5 fig/ml, calf 95 pre-infection, day
20 and day 68 post-infection sera were titrated from a 1/50 to a 1/3200 dilution in a
doubling series. Monoclonal, secondary antibody and tertiary conjugated antibody
concentrations were fixed at 1/2000 and 1/5000 dilutions, respectively. Figure 5.2
shows the titration curve obtained for the IgGl isotype and Table 5.3 shows binding
ratios for both IgGl and IgG2 isotypes. For both isotypes a sera dilution of 1/300
was chosen, as this was within the more linear phase of the titration curve.
Monoclonal, secondary antibody titration
Anti-bovine IgGl and IgG2 monoclonal antibodies were titrated in a
doubling series from 1/500 to 1/32000 dilutions of the 2 mg/ml working stock, with
antigen at 0.5 pg/ml, sera at 1/200 and tertiary conjugate antibody at 1/5000
dilutions. The binding ratios obtained with day 68 post-infection sera are shown in
Table 5.4. A dilution of 1/2000 for both monoclonals was decided upon. Again this is
slightly lower than optimum, but within the active region of the titration curve.
Table 5.2: Antigen titration binding ratios for the high molecular weight fraction and
IgGl antibody isotype, showing the optical density value ratio between calf 95
negative and days 20, 48 and 88 post-infection sera. Sera was used at 1/200,




Day 20 Day 48 Day 88
4 15.9 20.3 18.0
2 17.0 21.7 19.1
1 14.7 20.6 17.7
0.5 8.8 14.1 11.5
0.25 4.0 7.9 7.1
0.125 2.4 4.0 3.9
0.065 1.5 2.1 2.1
0 1.1 1.1 1.1
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Figure 5.1: Antigen titration curve for the high molecular
IgGl antibody isotype.
weight fraction and the
1.6
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
Antigen concentration (^g/ml)
NegativeDay 20 *- Day 48 —x—Day 88
Calf 95 pre-infection and days 20, 48 and 88 post-infection sera were used at a 1/200
dilution, with secondary anti-bovine IgGl at 1/2000 and tertiary antibody conjugate
at 1/5000 dilutions.

















0 0.005 0.01 0.015 0.02
Sera dilution
—*—Negative - Day 20 —Day 68
High molecular weight fraction was used at 0.5 pg/ml; secondary anti-bovine IgGl
at 1/2000 and tertiary antibody conjugate at 1/5000 dilutions. Calf 95 pre-infection
and days 20 and 68 post-infection sera was titrated from 1/50 to 1/3200 dilutions in a
doubling series.
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Table 5.3: Sera titration binding ratios for the high molecular weight fraction (0.5
pg/ml) and IgGl/IgG2 antibody isotypes, showing the optical density value ratio
between calf 95 negative and days 20 and 68 post-infection sera. The secondary





Day 20 Day 68 Day 20 Day 68
1/50 7.0 15.4 2.4 2.4
1/100 6.8 15.6 2.0 2.0
1/200 5.2 12.4 1.3 1.3
1/400 3.8 9.4 1.6 1.6
1/800 2.2 4.7 1.3 1.2
1/1600 2.0 3.0 1.0 1.0
1/3200 1.5 1.9 1.1 0.9
0 1.0 1.0 1.2 0.9
Table 5.4: Secondary monoclonal antibody titration for the high molecular weight
fraction (0.5 pg/ml) and IgGl/IgG2 antibody isotypes, showing the optical density
value ratio between calf 95 negative and day 68 post-infection sera. Sera was used at












5.3.3 Longitudinal IgGl and IgG2 antibody responses to the high molecular
weight fraction over the period days 0-98
The group mean optical density values for the IgGl and IgG2 antibody
responses to the high molecular weight fraction over the time-course studied are
shown in Figures 5.3 and 5.4. The results of Mann-Whitney U tests to compare
differences in optical density values between the four groups are shown in Tables 5.5
and 5.6.
An early rise in both the IgGl and IgG2 antibody isotype responses was
observed with groups A and B. The IgGl response was highest in group B at day 14,
but by day 28 this had altered so that group A showed the higher response. There was
a small rise in the group C IgGl antibody response during this early phase, which
reached a similar value to that of group B by day 28. In contrast, both groups A and
B showed a consecutive and matched early rise in IgG2 antibody levels during the
first 4 weeks of the experiment, whilst the IgG2 response of group C was negligible.
The difference in the IgGl response between groups A and B at day 28 was not
statistically significant, whilst that between groups A and C was significant.
After the secondary challenge infection, the IgGl antibody response was
boosted in all groups, although the rise in group A was minimal. Groups B, C and D
all showed a similar increase in mean optical density values, rising to a maximum at
day 56 and then gradually declining. The group B IgGl response was higher than
that of group D and this difference was significant on days 42 and 56. Although the
group C response was similar to that of B, it remained slightly lower and was not
significantly different to that of group D at any point. Groups B, C and D all showed
significantly higher IgGl responses than group A at days 56 and 70.
The pattern of the IgG2 response after secondary challenge was similar to
that seen with the IgGl isotype, although actual optical density values were much
lower. One notable difference was the fact that with the IgG2 isotype, group D
showed a greater response than group B, although this difference was not significant.
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Figure 5.3: Longitudinal IgGl antibody response to the high molecular weight
fraction over the period days 0-98, showing the group mean optical density values.
-♦- A B * C —D
Figure 5.4: Longitudinal IgG2 antibody response to the high molecular weight
fraction over the period days 0-98, showing the group mean optical density values.
-♦--A «- B * C D
Figures 5.3 and 5.4: The high molecular weight fraction was used at 0.5 pg/ml. with
sera at 1/300, secondary monoclonal antibody at 1/2000 and tertiary conjugate
antibody at 1/5000 dilutions. The arrow indicates the time of secondary challenge.
Error bars are not shown to aid clarity, however, the results of statistical analysis
comparing group differences are shown in Tables 5.5 and 5.6 on the following page.
Note: A copy of Figure 5.3, including error bars, is given in Appendix B.3.
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Table 5.5: Results of Mann-Whitney U tests comparing group differences for IgGl
and IgG2 antibody isotype responses to the high molecular weight fraction prior to
secondary challenge. The calculated P value is shown for the given comparisons.
Time-point IgGl response IgG2 response
A: B A:C A: B A:C
Day 14 0.27 0.27 0.41 0.01**
Day 28 0.10 0.05* 0.85 0.09
Key:
A result that is statistically significant is marked * and highly significant **.
Table 5.6: Results of Mann-Whitney U tests comparing group differences for IgGl
and IgG2 antibody isotype responses to the high molecular weight fraction after
secondary challenge. The calculated P value is shown for the given comparisons.
Isotype Comparison Day 42 Day 56 Day 70
IgGl A:D 0.19 0.0003*** 0.001***
B:D 0.001*** 0.05* 0.09
C:D 0.18 0.39 0.71
IgG2 A:D 0.06 0.001*** 0.004**
B:D 0.82 0.62 0.97
C:D 0.17 0.24 0.29
Key:
A result that is statistically significant is marked *, highly significant ** and very
highly significant ***.
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5.3.4 Longitudinal IgGl and IgG2 antibody responses to the cathepsin L1/L2
pool fraction over the period days 0-112
The longitudinal profile of the IgGl antibody response to the cathepsin-L
pool fraction is shown in Figure 5.5.
IgGl antibody levels in group A began to rise from day 35, climbing to a
sharp peak at day 70, declining to day 84 and then tailing off. Antibody levels in
groups B, C and D did not rise until after day 56. The response of group D was the
greatest, whilst groups B and C had lower and almost identical responses. The peak
response in the latter three groups occurred at day 98. There was no significant
difference between the response of group D and groups B or C at any time-point;
there was also no significant difference between the peak value of group A and that
of groups B, C or D (Figure 5.7).
The IgG2 antibody response to the cathepsin fraction was negligible in all
four groups and is not shown.
Table 5.7: Results of Mann-Whitney U tests comparing group differences for the
IgGl antibody response to the cathepsin-L pool fraction at the time-points shown.
The calculated P value is shown for the given comparisons.
Test A:B A:C A:D B:D C:D
Day 42 0.001*** 0.001*** 0.001***
Day 56 0.0002*** 0.0004*** 0.0002***
Day 70 0.001*** 0.43 0.96
Day 84 0.35 0.12 0.40
Day 98 0.06 0.27 0.23
Day 112 0.08 0.21 0.10
Key:
Results that are statistically very highly significant are marked ***.
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Figure 5.5: Longitudinal IgGl antibody response to the cathepsin-L pool fraction
over the period days 0-112, showing group mean optical density values.
-♦--A B * C —D
The cathepsin fraction was used at a concentration of 2.5 pg/ml, with sera at 1/150,
secondary monoclonal antibody at 1/2000 and tertiary conjugate antibody at 1/5000
dilutions. The arrow indicates the time of secondary challenge. Error bars are not
shown to aid clarity, but the results of statistical analysis comparing group responses
are shown on the preceding page.
Note: a copy of this figure, including error bars, is given in Appendix B.4.
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5.3.5. Estimated antibody cut-off titres for the high molecular weight fraction at
days 28 and 56
All day 28 and 56 sera were titrated in a three-fold dilution series from a
starting dilution of 1/100, for both antibody isotypes. An arbitrary negative cut-off
titre for each sera was determined by calculating the dilution giving an optical
density value of 0.2 for the IgGl isotype and 0.15 for IgG2. Negative cut-off titres
are often taken as the value given by the negative control standard plus three
standard deviations of replicates from the mean value. This convention was not used
in this study. Slight variation in the negative control standard value was observed
between plates. Although this variation was corrected by plate standardisation, a
small difference was still present. The significance of this difference could have been
magnified by taking curve intersections at such low optical density values. A higher,
arbitrary cut-off value was therefore chosen.
Cut-off titres were calculated by fitting a quadratic polynomial curve through
each data set using regression analysis in the Minitab 12® statistical package (Figure
5.6). The data points where the curve tended towards saturation (either high or low)
were omitted, because these had the effect of distorting the curve away from the
plotted data. The quadratic equation was solved numerically, by standard formula,
for x where y = 0.2 (for the IgGl response) or 0.15 (for the IgG2 response).
Group mean cut-off titre values for IgGl/IgG2 antibody responses to the high
molecular weight fraction at days 28 and 56 for the four groups are shown in Tables
5.8 and 5.9 and Figures 5.7 and 5.8. Differences between log titre values were
compared using the Student's t-test.
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Figure 5.6: Sera titration curves for calves 40 and 42 for the IgGl antibody isotype
response to the high molecular weight fraction on day 56, showing quadratic curves
fitted by regression analysis.
Regression Plot
Y = 7.97740 - 3.57702X+ 0.405816X"2
R-Sq = 100.0 %
Titre
Regression Plot
Y = 9.61399 - 4.43965X+ 0.517578X"2
R-Sq = 99.9%
Titre
Quadratic polynomial curves were fitted through sera titration data points, given as
log titre (x axis) and optical density value at 450 nm (y axis) using regression
analysis. In this figure, the regression curves for titration series of calves 40 and 42
for the IgGl response to the high molecular weight fraction at day 56 are shown. The
lower two log titre points of log 2.0 and 2.48 (equivalent to a 1/100 or 1/300 dilution)
are omitted, because the response had begun to saturate at high optical density
values. Cut-off titres were obtained by solving the given quadratic equation for x,
where y = 0.2 (for the IgGl isotype) or where y = 0.15 (for the IgG2 isotype). The r2
values indicate the goodness of fit for the curve; all r2 values were greater than 95%.
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Cut-off titresfor the high molecular weight response
At day 28, group A had the highest IgGl titre, followed by groups B then C;
group D remained effectively negative. The difference in titre between groups A and
B. and A and C was statistically significant (Table 5.10). The IgG2 isotype showed a
different pattern of response, with similar cut-off titres in groups A and B, whilst
groups C and D had low titres. Unlike the IgGl response, the slight difference
between the IgG2 cut-off titres for groups A and B was not significant. These results
support the observations from the longitudinal screens, in which group A showed a
higher IgGl response than group B, but a similar IgG2 response during the primary
phase of the experiment, just prior to secondary challenge.
After secondary challenge, at day 56, group D had the highest titre for both
IgGl and IgG2 isotypes, followed by B, C and lastly A. This was a slightly different
pattern to that observed with the longitudinal analysis, in which group B had a higher
optical density value for the IgGl isotype response than group D. The difference in
the IgGl and IgG2 cut-off titres between groups B and D was not statistically
significant, whereas that between C and D for the IgGl response was. Group A titres
were significantly lower than those of the other three groups.
5.3.6 Estimated antibody cut-off titres for the cathepsin-L pool fraction at day
105 (IgGl isotype only)
Sera were titrated out in a three-fold dilution series from a 1/50 dilution
onwards for the IgGl antibody isotype. An optical density value of 0.2 was again
chosen as the negative cut-off point and titres were estimated as explained
previously. Results are shown in Table 5.11 and Figure 5.9.
Group D gave the highest antibody titre to the cathepsin fraction, followed by
groups B, C and A. Despite the large difference in titre values, no significant
difference was detected by Student's t-test between group D and groups B or C (for
B versus D, P = 0.07 and C versus D, P = 0.06). This was due to the extent of titre
variation within groups. The titre results are in agreement with the optical density
profile obtained in the longitudinal screen (section 5.3.4), in which group D had a
higher optical density value than groups B or C.
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Table 5.8: Group mean cut-off titre values for IgGl and IgG2 antibody responses to
the high molecular weight fraction at day 28; shown as titre and log titre values.
Group
IgGl IgG2
Log Titre Titre Log Titre Titre
A 3.18 1497 2.72 530
B 2.68 483 2.62 414
C 2.40 251 2.19 157
D 1.35 22 1.90 80
Table 5.9: Group mean cut-off titre values for IgGl and IgG2 antibody responses to
the high molecular weight fraction at day 56; shown as titre and log titre values.
Group
IgGl IgG2
Log titre Titre Log titre Titre
A 3.23 1696 2.51 326
B 3.91 8212 3.25 1799
C 3.69 4937 3.01 1023
D 4.13 13535 3.44 2726
Table 5.10: Results of Students t-tests comparing group mean log cut-off titre values





Day 28 A vs B 0.02* 0.59
A vs C 0.004** 0.02*
Day 56 B vs D 0.11 0.33
C vs D 0.02* 0.08
Key:
Results that are statistically significant are marked * and highly significant ***.
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Figure 5.7: Group mean cut-off titres for IgGl and IgG2 antibody isotype responses




Figure 5.8: Group mean cut-off titres for IgGl and IgG2 antibody isotype responses




























Group mean titre values are shown as either a circle (IgGl) or a diamond (IgG2) for
each group, with error bars showing the standard error of the mean.
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Table 5.11: Group mean cut-off titre values for the IgGl antibody response to the
cathepsin-L pool fraction at day 105, shown as titre and log titre values.





Figure 5.9: Group mean cut-off titre values for the IgGl isotype antibody response
to the cathepsin-L pool fraction at day 105, showing log titre values, with error bars
indicating the standard error of the mean.
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5.3.7 Associations between antibody cut-off titre values and infection
parameters
Associations were investigated using Spearman's rank correlation between
log titre values and the following infection parameters: eosinophilia (averaged
between days 63 to 125), early faecal egg counts (averaged over the period days 121 -
128), peak glutamate dehydrogenase (GLDH) and peak gamma-glutamyl transferase
(y-GT) levels. The results are shown in Table 5.12.
Group B, C and D titres were analysed collectively as one group for the IgGl
responses to the cathepsin fraction at day 105 and for the high molecular weight
fraction at day 56. Significant positive correlations were noted between cathepsin
titres and early faecal egg out-put, eosinophilia, and peak y-GT levels. High
molecular weight IgGl titres at day 56 showed a significant positive correlation with
eosinophilia and IgG2 titres with peak GLDH levels. Scatter plots of cathepsin titre
against early egg output and peak y-GT values and of high molecular weight titre
against eosinophil counts are shown in Figure 5.10. A weak, but significant, positive
correlation was detected between cathepsin and IgGl high molecular weight day 56
titres (coefficient of 0.383, P = 0.04).
No significant correlations were detected for high molecular weight day 28
titre values for group B analysed independently, or for groups B and C analysed
collectively, and any of the above parameters. However, positive correlations were
observed between high molecular weight day 28 IgGl and day 56 IgGl titre values
(coefficient 0.653, P = 0.002) and day 28 IgG2 and day 56 IgGl values (coefficient
0.467, P = 0.04).
Table 5.12: Spearman's rank correlation coefficients showing the relationship
between antibody titres and various infection parameters, with the P value given in









Eosinophilia 0.37 (0.05) 0.55 (0.002) 0.34 (0.07)
Faecal egg counts 0.48 (0.01) 0.31 (0.11) 0.12(0.54)
Peak GLDH 0.29 (0.13) 0.18 (0.36) 0.42 (0.02)
Peak y-GT 0.51 (0.005) 0.15 (0.43) 0.22 (0.26)
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2.2 2.4 2.6 2.8 3
Cathepsin IgGl titre at day 105
3.2 3.4
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High molecular weight IgGl titre at day 56
Scatter plots to examine associations between infection parameters and titre values
were investigated for groups B, C and D, analysed collectively as a single group.
Cathepsin titre against peak y-GT levels is shown in (a), against faecal egg counts
averaged over days 121-128 in (b) and high molecular weight IgGl day 56 titre
against eosinophil counts (averaged from day 63 to 125) in (c).
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5.3.8 Association between the IgGl and IgG2 antibody isotype response
From the longitudinal profiles of the IgGl and IgG2 antibody response to the
high molecular weight fraction (Figures 5.3 and 5.4), it appears that after secondary
challenge the IgG2 response mirrored that of the IgGl response, but at a lower level.
Actual optical density values for the two isotype responses cannot be compared
directly, due to possible differences in monoclonal antibody affinity for their
respective targets, but also because the IgGl and IgG2 screens were performed
independently, on different days. However, a relative comparison between IgGl and
IgG2 responses for an individual animal can be performed by the use of scatter plots,
to examine possible correlation. Figure 5.11 shows a scatter plot for the IgGl
response plotted against the IgG2 response for the high molecular weight fraction at
day 56. Spearman's rank correlation showed a significant positive association
between the IgGl and IgG2 antibody responses in groups A and D, but not in groups
B and C: A, coefficient of 0.77*; B, 0.25; C, 0.65 and D, 0.72* (where * indicates
that the result is statistically significant with P < 0.05).
Figure 5.11: Scatter plot showing the relationship between IgGl and IgG2 antibody
isotype responses to the high molecular weight fraction at day 56, given as optical
density values (450 nm) for individual animals in groups B, C and D. Group B
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5.4 DISCUSSION
5.4.1 Antibody responses to the high molecular weight fraction appear early
during infection
A biphasic antibody response to the high molecular weight fraction was
observed over the time-course in groups A, B and C. In all three groups, an early
mixed IgGl/IgG2 isotype response was evident within 14 days of primary infection.
After secondary challenge, both pre-exposed groups B and C, together with the naive
group D, showed a rapid increase in antibody levels of both IgG isotypes. The peak
group mean optical density value obtained for group B during the second phase of
the experiment was greater than that of groups C and D. However, titration of day 56
sera found that the group D response was greater than that of group B. In the latter
case, the difference in antibody response between groups B and D was not
significant, although the difference between the day 56 IgGl response of groups C
and D was significant. IgGl antibody levels were always higher than those of the
IgG2 isotype. However, as binding of the two monoclonal antibodies for their
respective immunoglobulin targets had not been standardised, it was not possible to
conclude that the overall response of one isotype was greater than the other, although
this does seem likely. The secondary challenge infection in the chronic group A
appeared to check the early rise in both IgGl and IgG2 antibody responses to the
high molecular weight fraction.
It can be inferred from these results that the high molecular weight fraction
isolated from excretory-secretory products of adult flukes is either present or cross-
reactive with a similar protein in the early juvenile fluke. Both group B and C
animals were pre-exposed to flukes of less than 6 and 2 days old respectively, and
yet they were able to mount an antibody response during the first phase of the
experiment. It is possible that the presence of flukes that may not have been killed by
drug treatment were responsible for the group B and C response observed during the
primary phase. However, it is unlikely that the presence of a small number of escape
flukes would result in significant antibody production. Comparing the differences in
antibody titres between groups A and B during the primary phase of the experiment,
it should be noted that although group B values were significantly lower than those
of group A for the IgGl isotype, they were not for the IgG2 isotype. Early antibody
responses to the high molecular weight fraction have been seen previously in
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experimentally infected cattle as early as 1 week post-infection (McGonigle and
Dalton, 1995). Thus, the responses reported in this experiment with group B and C
animals are likely to be a genuine reaction to the short primary exposure that these
groups received.
During the primary infection period, group A appeared to develop a rising
antibody response to the high molecular weight fraction, which was cut short by the
secondary challenge on day 28. Comparing this with the response of group D, a
similar early rise of a parallel nature was observed after the secondary challenge
infection. However, group D reached a peak optical density value at day 56, 28 days
after infection. Why did group A animals not reach a similar peak value during the
first 28 days of primary exposure? Two possibilities could account for this
observation: either super-infection genuinely checked the rising antibody response to
the high molecular weight fraction in group A, or group D animals reacted
differently to a primary infection compared to animals of group A.
Considering the latter point, it is possible that the metacercariae of the
primary dose differed from those of the secondary dose, for example in terms of
viability, despite the fact that they were obtained from the same source. The primary
dose may have been less able to stimulate a strong antibody response in group A
animals, or metacercariae used for the secondary challenge may have grown more
rapidly in group D, releasing more antigen. However, the results of enzyme and
eosinophil analyses (section 3.3), show that the timing of events in longitudinal
profile for both groups A and D were very similar, and final peak enzyme and
eosinophil values were equivalent. This suggests that the course and nature of the
primary infections in both groups A and D was similar. Another factor which could
be responsible for the difference in the antibody response between the two groups
could be the slightly greater age of group D animals at first exposure. The additional
one months maturity may have enabled group D animals to mount a swifter immune
response to the antigen than group A animals.
Even if optical density and titre values at day 28 were indeed the group A
maximum for a single primary infection, the fact still remains that the secondary
challenge infection did not appear to boost the levels of antibody to the high
molecular weight fraction in group A animals. If the response was predominantly
stimulated by early juvenile expression of the protein and not by the presence of
more mature flukes, a further rise in response to the second wave of juveniles might
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be expected. One possible explanation for the dampened response could be that the
primary infection flukes were able to reduce the antibody response in some way to
the secondary challenge. Modulation of the observed antibody response could have
been brought about by diversion of antibody production to alternative, perhaps more
abundant antigenic targets; by direct regulation of B cell function (Deehan et al.,
1998); or by switching the antibody response to an isotype that was not measured in
this experiment. The presence of another antibody isotype, sharing the same
antigenic epitope, but present in greater quantities, could block binding of the isotype
under investigation in the ELISA reaction.
Alternatively, such a quantity of antigen may have been released by the
parasites into the peripheral circulation of the host that all available antibody was
bound in antigen-antibody complexes, a Gell and Coombs type III hypersensitivity
reaction (Meeusen, 1999). The quantity of free antibody in sera would be reduced,
giving the impression that the antibody response had decreased.
5.4.2 Antibody responses to the cathepsin-L pool fraction are not significant
during early infection
In contrast, antibody recognition of the cathepsin fraction was monophasic
and appeared later during the infection process. The response was dominated by the
IgGl isotype, with negligible changes in the IgG2 antibody response throughout
infection. An initial low rise in optical density values was observed in group A from
day 28 onwards, with the main increase occurring from day 42 and peaking at day
70. There was no detectable antibody response in groups B and C during the primary
infection period. IgGl levels subsequently rose in groups B and C and in group D
after the secondary challenge, peaking in all three groups at day 98, 28 days after the
peak observed with group A. Although both optical density and titre values
suggested that the response in groups B and C was lower than that in D, this
difference was not significant.
The appearance of antibody to cathepsin relatively late during the infection
process is consistent with the results from other studies. Control calves in cathepsin
protease vaccine trials showed only a minimal rise in antibody levels by ELISA at 3
weeks post-infection, but distinct recognition of doublet bands in Western blots of
excretory-secretory products, migrating at the cathepsin level, was noted from week
6 (Dalton et al., 1996). Recently, a comparison of diagnostic assays found that
145
antibody responses to crude excretory-secretory products and cathepsin-Ll peptide
fragments (peptides predicted by sequence analysis) were first detected from 4 weeks
post-infection after a heavy metacercarial challenge, whereas antibody to purified
whole cathepsin-Ll showed a lag of a further week (Cornelissen et al., 1999). The
presence of cathepsin-L proteases, as characterised by substrate analysis, has been
demonstrated in excretory-secretory products of newly excysted juvenile and three-
week-old flukes (Carmona et al., 1993). However, isolation and cloning of the only
major gelatin gel reactive protease in the 29 kDa region, present in newly excysted
juvenile ES, found that the protease was of the cathepsin-B class (Wilson et al.,
1998). N-terminal sequence analysis of newly excysted juvenile proteins has
demonstrated the presence of amino acids with homology to both cathepsin-B and
human cathepsin-L proteases (Tkalcevic et al., 1995). From these studies it is
apparent that early juvenile flukes do secrete a major protease which appears to be of
the cathepsin-B class, although the possibility of cathepsin-L protease secretion
cannot be ruled out. Absent or low expression of cathepsin-L by young flukes would
explain the later reactivity recorded in this study, in comparison to that observed with
the high molecular weight fraction.
It is interesting, given the low IgG response to the high molecular weight
fraction observed in group A after secondary challenge, that peak values for
cathepsin-specific antibody in groups A and D were so similar. Super-infection
appeared to have no modulating effect on the response to cathepsin, but additionally,
secondary challenge did not appear to boost the response either. Perhaps a secondary
infection has the action of prolonging the antibody response? If the antibody profile
to the cathepsin fraction had been followed for a longer period, differences in the
duration of response could have been examined. Alternatively, secondary flukes may
not have been able to mature in calves already carrying a primary infection.
Certainly, liver enzyme profiles were extended in group A animals compared to
those of group D (section 3.3.2), suggesting that the second fluke infection had a
damaging action on the liver and did reach the bile ducts. Directly testing the fate of
primary and secondary infections is difficult, although tagging metacercariae with a
marker resistant to shedding is a possibility. ^Selenomethionine has been used to
label Schistosoma mansoni cercariae, allowing the parasites to be localised within
host tissue after infection (Dean et al., 1984; Wilson et al., 1986).
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5.4.3 Associations between antibody titre and infection parameters
Moderate positive correlations were observed between cathepsin titres and
early faecal egg output, eosinophilia and peak gamma-glutamyl transferase levels,
suggesting that the cathepsin antibody levels acted in this study partly as markers of
infection. Associations between the response to the high molecular weight fraction
and infection parameters were less obvious, although moderate correlations were
noted with eosinophilia and peak glutamate dehydrogenase levels. A strong positive
association was also observed between pre- and post-challenge titres to the high
molecular weight fraction, indicating that animals that responded well during the
primary phase, were also those responding well after challenge. The analysis gave no
indication that higher antibody titres were associated with lower levels of infection.
However, Spearman's rank correlation is not a particularly powerful method for
measuring associations between parameters. A more detailed analysis, with the use
of regression models, should be attempted.
5.4.4 Specificity of reagents
To distinguish effectively between IgGl and IgG2 isotype antibody
responses, the specificity of the detecting reagent is crucial. In situations where very
strong IgGl or IgG2 responses are expected, a small degree of cross-reactivity is not
critical. However, where the response of an isotype may be negligible or very low,
specificity is important. Several large research establishments produce their own in-
house monoclonal antibodies to bovine IgGl and IgG2 isotypes; for those working
independently, sources are more restricted. The monoclonals used in this study were
chosen because they were available in reasonable lot sizes as purified material (in
some cases, monoclonal antibodies are supplied in the form of unpurified cell culture
supernatant fluid) and could be used at a high dilution, reducing the cost of screening
a large number of samples.
IgGl and IgG2 antibody responses to the high molecular weight fraction did
show a positive association. However, the presence of significant correlation does
not imply any causative effect and the fact that samples were positive for both IgGl
and IgG2 may be due to an independent factor. The scatter plot showed that in many
cases, there were groups of points with a close range in IgGl values, but a wide
range in IgG2 values. This would suggest that the IgG2 value obtained was not
associated with that of the IgGl value. However, it is also true to say that those that
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had a low IgGl response, also had a low IgG2 response i.e. poorly responsive
individuals were low to negative with both isotypes. This latter point may have
affected the correlation observed.
In summary, some degree of cross-reaction between the isotypes may have
occurred and requires investigation using purified bovine immunoglobulins.
However, the group B response during the primary phase of the experiment, during
which period the IgGl and IgG2 responses showed similar optical density and titre
results, suggests that an independent IgG2 response was also present.
5.4.5 Conclusions
An early mixed IgGl/G2 antibody response to the high molecular weight
fraction was detected in the animals receiving a 5-6 day drug-abbreviated primary
infection, indicating that this protein was expressed by very young flukes. IgGl
antibody titres at day 28 were highest in chronically infected animals, whilst IgG2
antibody titres were similar in chronically infected and 5-6 day pre-exposed animals.
After secondary challenge, 5-6 day and 24-48 hour pre-exposed animals developed a
predominantly IgGl antibody response, of similar magnitude to that seen in naive
animals. Pre-exposure did not, therefore, alter the progression of the antibody
response to this fraction. In contrast, the antibody response after secondary challenge
in chronically infected animals was minimal and did not increase substantially above
the primary infection levels, suggesting that the antibody response was "inhibited"
by the presence of maturing flukes.
The antibody response to the cathepsin-L pool fraction appeared later during
the infection process, was dominated by the IgGl isotype and did not appear to be
involved in the dynamics of the early immune response. Moderate positive
correlations between cathepsin titre and some infection parameters suggest that
antibody responses to the cathepsin fraction may act as markers of infection.
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CHAPTER 6
Peripheral and local IgG antibody responses to various F. hepatica protein
preparations in infected calves.
6.1 INTRODUCTION
In the previous chapter, IgGl and IgG2 antibody responses to two isolated
fluke proteins, cathepsin-L protease and a haem-containing high molecular weight
fraction, were examined. Although various other proteins have been isolated from
whole fluke (WFA) and excretory-secretory (ES) preparations (section 1.2.10), these
were not available for use in the current study. In order to examine antibody
responses to other fluke proteins during the early infection period in the various
groups of both Experiments A and B and to identify any differences between groups,
Western blot analysis was used. Of main interest was comparison of the pre-
secondary challenge antibody responses between chronically infected (group A) and
5-6 day pre-exposed (group B) animals and post-secondary challenge responses
between the latter and naive animals (group D). As well as investigating antibody
responses to adult-derived proteins, those to metacercarial and 14 day juvenile
preparations were examined.
Antibody produced locally, at the site of infection, may differ to that seen
peripherally, in sera. In F. hepatica infected rats, antibody produced by mesenteric,
hepatic and splenic lymph nodes recognise different proteins in homogenates
prepared from different ages of fluke (Meeusen and Brandon, 1994). The
predominant antibody isotype was also found to differ between the three nodes: IgA
was associated with the mesenteric node and IgE with the hepatic node. Although the
current study is not directly comparable, given the differences in protection against
challenge between sensitised cattle and rats (section 1.2.5), the methodology is
appropriate. Hepatic node cell culture fluid collected during Experiment B (section
4.2.11) was used to probe Western blots of fluke preparations, to examine the local
antibody response and to compare it with that seen in sera.
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6.2 MATERIALS & METHODS
6.2.1. Protein preparations
The following protein preparations were used: adult whole fluke antigen,
adult excretory-secretory protein, juvenile (14 day) fluke homogenate, metacercarial
crush preparation, high molecular weight fraction and cathepsin-L pool fraction
(section 2.1). WFA, ES, juvenile and metacercarial crush extracts were run under
reducing conditions on a large 10-15% SDS PAGE gradient gel (section 2.2) to
investigate the relationship between the various protein bands in the four
preparations.
6.2.2 Sera samples
Sera samples from calves of Experiment A (section 3.2.1) were tested on
blots of WFA and ES preparations. 7-8 animals from each group were used to
examine responses to WFA and 5 animals from each group for responses to the ES
preparation. Sera was tested at various time-points from the negative (pre-infection)
period to day 70 post-infection. Antibody responses to the cathepsin-L pool fraction
and juvenile and metacercarial crush preparations were tested on a limited number of
samples.
Sera samples from the 8 animals of Experiment B (section 4.2.1) were tested
for antibodies to WFA, ES, juvenile and metacercarial crush preparations. Samples
taken during the negative (pre-infection) period and on days 26 and 40/41 were
tested.
Hepatic lymph nodes from Experiment B animals were cultured unstimulated
in complete media as described in section 4.2.11. Cell culture supernatant fluid was
harvested after a 4 day incubation period and used neat as the primary antibody probe
on Western blots of WFA, ES, cathepsin-L pool and high molecular weight
preparations.
6.2.3 Secondary and tertiary antibody reagents
Polyclonal horseradish peroxidase conjugated anti-bovine IgG (Sigma A-
5295) and anti-bovine IgGl (Bethyl Laboratories Inc., USA), or monoclonal anti-
bovine IgGl/G2 antibodies (working stock 2 mg/ml; section 5.2.3), together with a
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polyclonal horseradish peroxidase conjugated anti-mouse IgG (Sigma A-9044) were
used to detect bound test antibody.
6.2.4 Polyacrylamide gel electrophoresis and Western blotting
Protein preparations were separated under reducing conditions on SDS PAGE
mini-gels of an appropriate acrylamide percentage, or on large 10-15% gradient gels
(section 2.2). The high molecular weight fraction was run under non-reducing
conditions. The separated proteins were then transferred onto 0.45 pm nitrocellulose
membrane (Amersham) using a semi-dry blotting system (TransBlot® SD, BioRad
Laboratories). Nitrocellulose membrane, Whatman 3M filter paper and the
acrylamide gel were incubated in transfer buffer for 30 minutes at room temperature
(RT). The gel sandwich was assembled and proteins transferred at 18-20V for 40
minutes. After transfer, the membrane was washed briefly in Tris-buffered
saline/Tween 20 (TBS-T, Appendix A).
The lanes containing the protein standards and some of the separated sample
proteins were cut off and stained with colloidal gold solution (BioRad Laboratories)
to show the position of the markers and sample proteins. The main blot was placed in
blocking buffer and incubated at RT with agitation for approximately 1 hour. The
blocking buffers varied according to the antibody conjugate that was used. Table 6.1
shows the type of gel, blocking buffer and antibody conjugates used with the various
protein preparations.
The blocked membrane was cut into 3-4mm strips (mini blots) or 5mm strips
(large blots) and rinsed briefly in TBS-T. Test sera was prepared at the required
concentration in blocking buffer and incubated with the membrane strips for 1 hour
at RT, with agitation. The strips were then washed four times in TBS-T. Strips were
incubated with either a directly conjugated horseradish peroxidase-labelled
polyclonal anti-bovine IgG or IgGl reagent, or with unconjugated monoclonal anti-
bovine -IgGl or -IgG2 antibodies, diluted in the appropriate blocking buffer, for 1
hour. The strips were again washed four times in TBS-T. Where a monoclonal
antisera had been used for the secondary antibody step, a further incubation was
carried out using a rabbit polyclonal anti-mouse IgG horseradish peroxidase-labelled
conjugate, for 1 hour at RT. After washing, any bound horseradish peroxidase
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conjugate was detected using 3,3',5,5'-tetramethylbenzidine (TMB) substrate (Vector
Laboratories, Inc.). The reaction was stopped with water and strips air dried in the
dark. Strips were mounted and scored visually.
The conditions used for each protein preparation, including gel type, sera
dilution and the nature of the secondary antibody reagent, are shown in Table 6.2.
Table 6.1: Secondary and tertiary antibody reagents used for Western blot analysis,
showing the antibody target, nature and source together with the dilution and
blocking agent used. The optimum dilution of the reagents was determined by
titration.
Target Type Source Conjugate Dilution Block
Bovine
IgGl
Polyclonal Sheep HRPO 1/2000 2% NSS
Bovine
IgG
















Key: NSS = normal sheep sera
HRPO = horseradish peroxidase conjugate
*: 2% soya milk was used for Western blots performed with cell
culture supernatant fluid and 3% soya milk for all other blots.
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Table 6.2: Conditions used for Western blots of the various protein preparations.
Optimal sera dilutions were determined by titration.
Protein preparation Gel type, with Sera Secondary and
(Eg) acrylamide % dilution tertiary reagents
WFA Large 10-15% 1/400 Polyclonal
(120 pg) anti-bovine IgGl
WFA Large 10-15% 1/400 Monoclonal
(120 pg) anti-bovine IgGl/G2
ES Mini 10 or 1/200 Polyclonal
(50 pg) 12% anti-bovine IgG
ES Mini 10 or 1/200 Monoclonal
(50 pg) 12% anti-bovine IgGl/G2
Juvenile Mini 12% 1/200 Polyclonal
(30 pg) anti-bovine IgG
Metacercarial Mini 12% 1/200 Polyclonal
(9 pg) anti-bovine IgG
Cathepsin-L pool Mini 14% 1/200 Polyclonal
(15 pg) anti-bovine IgG
High molecular Mini 7.5% 1/200 Polyclonal
weight (10 pg) anti-bovine IgG




6.3.1 Comparison of protein bands present in whole fluke antigen, excretory-
secretory, 14 day juvenile and metacercarial preparations
Figure 6.1 demonstrates the relationship between bands present in the four
preparations. Many of the proteins bands present in the ES and WFA preparations
were common to both, although a few protein bands were distinct in each of the two
preparations. Approximate band sizes in kDa were calculated from relative migration
distances, using a standard curve of known protein markers (Broad range markers,
BioRad Laboratories). Table 6.3 shows the size of immunoreactive bands in WFA
and ES preparations.
The juvenile preparation contained fewer protein bands than were present in
the WFA and ES extracts. The majority of reactive bands in the juvenile preparation
were common to those in either WFA or ES preparations. Nine reactive bands were
noted in the metacercarial crush preparation. Only one, of 45 kDa, appeared to be
common to bands present in the other preparations, although in some cases band
sizes were very close. Table 6.4 shows the size of immunoreactive protein bands
present in the juvenile homogenate and metacercarial crush preparations.
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Figure 6.1: Colloidal gold stain of blotted whole fluke antigen (WFA), excretory-
secretory (ES), juvenile and metacercarial preparations to show band relationships.
ES, 4 pg (lane 1), WFA, 4 pg (lane 2), juvenile, 4 pg (lane 3, 3*) and metacercarial
crush, 1 pg (lane 4, 4*) preparations were separated on a 10-15% gradient SDS
PAGE reducing gel and blotted onto nitrocellulose membrane. The positions of the
main immunoreactive bands are marked by arrows, with their size given in kDa.
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Table 6.3: Comparison of band relationships between whole fluke antigen (WFA)
and excretory-secretory (ES) preparations, showing sera reactive bands and their
estimated size in kDa.
Band size
in kDa
WFA ES Band size
in kDa
WFA ES
190 y y 54 / X
160 y 52 y y
140 y X 48 y y
120 X 45 y y
96 ✓ y 43 y y
93 ✓ y 41 y y
87 y 38.5 y y
82 ✓ y 38 y y
76 ✓ X 34 y X
72 X y 33 y X
70 y y 31 y y
68 y y 30 y y
65 X y 28 y y
60 X y 27 y y
59 y X 26 y X
58 X y 15 y y
57.5 y X 7 y y
55 y y
Where y indicates the band is present and X that the band is absent.
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Table 6.4: Protein bands present in F. hepatica 14 day juvenile and metacercarial




















All protein bands in the metacercarial preparation, except for band 45 marked *, had
differing relative migration (RF) values to the bands in the other fluke preparations,
even though calculated band sizes, to the nearest kDa, were the same (see Figure
6.1).
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6.3.2 Results of Western blots performed with samples from Experiment A
6.3.2.1 Longitudinal IgGl antibody responses to wholefluke antigen
A longitudinal analysis of sera IgGl antibody responses to WFA at days 0 to
49 was carried out with the sera from one animal in each of the groups A (calf 46), B
(calf 40), C (calf 66) and D (calf 69). The results are shown in Figures 6.2 and 6.3.
The group A animal, calf 46, showed little response to infection until day 28,
at which time there was weak reactivity to bands of size 96-82, 70 and 68, 59 and
57.5-45 kDa. After secondary challenge, at days 35 to 49, the response to these bands
was much stronger; in addition, there was a strong reaction to two bands of size 30
and 28 kDa. During the first 28 days of infection, sera from the group B animal (calf
40) only detected one band of 52 kDa in the WFA preparation. However, after
secondary challenge, calf 40 responded strongly to the 96-82, 70 and 68 kDa bands
and particularly to bands of 59 and 57.5-54 kDa. The pattern of response with calf
66, a group C animal, was very similar to that of calf 40, although reactivity to bands
70-68 and 59-57.5 kDa appeared slightly earlier, at day 21. Sera from the group D
animal (calf 69) was negative until after secondary challenge, after which point 96-
82, 70 and 68, 59 and 57.5-45 kDa bands were recognised, as for groups B and C.
There was no reaction to the 30 and 28 kDa bands at any point with sera from the
three animals of groups B, C and D.
The longitudinal antibody response to WFA was also examined with sera
from 8 animals in each of the four groups at days 0, 28 and 42 (mini time-series).
Separate blots were used for the different groups, however, conditions were
standardised, to allow comparison between groups. The response of group A is
shown in Figure 6.4. These blots confirmed the trends observed in the longitudinal
weekly series analysis, although the reactivity of group B animals at day 28 to bands
of 96-82, 76-68 and 59-52 kDa was greater than observed with calf 40, above (Table
6.5).
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Figure 6.2: Experiment A; longitudinal IgGl antibody responses to whole fluke
antigen for calf 46 (group A) and calf 40 (group B), from days 0 to 49.










Lanes 1-8 (calf 46, group A) and 9-16 (calf 40, group B) were incubated with sera
taken at days 0, 7, 14, 21, 28, 35, 42 and 49 post-primary infection, respectively. The
positions of the main reactive bands are marked by arrows, with the band size shown
in kDa. WFA was separated on a 10-15% SDS PAGE gradient gel under reducing
conditions.
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Figure 6.3: Experiment A; longitudinal IgGl antibody responses to whole fluke
antigen for calf 66 (group C) and calf 69 (group D), from days 0 to 49.
Lanes 1-8 (calf 66) and 9-16 (calf 69) were incubated with sera taken at days 0, 7,
14, 21, 28, 35, 42 and 49 post-primary infection. Major reactive bands are shown by
arrows, with band sizes marked in kDa. WFA was separated on a 10-15% SDS




: Experiment A; longitudinal IgGl antibody responses to whole fluke







Lanes 1-3, 4-6, 7-9, 10-12, 13-15, 16-18, 19-21 and 22-24 show the IgGl antibody
responses of 8 individual group A animals at days 0, 28 and 42 post-primary
infection, respectively. The positions of the major reactive bands are shown by
arrows, and band sizes marked in kDa. WFA was separated on a 10-15% SDS PAGE
gradient gel under reducing conditions.
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6.3.2.2 Fixed time-point group screens for IgGl antibody responses to whole fluke
antigen
The results of the longitudinal analysis indicated that the most important
period in terms of group differences in band reactivity lay between days 28 and 49.
By day 49, group A animals recognised 19 different protein bands. Sera antibody
responses of all four groups to WFA were therefore examined at days 28, 42, 49, 56
and 70. The same blot and identical conditions were used for all samples at a given
time-point, except for day 28 samples. Figures 6.5 and 6.6 show blots tested with day
42 and day 70 sera, respectively. The day 28 response (pre-secondary challenge) was
investigated using the mini time-series blots described in section 6.3.2.1. The day 28
response was compared between groups by scoring the response of every animal to
each band in the preparation (as either present or absent) and then collating the total
for the group. The number of animals in each group positive for a particular band at
day 28 is shown in Table 6.5.
(a) Early, pre-secondary challenge response
The group A response to bands 96-82, 70, 68 and 59-52 kDa at day 28 was
strong, with 6/8 to 8/8 animals recognising each band. The response to the lower
region bands of 30 to 27 kDa was faint and seen in only 1/8 to 2/8 animals. Sera from
group B also reacted to the 96-82, 70, 68, 59, 57.5 and 52 kDa bands, although the
response was not as great as for group A; no response to the 30-28 kDa bands was
detected for any group B animal. The group C response was similar in pattern to that
of group B, although it was weaker and bands were positive less frequently.
(b) Post-secondary challenge response
The band response pattern changed after the secondary challenge infection. At
day 42, 14 days post-challenge, group A animals still recognised the bands detected
at day 28, but additionally, the two bands of 30 and 28 kDa were strongly recognised
by all animals. In contrast, the group B response to the mid region bands of 96-82,
70, 68 and 59-54 kDa was enhanced after challenge, whilst no antibody response to
the 30 and 28 kDa bands was detected. Groups C and D also recognised the mid
region bands, but with less intensity than group B, with the group D response being
the weakest. By day 49, the differences between group A and the other three groups
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were quite pronounced: the antibody response to the lower region 30 and 28 kDa
bands was outstanding in group A and virtually absent in the other groups. In
contrast, recognition of bands 96-82, 70, 68, 59 and 57.5-54 kDa was very strong in
group B, but very weak in group A, and weak to moderate in group D. By day 70,
this difference in the band recognition pattern of lower weight versus mid weight
proteins, between group A and the other three groups, was further accentuated.
Although groups B, C and D did show some reactivity to the 30 and 28 kDa bands at
day 70, this was markedly less than that seen with group A.
Bands of 190, 160, 140 and 120 kDa were weakly recognised by sera from
various animals in all groups inconsistently after secondary challenge. The response
to the 120 kDa band was the most regular.
(c) IgGl/IgG2 antibody isotype responses at day 56
The IgGl antibody response pattern to the WFA protein described above, was
examined using a polyclonal antisera. Monoclonal antisera to both IgGl and IgG2
antibody isotypes became available later in the study. A further blot was performed
using day 56 sera from four animals in each of groups A, B and D, to examine the
IgGl/IgG2 isotype response. The IgGl response pattern was similar to that observed
at days 42 and 49 using the polyclonal anti-IgGl reagent for all three groups. The
IgG2 response at day 56 was minimal: weak reactivity to some of the bands
recognised by the IgGl isotype was detected. However, no moderate or strong IgG2
band reactivity was observed with any of the sera tested, suggesting the absence of a
specific IgG2 response at day 56.
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Table 6.5: IgGl antibody responses to whole fluke antigen at day 28 in groups A, B

















190 2/8 0 0 54 8/8 4/8 5/8
160 2/8 0 0 52 7/8 5/8 6/8
140 0 0 0 48 3/8 2/8 0
120 2/8 0 0 45 2/8 1/8 2/8
96 7/8 5/8 2/8 43 0 1/8 3/8
93 7/8 5/8 2/8 41 3/8 1/8 2/8
87 7/8 6/8 2/8 39 5/8 2/8 3/8
82 7/8 6/8 2/8 38 1/8 0 0
76 1/8 4/8 2/8 34 2/8 0 2/8
70 6/8 4/8 3/8 33 1/8 0 2/8
68 7/8 5/8 3/8 31 2/8 0 1/8
59 7/8 6/8 4/8 30 1/8 0 1/8
57.5 7/8 6/8 5/8 28 2/8 0 1/8
55 8/8 4/8 0 27 1/8 0 1/8
Key:
The score is highlighted in bold where more than three-quarters of animals in a group
recognised a particular band.
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Figure 6.5: Experiment A; IgGl antibody responses to whole fluke antigen at day 42
for groups A, B, C and D.
Group C
Day 42 IgGl antibody responses to WFA preparation for individual animals in
groups B (lanes 1-8), C (lanes 9-15), A (lanes 16-23) and D (lanes 24-31). Alternate
lanes are numbered. The positions of major reactive bands are shown by arrows, with
band sizes marked in kDa. WFA was separated on a 10-15% SDS PAGE gradient gel
under reducing conditions.
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Figure 6.6: Experiment A; IgGl antibody responses to whole fluke antigen at day 70
for groups A, B, C and D.
Day 70 IgGl antibody responses to WFA preparation for individual animals in
groups A (lanes 1-8), B (lanes 9-16), C (lanes 17-24) and D (lanes 25-32). Alternate
lanes are numbered. The positions of major reactive bands are shown by arrows, with
band sizes marked in kDa. WFA was separated on a 10-15% SDS PAGE gradient gel
under reducing conditions.
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6.3.2.3 IgG, IgGl and IgG2 antibody responses to F. hepatica excretory-secretory
preparation
(a) Total IgG antibody responses
Antibody responses in groups A and B to the ES preparation were detected in
all animals tested by day 28. The band recognition pattern in both groups was similar,
with antibodies to proteins in the mid region of 96-82, 72-68, 60, 58, 55 and 52 kDa
pre-dominating (Figure 6.7). At day 35, 7 days after secondary challenge, responses
to 96-52 kDa bands were still detected in both groups A and B, but by day 42, the
group A response to this region had begun to wane and a strong response to bands of
30 kDa and less was detected (Figure 6.8). In contrast, group B animals maintained a
good response to the mid region bands for a longer period than group A: significant
band reactivity was still present at days 49 and at day 56 (Figure 6.9). Both groups C
and D detected bands of 96-82, 72-68, 60, 58, 55 and 52 kDa from days 42-49
onwards, showing a similar response to that observed in groups A and B prior to
secondary challenge. Groups B, C and D only reacted weakly to bands of 30 kDa and
less at day 56, in complete contrast to the group A response.
(b) IgGl/G2 antibody isotype responses
The IgGl/IgG2 isotype antibody response pattern to the ES preparation was
examined at day 56 for groups A, B and D. The IgGl banding pattern was identical to
that obtained with the polyclonal anti-total IgG reagent, although recognition of
bands of 30 kDa and less in group A was not as strong. However, the group A
response to these protein bands was still clearly greater than that of groups B and D.
As with the WFA preparation, the IgG2 response was minimal, although samples
from three animals recognised bands of either 45, 60 and 58 and 41 kDa. No band
specific trend for the IgG2 response was noted.
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Figure 6.7: Experiment A; IgG antibody responses to F. hepatica excretory-






















IgG antibody responses to the excretory-secretory preparation for individual animals
in groups A (day 21: lanes 1-5, day 28: lanes 11-15) and B (day 21: lanes 6-10, day
28: lanes 16-20) The same individuals were used and were placed in order for each
time-point. The major sera-reactive bands are marked with arrows, with band sizes
given in kDa. ES was separated on a 10% SDS PAGE gel under reducing conditions.
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Figure 6.8: Experiment A; IgG antibody responses to F. hepatica excretory-










Pre-infection and day 42 IgG antibody responses to the excretory-secretory
preparation for individual animals in groups A (pre-infection: lanes 1-5, day 42:
lanes 6-10) and B (pre-infection: lanes 11-15; day 42: lanes 16-20). The position of
major sera reactive bands are marked with arrows, with band sizes given in kDa. ES
was separated on a 10% SDS PAGE gel under reducing conditions.
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Figure 6.9: Experiment A; IgG antibody responses to F. hepatica excretory-
secretory preparation for groups A, B, C and D at day 56.
Day 56 IgG antibody responses for individual animals in groups A (lanes 1-5), B
(lanes 6-10), C (lanes 11-15) and D (lanes 16-20). Major sera-reactive bands are
marked with arrows, with band sizes given in kDa. ES was separated on a 10% SDS
PAGE gel under reducing conditions.
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6.3.2.4 Comparison of antibody responses to whole fluke antigen and excretory-
secretory preparations
Group antibody responses to the ES preparation followed a similar pattern to
that observed with the WFA preparation. Early during infection, bands of 96-82, 70,
68 and 55-52 kDa common to both preparations were recognised by the chronic
infection group, A, and the 5-day pre-exposed group, B. After secondary challenge,
group A recognition of these mid region bands became less significant, and a
response to bands of size 30 and 28 kDa became prominent. In contrast, group B
maintained a strong antibody response to the mid region bands after secondary
challenge. Group B recognition of the 30 and 28 kDa bands appeared 3-4 weeks later
than that in group A, at a similar time to the response in the naive group, D. Although
the immediate post-secondary challenge response to the 96-82, 70, 68 and 55-52 kDa
bands in the WFA preparation was stronger in group B than D, by day 70 there was
no clear difference in band intensities between the two groups.
Reactive bands present in the ES preparation but absent in the WFA
preparation included those of 72, 60 and 58 kDa. Antibody responses to these bands
were present particularly during early infection in groups A and B and after
secondary challenge in groups C and D. The response to these bands became less
significant as the infection progressed. Reactive bands exclusive to the WFA fraction
included those of 59, 57.5 and 54 kDa to which there was a strong response early
during infection and bands of 120, 76, 34 and 33 kDa, which were only weakly
positive at various time-points throughout infection.
6.3.2.5 Total IgG antibody responses to the cathepsin-L poolfraction
The sera antibody IgGl and IgG2 responses of animals in Experiment A to
the cathepsin-L pool fraction were investigated by ELISA and are shown in section
5.3. Western blots of this fraction were also performed with a limited number of
samples to support the ELISA analysis.
Sera collected at days 35, 49 and 77 from 5 animals in each of groups A, B
and D was tested. At day 35, 7 days post-secondary challenge, group A showed only
weak reactivity to the 29.5-28 kDa band doublet and no response was detected in
groups B and D. At day 49 (Figure 6.10), the group A response was stronger, but
only minimal band recognition was observed in groups B and D. By day 77, sera
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from animals in all three groups recognised the cathepsin doublet, with group A
showing the strongest response and group B the weakest.
6.3.2.6 Total IgG antibody responses to the metacercarialpreparation
Sera samples from 5 animals in each of groups A and B were tested at day 21
(Figure 6.11a) for total IgG responses to the metacercarial preparation. 6 animals
from groups A, B and D were also tested at day 49, 21 days after the secondary
challenge. Due to scarcity of material, the minimum quantity of the preparation was
loaded onto the gels and this is likely to account for the poor responses seen.
A weak response to 49, 45, 43, 41 and 37.5 kDa bands was present by day 21
with the majority of group A and B samples tested. Weak reactivity to the 37.5 kDa
band was also observed with pre-infection samples, suggesting recognition was not
t
infection specific. Some samples from each group also detected 85, 79 and 66 kDa
bands, particularly those from group B. By day 49, group A samples showed
moderate reactivity to 49, 45, 43, 41 and 37.5 kDa bands and a response to another
band of 21 kDa was detected. In group B, 4/6 samples recognised the mid region
bands of 85, 79 and 66 kDa, although no reaction to the 45, 43 and 41 kDa bands was
detected. Group D sera samples were unreactive at day 49, except for that of one
animal, which recognised the 85 and 79 kDa bands. As with the juvenile preparation,
material was extremely limited, preventing further investigation.
6.3.2.7 Total IgG antibody responses to the 14 dayjuvenile preparation
Group A and B sera samples were tested at day 14 for responses to the
juvenile homogenate preparation. No specific band responses were detected for any
of the samples tested at this time-point. However, a secondary challenge response to
this extract was observed in group A at days 42 and 49 (Figure 6.11b). The
recognition of two bands of 30 and 28 kDa was particularly prominent and a
moderate response to 41, 38 and 38.5 kDa bands was also detected. Groups B, C and
D showed a minimal response to the extract at days 42 and 49, although weak
recognition of 48, 45, 38 and 30 kDa bands was observed with some samples.
Unfortunately, adequate material was not available to allow further investigation of
responses to this extract.
172
Figure 6.10: Experiment A; IgG antibody responses to the cathepsin-L pool fraction









Group A Group B Group D
Lanes were incubated with sera taken from 5 animals in each of groups A (lanes 1 -
5), B (lanes 6-10) and D (lanes 11-15) on days 49 (a) and 77 (b), using the same
animals at each time-point. Cathepsin was separated on a 14% SDS PAGE gel under
reducing conditions.
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Figure 6.11: Experiment A; IgG antibody responses to metacercarial and 14 day




Group A Group B Group C ; Group D
Metacercarial preparation (a), was incubated with sera taken at day 21 (group A:
lanes 1-5 and group B: lanes 6-10) and day -7 (group A: lanes 11-15 and group B:
lanes 16-20). Juvenile preparation (b) was incubated with day 49 sera from groups A
(lanes 1-5), B (lanes 6-10), C (lanes 11-15) and D (lanes 16-20). Both preparations
were separated on 12% SDS PAGE gels under reducing conditions.
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6.3.3 Results of Western blots performed with samples from Experiment B
6.3.3.1 Sera IgGl antibody responses to wholefluke antigen
Antibody responses to WFA in the 5-6 day pre-exposed group of Experiment
B (group B) were similar to those observed with samples from group B of
Experiment A (section 6.3.2.2). At days 19 and 26 post-primary infection, 3/4 sera
samples were strongly reactive to the 59 and 57.5 kDa bands and 2/4 samples were
moderately reactive to 55, 54, 43, 41, 34 and 33 kDa bands. After secondary
challenge at days 40/41, all pre-exposed group B animals reacted strongly to the 59,
57.5, 54, 43, 41 and 31 kDa bands. However, bands of 96-82 and 70-68 kDa were
only weakly recognised by sera in this experiment, in contrast to the antibody
response observed in Experiment A. No bands were detected by group D sera at day
40/41. Bands of 30 and 28 kDa were not detected by any group B sample at any time-
point.
6.3.3.2 Hepatic lymph node IgGl and IgG2 antibody responses to whole fluke
antigen
The cell culture fluid IgGl response to WFA is shown in Figure 6.12.
Samples from the trial animals, calves 813 and 827 (section 4.2.1), reacted strongly
to 190-120, 96-82, 76, 70, 68, 59, 57.5 and 52 kDa bands. Calf 827 also reacted very
strongly to the 30 and 28 kDa bands. Group B animals showed a response pattern to
the high and mid region bands which was identical to that of calves 813 and 827,
although the response was weaker overall. However, the 30 and 28 kDa bands were
not recognised by any of the group B samples. The most immunoreactive bands in
the preparation were those of 160-140, 70, 68, 59 and 57.5 kDa. There was no
reaction to any band with cell culture fluid from group D animals. Cell culture fluid
from calves 813 and 827 was tested with a polyclonal anti-IgG2 reagent and culture
fluid from all other animals was tested with the monoclonal anti-IgGl and IgG2
antibodies. No IgG2 response was detected with any sample.
Both sera and cell culture fluid detected the same bands in the WFA
preparation, with antibody responses to 59 and 57.5 kDa bands predominating.
However, the cell culture fluid also recognised higher region bands of 190-120, 96-
82 and 76-68 kDa, which were not detected by sera samples.
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Figure 6.12: Experiment B; hepatic lymph node cell culture supernatant fluid IgGl
antibody responses to the whole fluke antigen (WFA) preparation.
Lanes were incubated with hepatic lymph node cell culture fluid (undiluted) as
follows: culture media negative control (lane 1), trial calves 813 and 827 (lanes 2-3)
and main experiment calves 1, 2, 6*, 9, 12*, 13, 16* and 17* (lanes 4-11). Lanes
incubated with group D calves are shown by an asterisk *. WFA was separated on a
10-15% SDS PAGE gradient gel under reducing conditions.
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6.3.3.3 Sera IgG antibody responses to the excretory-secretory preparation
The IgG antibody response of the 5-6 day pre-exposed group, to proteins in
the ES preparation was again very similar to the pre- and post-challenge responses of
group B animals of Experiment A (section 6.3.2.3). At day 19, sera reacted strongly
to 96-82, 60, 58, 55 and 52-45 kDa bands. After secondary challenge at day 40/41,
the response to the above bands was maintained and further bands of 72-68 kDa were
also detected. There was no detectable antibody response to bands in the region of 30
kDa or less. Samples from group D animals were negative prior to the secondary
challenge and only showed a weak response to 60, 58, 55 and 52-45 kDa bands at
days 40/41.
6.3.3.4 Hepatic lymph node IgG antibody responses to the excretory-secretory
preparation
Cell culture supernatant fluid from all pre-exposed animals (group B)
recognised bands of 96-82, 72-68, 60, 58, 55 and 52 kDa (Figure 6.13). The
responses of calves 9 and 13 were particularly strong. Only one animal in the nai've
group, D, (calf 12) showed any reaction to these bands, and this was minimal.
Control media, and hepatic node cell culture fluid from an uninfected animal, calf
241, were negative.
Both sera and cell culture fluid samples recognised the same bands in the ES
preparation. In all cases the culture fluid responses were much weaker than the sera
responses.
6.3.3.5 Hepatic lymph node IgG antibody responses to the cathepsin and high
molecular weightfractions
An attempt to investigate the presence of antibodies in hepatic node cell
culture fluid to the high molecular weight and cathepsin fractions by ELISA were
unsuccessful, due to the high background response induced by the culture media.
Western blots were therefore performed. Figure 6.14 shows the IgG response of cell
culture samples to the cathepsin and high molecular weight fractions. All samples,
except that from calf 827, were negative for antibody to the cathepsin fraction. The
positive control sample of sera from calf 95 at day 69 gave a very strong response to
the cathepsin preparation showing that the blot transfer and incubation steps were
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successful. In contrast, samples from the trial calves 813 and 827, calves 1, 2 and 13
(group B) and calf 12 (group D) showed weak reactivity to the high molecular weight
fraction.
6.3.3.6 Sera total IgG antibody responses to the metacercarialpreparation
Sera responses to the metacercarial preparation were tested on both large
gradient and small mini-blots. Results of the mini-blot tested with samples from the
pre-exposed group, B, is shown in Figure 6.15a. Most group B animals showed a
weak non-specific response to the 37.5 kDa band with negative pre-infection and
early infection samples. However, after challenge at days 40/41, the response to the
37.5 kDa band and those of 49, 43 and 41 kDa was very strong with all animals
except calf 2. Moderate reactivity to 85, 79, and 66 kDa bands was also present. Sera
from group D animals showed only a minimal response to the 49 and 43-37.5 kDa
bands after challenge.
6.3.3.7 Sera total IgG antibody responses to the 14 day juvenile preparation
A strong post-challenge response to the juvenile preparation was present at
day 40/41 with 3 out of 4 animals in group B. The greatest response was to bands of
57.5, 48, 45, 38 and 30 kDa (Figure 6.15b). Two animals in group B also showed a
weak response to these bands during the primary infection period at day 26. Group D
animals showed no reaction to any bands at any of the time-points studied.
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Figure 6.13: Experiment B; hepatic lymph node cell culture supernatant fluid IgG
antibody responses to F. hepatica excretory-secretory preparation.
1 2 3* 4 5* 6 7* 8* 9 10 11
Lanes were incubated with hepatic lymph node cell culture fluid (undiluted) as
follows: calves 1, 2, 6*, 9, 12*, 13, 16* and 17* (lanes 1-8); negative controls:
culture fluid from hepatic nodes of two uninfected calves, 237 and 241 (lanes 9 and
10) and culture media alone (lane 11). Lanes incubated with group D calves are
marked by an asterisk *. ES was separated on a 12% SDS PAGE gel under reducing
conditions.
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Figure 6.14: Experiment B; hepatic lymph node cell culture supernatant fluid IgG
antibody responses to the cathepsin-L pool and high molecular weight fractions.
(a) Cathepsin-L pool fraction
1 2 3* 4 5* 6 7* 8* 9 10 11 12 13
28-29 kDa
(b) High molecular weight fraction
1 2 3* 4 5* 6 7* 8* 9 10 11 12
200 kDa
In both (a) and (b) lanes were incubated with hepatic lymph node cell culture fluid
(undiluted) as follows: calves 1, 2, 6*, 9, 12*, 13, 16* and 17* (lanes 1-8); negative
control samples of culture media alone (lane 9) and culture fluid from an uninfected
calf, 241 (lane 10). Lanes incubated with group D calves are marked by an *.
Positive controls in (a) were trial calves 813 and 827 (lanes 11 and 12) and day 68
infection sera from a chronically infected calf, 95 (lane 13). The latter sera sample
was used at a 1/200 dilution. Positive controls in (b) were trial calves 813 (lane 12)
and 827 (lane 11). In (b), supernatant fluid for group B and D calves was obtained
from cells cultured at 1 x 106 cells/ml, whereas all other samples were cultured at 2 x
106 cells/ml.
Cathepsin was separated on a 14% SDS PAGE gel under reducing conditions and the
high molecular weight fraction was separated on a 7.5% SDS PAGE gel under non-
reducing conditions.
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Figure 6.15: Experiment B; IgG sera antibody responses to metacercarial and 14 day
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Day 26 Day 40/41
Lanes 1-4, 5-8 and 9-12 were incubated with sera taken from group B calves 1, 2, 9
and 13 at days 0, 26 and 40/41 post-primary infection, respectively. Both
preparations were separated on 12% SDS PAGE gels under reducing conditions.
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6.4 DISCUSSION
6.4.1 Distinct banding patterns for the early and late phases of infection
One of the most striking differences in the band response pattern to WFA and
ES preparations with the four groups in Experiment A, was the immunodominance of
high to mid weight protein bands during early infection and the subsequent switch to
recognition of lower weight proteins as infection progressed to chronicity.
A strong antibody response to the 96-82 and 70-52 kDa protein bands was
detected in group A, and to a lesser extent in group B, during the primary infection
period at day 28 and in groups B and D, after the secondary challenge infection.
Antibody responses to bands of 96-82, 70, 68, 55 and 52 kDa common to both ES
and WFA preparations were especially distinctive. With the WFA preparation,
antibody responses to these bands were particularly strong in group B between days
42 to 56, at a point when the group A response appeared to have waned and that of
group D was yet to become substantial. This trend differs slightly from the response
pattern observed with the ES preparation, where the timing and strength of the group
B response to the high to mid range proteins was similar to that of the nai've control
group, D, after the secondary challenge infection.
As infection progressed in the chronic group A and after the secondary
challenge, the antibody response switched from the recognition of the high to mid
weight bands to those of 30-28 kDa. This switch became apparent at day 42, and by
day 70 the response to the 30-28 kDa region in group A was extremely strong. In
contrast, group B and C animals did not show any reactivity to 30-28 kDa bands until
much later, at around day 70, and at the same time as antibody responses were
detected in group D.
The antibody response to proteins exclusive to either of the two preparations,
the doublet bands 60 and 58 kDa present in ES, and 59 and 57.5 kDa present in
WFA, were also predominant during early, but not late infection. Antibody
recognition of the 59 and 57.5 kDa bands was particularly strong in group B after the
secondary challenge infection. Although these bands may be merely markers of the
juvenile stages of infection, their prominence in the pre-exposed group B, which
displayed signs of reduced liver damage after secondary challenge infection (section
3.3), is significant. Antibody responses to these bands should be examined in more
182
detail using a quantitative method such as ELISA and any possible correlations with
infection parameters investigated.
Why did the secondary challenge infection not boost the response to the high
to mid region proteins in group A, as it had with group B? This observation is similar
to the situation demonstrated by the IgGl/IgG2 ELISA analysis of antibody responses
to the high molecular weight fraction (section 5.3.3), in which the antibody response
in group A was dampened immediately after secondary challenge. In order to clarify
whether the waning response was a result of the superimposed secondary challenge
infection, an additional group could have been run alongside group A, receiving only
a single primary infection. Alternatively, the response to the high to mid region bands
may not have been boosted because the secondary challenge flukes were unable to
establish in the presence of a primary infection. However, infection parameters did
provide indirect evidence that the secondary infection flukes were able to invade and
cause damage to the liver (sections 3.3.1-3.3.3).
Other studies, using sera from naturally and experimentally F. hepatica
infected cattle have detected antibody responses to proteins of similar size to the high
and mid weight proteins reported in this study. The methods used for separating
proteins by SDS PAGE and for calculating band sizes vary between different
investigators. Therefore, actual band sizes in kDa may not be comparable between
different studies. However, a comparison of antibody reactivity to regions of the
protein profile and similarities in the binding patterns can be made. Diffuse binding
to a 65-52 kDa region in adult whole fluke preparation has been observed with sera
from naturally and experimentally infected cattle in Japan (Itagaki et al., 1995).
Another study also detected antibody to proteins of 56, 64 and 69 kDa at 4-6 weeks
post-infection in cattle (Santiago and Hillyer, 1988). Immunoreactive proteins of 95,
75, 70, 66, 55 and 50 kDa in adult whole fluke and excretory-secretory preparations
have also been detected with sera from infected Peruvian cattle (Oblitas, 1997). The
latter study also detected antibodies to various proteins less than 45 and greater than
100 kDa in size. Bovine IgG antibody responses to proteins of 76-68 and 60-52 kDa
are therefore consistently detected in studies conducted in different countries, using
different parasite and host stocks.
It is likely that the naturally exposed cattle from Japan and Peru were being
continually super-infected throughout the fluke season, and yet antibody to these high
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and mid weight proteins was still detected in field sera samples, probably obtained
from animals with mature infections. In contrast, in this experiment, the chronically
infected group, A, showed a diminished antibody response to this region after
secondary challenge, with the 30-28 kDa region becoming immunodominant within 6
weeks of primary infection. A possible explanation for this difference between the
studies could be the method of super-infection and the size of infective dose:
naturally infected animals probably ingest low doses of metacercariae over a
prolonged period, whereas in this study, animals were given moderate bolus doses.
The host immune response may react differently in the two situations.
The change in the antigen recognition profile, from the detection of protein
bands in the high and mid weight region during early infection, to recognition of
bands of less than 30 kDa during late infection, has also been observed in other
ruminant studies (Chauvin et al., 1995, Itagaki et al., 1995). However, this study is
unique because a dominant antibody response to these proteins was demonstrated
after secondary challenge in 5-6 day pre-exposed animals, which had showed
evidence of a degree of functional protection to challenge, when compared to naive
animals.
6.4.2 Antibody responses to metacercarial and juvenile protein preparations
IgG antibody responses to the 14 day juvenile preparation were not detected
in any of the groups of Experiment A until after the secondary challenge infection.
Given the presence of certain antigens common to this and the adult fluke
preparations, this observation is unusual and could be due to poor optimisation of the
assay for this particular protein preparation. As with responses to the WFA and ES
preparations, there was a clear difference between antibody responses after secondary
challenge in the chronically infected group, A and the pre-exposed group, B. Group
A showed a strong response to the 30-27 kDa bands, which were not detected by sera
from any of the other groups at this time-point. Instead, all of the group B animals
tested and some animals in groups C and D recognised bands of 48, 45, 41 and 38
kDa. Group B animals from the second experiment (B), showed a similar but
stronger reaction to these bands, additionally recognising those of 76, 68 and 57.5
kDa.
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One difference between antibody responses to the juvenile preparation and
adult preparations, was the fact that the majority of the mid weight proteins of 70-55
kDa were not detected in the juvenile homogenate by antibody, whilst antibody
responses to proteins of 48-38 kDa, which were poorly recognised in adult WFA and
ES preparations, were detected in the juvenile homogenate. IgG antibody responses
to bands of 66, 45, 38 and 25-30 kDa, present in a 21 day homogenate preparation,
have previously been detected in experimentally infected cattle (Oblitas, 1997).
The metacercarial preparation contained a different set of proteins, with the
exception of a 45 kDa band, to those found in the adult and juvenile preparations.
Unlike the juvenile preparation, an early antibody response to primary infection was
observed at days 14 and 21, with sera from groups A and B of Experiment A, even
though a smaller quantity of the metacercarial extract was used. During the primary
infection antibody responses to 49, 45, 43, 41 and 37.5 kDa proteins were detected.
After secondary challenge, group A maintained a reaction to these bands and a
further band of 21 kDa was detected. However, sera from group B was poorly
responsive after challenge, although a weak reaction to bands of 85, 79 and 66 kDa
was observed. Group B animals from the second experiment (B) showed a stronger
antibody reaction, recognising 85, 79, 66, 49, 45, 43, 41 and 37.5 kDa bands. Oblitas
(1997), detected antibody responses to metacercarial proteins of 40-38 and 22-18
kDa with infected cattle sera, which may correspond to some of the bands recorded in
this study.
6.4.3 Nature of reactive bands
A variety of proteins have now been isolated from F. hepatica adult flukes.
The majority of these are of low weight, including the cathepsin-L and B proteases,
28-30 kDa (Smith et al., 1993a; Heussler and Dobbelaere, 1994; Wilson et al., 1998),
glutathione S-transferase, 26-28 kDa (Howell et al., 1988; Muro et al., 1993), fatty
acid binding protein, 12-14 kDa (Hillyer, 1985), calcium binding protein, 22 kDa
(Ruiz de Eguino et al., 1999) and cytochrome c peroxidase, 31 kDa (Campos et al.,
1999). Some greater than 200 kDa have also been identified such as the high
molecular weight haem-containing fraction (McGonigle and Dalton, 1995) and a
dipeptidylpeptidase (Carmona et al., 1994). One or more of the proteins of 30-28 kDa
detected in the WFA and ES preparations may correspond to a cathepsin protease.
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Antibody to these bands was first detected at a similar time-point to that of antibody
to the purified cathepsin-L pool fraction. The use of 2 dimensional electrophoresis or
specific antisera to the cathepsin fraction would be necessary to demonstrate this
unequivocally. It should be noted that cathepsin proteases have also been isolated
from juvenile flukes (Creaney et al., 1996; Wilson et al., 1998) and so it is possible
that the 30-28 kDa bands in the juvenile preparation also correspond to a cathepsin
protease. Other possible proteins that could be present in this region of the WFA or
ES preparations include cytochrome c peroxidase and glutathione S-transferase.
The identity of many of the high to mid weight proteins to which antibody
responses were observed in this study remains unknown. As the response to this
region was first seen during early infection, they must be associated with juvenile
fluke stages, although held in common with mature flukes. Two isolated proteins fall
within the 96-52kDa region: a leucine aminopeptidase, which runs at 65 kDa on
reducing SDS PAGE, with minor bands of 43-30 kDa (Acosta et al., 1998) and
paramyosin, of approximately 94 kDa (Spithill et al., 1998). Some of the unknown
proteins may be surface antigens. The tegument of the fluke contains granules, called
TO, T1 or T2 granules. Proteins within the granules are incorporated into the surface
glycocalyx covering of the tegument (Hanna, 1980b). TO granules are only found in
newly excysted juveniles, whilst T1 granules appear soon after liver penetration, at
around day 5 (Bennett and Threadgold, 1975). T2 granule proteins do not appear on
the surface until the flukes begin to enter the bile ducts, at around 6 weeks post¬
infection. The protein composition of the T1 granules is therefore of most interest in
this study, particularly regarding the responses of the 5-6 day pre-exposure group, B.
Monoclonal antibodies have identified an antigen of 50 kDa and minor components
of 40 and 25 kDa in the T1 granule (Hanna and Trudgett 1983). In this study,
proteins of size 48 and 52 kDa were detected, which could be equivalent to one of the
components of the T1 granule. Several surface proteins of 78, 46 and less than 32
kDa have been identified on juvenile flukes of up to 14 days old, by
immunoprecipitation with sera from infected animals (Lammas and Duffus, 1985).
21 day old flukes show similar surface glycoprotein profiles to mature flukes,
although the expression of a group of proteins of approximately 70 kDa is greatest in
the juvenile, whilst 85, 94 and 110 kDa proteins are not detected in the adult (Dalton
et al., 1985). The 70 kDa cluster and those of 85 and 94 kDa identified in the latter
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study could be equivalent to the proteins eliciting strong antibody responses during
early infection in this experiment. Juvenile and mature fluke surface preparations also
contained a 52 kDa antigen, which again could be equivalent to bands detected in this
experiment.
6.4.4 Isotype specific antibody responses
With both WFA and ES preparations, an IgGl antibody isotype response
dominated in all groups, and only a minimal IgG2 response was observed. The weak
IgG2 response had a similar antigen recognition profile as that of the IgGl isotype,
which may have been due to background binding of the anti-IgG2 monoclonal
antibody to IgGl immunoglobulin. In contrast, a small number of bands in the ES
preparation were detected that exhibited an intensity greater than that seen with the
IgGl monoclonal, suggesting the presence of a specific IgG2 response. However, no
consistent pattern with the IgG2 response was noted. Ideally, other time-points
should have been tested for isotypic antibody responses, particularly during the first 4
to 5 weeks of infection. Although the day 56 time-point allowed both a chronic
infection in the early stages (group D) and late stages (group A) to be examined, early
isotype responses in animals receiving abbreviated primary infections (groups B and
C) were not investigated. Previous results from the ELISA study with the high
molecular weight fraction showed that some animals in group B had a definite IgG2
response at day 28 (section 5.3.3). However, from the results obtained in this
Western blot study, it can be concluded that infection in all groups stimulated a
predominantly IgGl antibody response, typical for F. hepatica infection (Clery et al.,
1996; Bossaert et al., 2000).
Other antibody isotypes responses were not studied: an effective antisera to
bovine IgE is still not available and there was inadequate time available to investigate
IgM and IgA responses. An investigation of specific IgE responses to fluke proteins
would be very useful. In some human schistosomiasis studies, IgE antibody levels
correlate with resistance to reinfection (Hagan et al., 1991; Rihet et al., 1991; Dunne
et al., 1992; Demeure et al., 1993). It should also be noted that the group B animals
of Experiment A tended to show an overall increase in strip background after the
secondary challenge response, a reaction not noted with the other three groups. The
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presence of an excess of antibody of another isotype binding non-specifically to the
nitrocellulose membrane could have been responsible for this effect.
6.4.5 Antibody in hepatic lymph node cell culture fluid
Culture of unstimulated hepatic node cells to investigate local antibody
production was successful. Cell culture supernatant fluid from all pre-exposed
animals (trial and main study) detected various proteins in the WFA and ES
preparations, whilst that from naive challenged animals did not. This suggests that at
10 days post-infection, a single primary infection was unable to stimulate a detectable
local antibody response to the adult-derived WFA and ES preparations. The antibody
produced by the hepatic lymph node cells of pre-exposed animals may have been in
response either to the primary, drug-abbreviated infection received at day 0, or to the
secondary challenge infection evoking a memory response. A control group receiving
only the primary pre-exposure should have been run alongside the challenged group,
in order to determine whether antibody was induced locally by the primary drug-
abbreviated infection, which was still detectable by day 40.
Hepatic node antibody response profiles were similar to those obtained with
sera, with the exception of 190, 160 and 140 kDa proteins. These high molecular
weight proteins were weakly and inconsistently detected by sera, but consistently
recognised by antibody in cell culture fluid. The trial calf, 827, unlike all other pre-
exposed animals, gave a strong reaction to the 30-28 kDa bands. This suggested that
a positive response to the purified cathepsin-L fraction might also be obtained. Calf
827 did react strongly to the cathepsin fraction, showing a response similar to that of
chronic infection sera. This sample therefore acted as a good positive control,
indicating that the negative response to the cathepsin fraction obtained with all other
cell culture fluids was genuine. The reason that calf 827 gave a positive response to
this region is not clear, although it is possible that the primary infection was not
completely terminated by triclabendazole treatment and maturing flukes were present
in the liver at the time of secondary challenge. The absence of such a response with
the other pre-exposed animals in this experiment (B) and with sera from group B and
C animals of Experiment A prior to day 70, suggests that the termination of the
primary infection by triclabendazole treatment was successful in all other cases.
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Cell culture supernatant fluid from some group B animals gave a weak IgG
antibody response to the high molecular weight protein fraction. This supports the
observations of cell culture studies (section 4.3.5), in which hepatic lymph node cells
showed a strong proliferative response after stimulation with the high molecular
weight fraction 10 days after infection. In contrast, the same cells showed only a
weak proliferative response to culture with the cathepsin-L pool fraction. In addition,
sera antibody responses to the high molecular weight fraction were seen early during
the primary and secondary challenge periods in Experiment A animals, whilst
antibody to cathepsin did not appear for a further few weeks (sections 5.3.3-5.3.4).
6.4.6 Limitations of the analysis
Interpretation of antibody responses to proteins by Western blot analysis is
limited by the detection capabilities of the reagents available. A trade-off between
sensitivity and effective blocking of non-specific background responses must be
carefully balanced. In this study, the polyclonal anti-IgGl and total IgG reagents did
show a degree of background response that was not ideal, which meant low
concentrations of sera and reagents had to be used. This is likely to have affected the
detection of weak band responses during the early days of primary infection, with the
result that little reaction was noted during the first 21 days of infection, particularly in
the drug-abbreviated groups B and C. The monoclonal antibodies that became
available later in the study resulted in a lower background response, although they
were less sensitive. A full analysis of samples with these reagents may have produced
clearer blots, however time was limiting and repetition of blots was not possible. Not
all time-points were investigated with all the various sera, particularly with the
juvenile and metacercarial extracts. A fuller investigation of the latter responses
could be useful, however material was severely limited due to the cost of
metacercarial cysts, making this impossible for the current project.
Previous work comparing antigenic profiles of juvenile flukes during the first
10 days of infection, has demonstrated that protein expression differs markedly with
age, but also with fluke location (Tkalcevic et al., 1996). Up to 6 days old, juvenile
flukes recovered from different locations, i.e. peritoneum or liver, showed different
antigenic profiles, even if of the same age. However, by day 8, flukes recovered from
either site had the same protein profiles, similar to that of adult flukes. A major
189
switch in antigen expression appeared to occur at 3-4 days post-infection. However, a
common 49 kDa antigen was present in all fluke stages, which could be equivalent to
the 49 kDa band present in the metacercarial preparation, or the 48 kDa bands in the
other preparations used in this study. Given that the antibody responses during very
early infection were of particular interest in this study, the use of a protein
preparation from much younger flukes would have been appropriate. In particular,
responses to a 5-7 day old fluke preparation should have been investigated, as this is
the age at which infection was terminated in the group B pre-exposed animals.
6.4.7 Conclusions
The results displayed in this chapter clearly illustrate the recognition of a
group of high to mid weight proteins of 96-82, 76-68 and 60-52 kDa, of unknown
identity, by antibody present in early infection sera from animals receiving drug-
abbreviated and chronic infections. Pre-exposed animals maintained a strong
antibody response to these proteins after secondary challenge, whilst chronically
infected animals did not. Lower weight proteins of 30 kDa and less, were not reactive
with sera from infected animals until later in infection, from approximately day 40
onwards. Western blots also confirmed the absence of an IgG antibody response to
cathepsin-L protease during the early stages of infection.
This study has also demonstrated for the first time the presence of a strong
local hepatic IgGl antibody response to fluke proteins, particularly those of 190-120,
96, 87, 70, 68, 59 and 57.5 kDa, during early infection. Although there was no
difference in the nature of proteins recognised by sera and hepatic lymph node
culture fluid, the analysis was useful in emphasising the particular bands most
reactive with locally-derived antibody.
Further investigation into the identity and nature of the high to mid weight
proteins, especially those of 190-120, 96-82, 72-68 and 60-54 kDa, is necessary to
fully understand the immune responses that occur in infected animals during the early
migratory stages of F. hepatica infection.
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CHAPTER 7
GENERAL DISCUSSION & CONCLUSIONS
7.1 Summary of experimental results
This study has demonstrated that pre-exposure to juvenile flukes during the
first 5-6 days of infection is beneficial to cattle. Upon subsequent re-challenge, pre-
exposed animals showed evidence of reduced liver damage (lower levels of the
enzymes y-GT and GLDH), had a lower final eosinophilia and a transient reduction
in early egg output levels, when compared to naive animals.
The presence of a fluke-specific immune response in pre-exposed animals
was detected in peripheral lymphocytes and in hepatic lymph node cells, but not in
cells from mesenteric lymph nodes. No difference in the magnitude of proliferative
responses of peripheral blood mononuclear cells or hepatic lymph node derived cells
to fluke proteins was observed between pre-exposed or naive challenged animals.
However, a difference in the cytokine profile of hepatic node cells was detected, with
pre-exposed animals producing less IFN-y than naive animals after stimulation with
whole fluke antigen (WFA), excretory-secretory (ES) and cathepsin-L preparations.
The IgG antibody response to crude fluke protein preparations (WFA and ES)
and to the high molecular weight and cathepsin-L fractions was qualitatively similar
in pre-exposed and naive animals after secondary challenge. In contrast, a distinct
difference in the antibody response of chronically infected and pre-exposed animals
was observed. Chronically infected animals showed a reduction in peripheral cellular
reactivity to fluke proteins after challenge, which was greater than the reduction
observed in proliferative responses of cells from 5-6 day pre-exposed animals. A
shift in the antibody recognition profile from protein bands of high to mid molecular
weight, to those of less than 30 kDa was also observed after challenge in chronically
infected animals. Furthermore, the antibody response to the high molecular weight
fraction was significantly reduced in chronically infected animals, compared to nai've
or pre-exposed animals, following secondary challenge.
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7.2 The early immune response to F.hepatica infection
One of the aims of this study was to examine the cellular and antibody
responses occurring during the early stages of infection with F. hepatica. This was
performed by examining the immune responses present within the chronic group (A)
prior to secondary challenge and within the nai've group (D) after secondary
challenge, throughout the course of Experiment A. Several conclusions can be drawn
from the results.
Western blot analysis of WFA and ES fluke preparations found that a
predominantly IgGl antibody response was directed against a group of proteins sized
96-54 kDa during the first 4 to 5 weeks of infection. The identity of these proteins is
not known, however they do not appear to correspond to any of the proteins that have
been previously used in vaccination trials (Spithill and Dalton, 1998), with the
exception of a 65 kDa leucine aminopeptidase (Acosta et al., 1998; Piacenza et al.,
1999) and a 94 kDa paramyosin (Spithill et al., 1998). As flukes matured within the
host, the pattern of antigenic recognition changed. Antibody responses directed
against the 96-54 kDa proteins diminished, whilst those to several proteins of less
than 30 kDa became more prominent.
Antibody responses to cathepsin-L, an antigen considered to be a prime
vaccine candidate (Dalton et al., 1996), examined by ELISA and Western blot
methods, were not prominent during the first 5 weeks of infection. A possible
explanation for this observation is that expression of this protein by juvenile flukes
did not occur in quantities able to stimulate a detectable antibody response.
Additionally, whilst hepatic lymph node cells were moderately responsive to the
haem-containing high molecular weight fraction, also a vaccine candidate (Dalton et
al., 1996), cellular proliferation in response to cathepsin 10 days after fluke
challenge, was poor. However, cells did respond to cathepsin during early infection
by the production of IFN-y. Perhaps cathepsin released by juvenile flukes modulates
or downregulates specific antibody production during early infection. These results
suggest that a cathepsin vaccine may not be efficient at generating an immune
response to the early invasive stages of the fluke. In contrast, antibody to the high
molecular weight fraction appeared within the first 7-14 days of infection, even in the
5-6 day and 24-48 hour pre-exposure groups. The high molecular weight protein
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must therefore be expressed by flukes of less than 7 days old. Further investigation
into the role of this protein fraction in the juvenile fluke and the host response
generated during early infection is therefore warranted.
7.3 The effect of pre-exposure upon subsequent infections
The second objective of the study was to investigate whether pre-exposure to
juvenile flukes stimulated resistance to secondary challenge infections. Pre-exposure
to flukes over the first 5-6 days of infection did induce a degree of protection against
challenge, but exposure to flukes during the first 24-48 hours of migration did not.
Flost exposure to the gut and peritoneal migratory fluke stages only, therefore, did not
appear to stimulate a protective effect. In rats, in which resistance to challenge is
effected at both the level of the gut and peritoneum/liver, pre-exposure to the gut
migratory stages alone does not induce resistance to subsequent challenge (van
Milligan et ai, 1998c). However, priming animals by implanting newly excysted
juveniles into the peritoneal cavity and allowing the infection to progress, does result
in resistance. These observations suggest that exposure to the presence of flukes in
the peritoneal cavity or liver is required for the development of effective resistance in
the rat, a mechanism which is undoubtedly immune-mediated. A similar process in
cattle may have been operating in this study.
Resistance to reinfection after a primary, drug abbreviated infection has been
observed previously in cattle (Doy and Hughes, 1984). Infection was terminated by
the administration of rafoxanide at 16-24 weeks post-infection, by which time mature
flukes would have been present in the bile ducts for several weeks. As a result of
juvenile migration through the liver and the presence of adults in the bile ducts, it is
likely that considerable fibrotic changes in the parenchyma and around the bile ducts
would have been induced. Such changes may have resulted in the development of a
physical barrier to fluke migration. In the experiments described in this thesis, the
contribution of fibrotic changes in the parenchyma to the inhibition of fluke
migration are likely to be much less significant. This is because juvenile flukes would
have been killed whilst still small, and so before substantial damage occurred. This
theory is supported by the results of liver enzyme analysis: little change was observed
in GLDH levels above pre-infection values, in pre-exposed animals during the first
few weeks of the experiment. The protective effect of pre-exposure to 5-6 day old
193
flukes may therefore be immunologically based, although definitive evidence
supporting this theory is still lacking.
Peripheral and local hepatic cellular immune responses in 5-6 day pre-
exposed animals were similar to those found in naive challenged animals.
Furthermore, although antibody from pre-exposed animals recognised various fluke
proteins of 96-54 kDa on Western blots with greater intensity than that of nai've
animals shortly after the challenge infection, no antigens exclusive to the pre-exposed
group were detected. Two issues follow from these observations.
Firstly, a distinctive antibody response in the pre-exposed group may not have
been detected because responses to an appropriate antibody isotype or fluke protein
preparation were not investigated. Maturation of the antibody response in pre-
exposed animals may have also led to the development of protective antibodies of the
same isotype, directed against the same protein, but of greater affinity for particular
antigenic epitopes. This issue requires further exploration.
The second issue is the question of the significance of antibody in mediating
protective immune responses to parasite helminths. Distinct differences in the
antibody response between pre-exposed and nai've animals may not have been
observed simply because antibody was not involved in the development of the
protection observed in the pre-exposed group.
Substantial evidence does exist to support the concept that antibody-
dependent immune protective mechanisms are involved in host resistance to
trematode and cestode parasites. Epidemiological studies support the view that
antibody plays an important role in the resistance to schistosomiasis during natural
infections in humans. IgGl and IgE antibody titres have been found to correlate
significantly with resistance to reinfection after parasites have been cleared by drug
treatment (Hagan et al., 1991; Rihet et al., 1991: Dunne et al., 1992; Demeure et al.,
1993). In vitro studies have also demonstrated the ability of eosinophils to kill
schistosomula in the presence of specific antisera (Butterworth, 1984; Veith and
Butterworth, 1983). The most effective recombinant antigen parasite vaccines that
have been produced so far are those used to protect sheep against infection with
Taenia ovis (Johnson et al., 1989, Flarrison et al., 1996) and Echinococcus
granulosus (Lightowlers et al., 1996a; 1999). The protective effect with both these
vaccines appears to be mediated by antibody and can be transferred in colostrum to
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the neonate (Lightowlers et al., 1996b; 2000).
A clear association between antibody and resistance to reinfection was not
apparent with the cathepsin, high molecular weight and glutathione S-transferase F.
hepatica vaccines. An initial study found no correlation between IgG antibody titres
and the level of protection obtained by inoculating cattle with a combined cathepsin
and haem-containing high molecular weight fraction vaccine (Dalton et al., 1996). In
a further investigation, a negative correlation was observed between the degree of
fluke burden and IgG2 or IgGl titres in vaccinated animals (Mulcahy et al., 1998).
However, the level of protection induced in the vaccinated group was not significant
and animals receiving adjuvant alone also displayed a negative correlation of
antibody titre against fluke burden. Similarly, studies investigating the protective
effect of vaccination with the antigen glutathione S-transferase found no association
between antibody titre and the level of protection in sheep (Sexton et al., 1994) or in
the ability of sera from vaccinated cattle to inhibit GST activity in vitro (Morrison et
al., 1996). A possible explanation for these observations is that protection may have
been mediated by different antibody isotypes to those studied. In S. mansoni
infections in humans, a positive association has been detected between IgA antibody
specific to the recombinant antigen Sm28GST, a trial schistosomiasis vaccine
antigen, and resistance to reinfection after parasite elimination by chemotherapy
(Grzych et al 1993). IgA present in the sera from these individuals was also able to
inhibit GST activity in vitro. The presence of any association between antibody titres
of other isotypes and the degree of protection induced by the trial F. hepatica
vaccines should be investigated.
An alternative reason for the absence of specific antibody associated with
protection in the F. hepatica vaccination studies and in this experiment, could be that
an antibody independent immune response, yet to be identified, was involved in
resistance.
7.4 The role of strategic drug delivery in the control of fascioliasis
Is it possible to utilise the benefit obtained in this experiment by drug-
abbreviated pre-exposure to juvenile flukes in the control of fascioliasis in the field?
The timing of drug treatment may be critical, with administration during the first
week or two of exposure perhaps being necessary to obtain significant benefit. In
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Experiment A, a 4 week old infection (chronic group, A), resulted in substantial
depression of the antibody response to a variety of antigens after secondary
challenge, as well as a reduction in peripheral cellular reactivity to fluke proteins.
Treating animals carrying old juveniles and adult fluke may therefore be ineffective,
because they may exert a modulating effect on the host response to challenge.
Strategic early drug treatment would not be practical for stock kept on pasture all
year, because it would not be possible to accurately identify the point of first
infection. However, early chemotherapy could be useful in the management of cattle
overwintered indoors, which are subsequently turned out during the early spring onto
contaminated pasture.
Interaction between drugs and the immune response has been demonstrated
with the drug praziquantel, which is used in the treatment of schistosomiasis.
Praziquantel acts synergistically with antibody directed against schistosomula
tegumental antigens, to accelerate parasite clearance in animal models (Brindley and
Sher, 1987; Fallon et al., 1994; Fallon and Doenhoff, 1995). Evidence for an
alteration in the immune response in humans after drug treatment has also been
demonstrated in the field by numerous workers (section 3.4.5). Furthermore, these
changes are maintained for some time after chemotherapy: an alteration in the
antibody response to specific S. mansoni proteins has been demonstrated up to 36
weeks following treatment (Mutapi et al., 1998). Whether a similar process occurs
with triclabendazole treatment during the early stages of Fasciola infection, which
could be exploited in strategic drug control, remains to be demonstrated.
7.5 Limitations of the study
The results of this study are particularly useful because it has been conducted
in cattle, one of the natural hosts for F. hepatica. However, several problems are
associated with experimental work involving cattle. These include the lack of
available reagents for examining immune responses, specifically an anti-IgE antibody
and methods for measuring cytokine production by bovine cells in vitro. The cost and
logistics of housing and dealing with large animals is also an issue, restricting the
size of experimental groups.
Another problem that became apparent during this study was the degree of
variability in the response to infection, both physiological and immune-mediated, that
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was observed between different animals receiving the same treatments. The source of
variability may be two-fold: that as a result of variability between individual animals,
but also variability associated with the "take" of infection.
Host variability is influenced by both genetics and environment: the calves in
the first study (Experiment A) were obtained from different farms, forming a
distinctly outbred population, which would also have experienced different
environmental conditions during their first weeks of life. Responses of calves in the
second experiment, B, showed a lower level of variability, and were obtained from a
single closed farm. Using laboratory bred animals reduces the effect of both genetics
and environment, because inbred strains of animals are available and living
conditions can be closely regulated (Gartner, 1999). The recent advances in the
development of large animal clones (Wilmut et al., 1997; Cibelli et al., 1998), brings
the possibility of the production of genetically identical animals on a relatively large
scale. However, it has been demonstrated that variability in a series of physiological
characteristics measured in a group of cloned calves (cloned by splitting a blastocyst
and implanting cells into enucleated oocysts), was greater that that observed for
monozygotic twins calves (Gartner et al., 1998). It was hypothesised that oocyst
signals during very early development may have a significant impact on the
development of variability. The use of monozygotic twins may still, therefore, be the
best available method of reducing the effects of genetic variability in experimental
studies.
Variability in the progress of fluke migration is another component which
may have influenced the responses observed during this study. The proportion of
metacercariae establishing as mature flukes is low and can vary considerably between
animals (Dawes and Hughes, 1964; Ross et al., 1966). Metacercariae may not excyst
within the intestine, may become trapped in the intestinal wall or even the pancreas
and have been found in the diaphragm, pleurae and lungs, suggesting that migration
is random (Boray, 1969). The actual burden of flukes reaching the target organ, the
liver, is therefore not predictable and may well have a significant impact on host
immune and physiological responses during infection.
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7.6 Further work
Whilst the results of this project have provided an important insight into early
and local immune responses during F. hepatica infection in cattle, many areas of the
host immune response to infection remain to be investigated.
The nature of peripheral and local antibody responses present during early
infection require further investigation, specifically those to metacercarial and early
juvenile preparations. An analysis of IgE and IgA isotype responses to adult and
immature preparations may reveal further differences in the immune responses of the
experimental groups used in this study. Immunohistochemical investigation of
isotype antibody responses to flukes using resin-embedded fluke sections (Hanna,
1980b) would only require a small number of flukes and would be very useful for
examining antibody responses to the early juvenile stages, for which material is
limited. An alternative approach for identifying F. hepatica immunoreactive proteins
is by screening cDNA expression libraries with sera from infected animals or from
animals vaccinated with ES products. Various proteins, including a calcium-binding
protein (Ruiz de Eguino et al., 1999), peroxiredoxin (McGonigle et al., 1997) and
thioredoxin (Shoda et al., 1999) have been identified by this method. Screening
cDNA libraries of juvenile flukes with pooled sera from animals in pre-exposed,
naive and chronically infected groups may result in differential recognition of
immunoreactive fluke proteins.
The response of peripheral and lymph node cells to culture with fluke proteins
provides useful information regarding the particular protein fractions which stimulate
an immune response and the type of cytokine profile induced. This in turn provides
an indication of the nature of the immune effector mechanisms operating during
infection. In this study, it would have been appropriate to have examined hepatic and
mesenteric lymph node cell responses to metacercarial, newly excysted juvenile and
7 day juvenile protein preparations. The response to these fractions may differ to that
seen after stimulation with adult fluke preparations, and this may be particularly
relevant regarding the immune response of the 5-6 day pre-exposed animals. Analysis
of cell phenotypes present after culture with fluke preparations, or the use of selected
cell population depletion prior to culture could give an indication of the cell types
responsible for the observed responses. Previous work has demonstrated that both
CD4+ and CD8+ T cells contribute to cell proliferation after antigenic stimulation
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during F. hepatica infection (McCole et al., 1999a). Phenotype analysis may also
provide an insight into the reason for the depression of cellular reactivity, observed
after secondary challenge infection with chronically infected animals (section 3.3.9).
Another cell type that may be involved in the downregulation of lymphocyte
responses in this study is the y5+ T cell subset. y5+ T cells are found at mucosal and
epithelial surfaces, as well as in the peripheral circulation. Various studies have
supported the idea that they may play a role in regulating the host immune response
to environmental proteins, such as ingested or inhaled antigens, inducing a degree of
tolerance (reviewed by Kaufmann, 1996). y5+ T cells are able to react quickly to
pathogen stimulation by producing a variety of cytokines including IFN-y and IL4
(Ferrick et al., 1995). Such cells have been implicated in the downregulation of
specific ap+ T cell responses (McMenamin et al., 1995; Szczeparik et al., 1996),
although there is also evidence for a positive stimulatory role of y§+ T cells in cell-
mediated immune responses (Askenase et al., 1995; Ptak et al., 1996). Additionally,
y§+ T cells may have a positive role in the stimulation of antibody-mediated immune
responses (Szczeparik et al., 1998).
Depletion of y8+ T cells prior to cell culture appears to have little effect on
lymphocyte proliferative responses during F. hepatica infection (McCole et al.,
1999a), however, the role of this phenotype in cell cultures where the proliferative
response is reduced after secondary challenge has not been investigated. The
proportion of y§+ T cells present in bovine peripheral blood varies with age, being
high in the neonate and declining as animals mature (Wilson et al., 1996; Flein,
1994). In this study, calves of 4-6 months old were used; the contribution of y5+ T
cells to F. hepatica infection in calves and adult cattle may therefore vary and is a
point of consideration when comparing cellular responses between different studies.
The use of alternative methods for measuring cytokine production by
lymphocytes in response to stimulation with fluke preparations would have been
helpful in confirming the cytokine responses observed in this study. Standard or
semiquantitative RT-PCR (Brown et al., 1995; Mclnnes et al., 1998) or multiplex
PCR (McKeever et al., 1997), would have allowed investigation of a greater number
of cytokines than were examined in this study. These techniques could also be used
to examine the cytokine profiles of fresh, unstimulated cells, particularly lymph node
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derived cells. It was unfortunate that although RNA was isolated from unstimulated
and cultured cells, inadequate time was available to perform these assays.
An area that was not investigated during this study was the histological and
immunohistochemical appearance of the liver parenchyma and gut mucosa during
infection. Differences in the nature and frequency of immune cell phenotypes present
within hepatic tissue could provide an insight into the underlying reasons for the
disparate responses observed between pre-exposed, nai've and chronically infected
animals. Recently, the presence of distinct hepatic lymphocyte populations present in
normal human liver tissue, compared to those present in the peripheral circulation,
has been demonstrated (Norris et ai, 1998). The majority of human hepatic-derived
lymphocytes were found to consist of natural killer (NK) cells, y5+ T cells and T cells
co-expressing NK molecules (NKT), with CD4+ or CD8+ cells comprising less than
40% of the total population.
NK cells, yS+ T cells and NKT cells express invariant type receptors that
respond to a variety of antigens, often non-peptide, such as lipids or glycoproteins
and are involved in the innate immune response (reviewed Doherty and O'Farrelly,
2000). yS+ T cells are also able to bind specific peptides in combination with antigen
presenting molecules, via the highly variant regions of the y8 TCR (Kaufmann,
1996). Although there is no evidence that such cells can kill juvenile flukes by direct
cytotoxic actions, these cells are able to produce a variety of cytokines in response to
receptor or cytokine stimulation and may be important in defining the local cytokine
environment within the liver (Doherty and O'Farrelly, 2000). This in turn could
regulate the CD4+ helper T cell response to fluke specific antigens and products. The
presence of a surface lipoglycan on F. hepatica has recently been demonstrated
(Singh and Semprevivo, 1999) and it is possible that this molecule may be
recognised by receptors on NK, NKT or y8+ T cells. Meeusen et al. (1995) found
large numbers of CD8+ and y8 cells within the hepatic parenchyma during chronic
infections in sheep and speculated a possible role for these cells in immune
regulation. If similar cells were identified within the hepatic tissue of chronically
infected animals shortly after challenge infection (group A) in greater numbers than
in pre-exposed or nai've animals, this may provide an explanation for the depression
in cellular responses observed in this study.
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The production of cytokines locally, within the liver, could be investigated by
extraction of total mRNA from sections of hepatic tissue. In a study using normal
mouse liver, resting levels of cytokine mRNA were found to be low and mRNA
encoding IL4 and IFN-y was not detected (Diehl, 2000). If this is also the case in
cattle, any cytokine mRNA detected in liver samples is likely to be a specific
response to liver infection. This method of analysing local cytokine expression could
be extremely useful in the context of the current study and may be important in
defining the differences in host response to challenge between pre-exposed and nai've
animals. Lymphocytes could also be extracted directly from the liver and cell and
cytokine responses to fluke proteins examined in culture.
The role of the hepatic antigen presenting cells during fluke infection, the
sinusoidal endothelial cells and Kupffer cells, also requires investigation. Unusually,
Kupffer cells from Schistosoma mansoni infected mice are able to produce IL4, IL6,
IL10 and IL13 in response to schistosome proteins, an atypical response for
macrophage cells (Hayashi et ai, 1999). Kupffer cells may also be involved,
therefore, in influencing the local cytokine environment and so T cell response to
infection. Alternatively, Kupffer cells could respond to fluke infection by the
production of toxic metabolites, such as nitric oxide. As Kupffer cells exist as a
resident macrophage population within the liver, their role during F. hepatica
infection should be investigated further.
There is therefore great scope for a detailed and thorough investigation of the
local liver and hepatic lymph node immune responses occurring during the early
stages of F. hepatica infection in cattle. Given the lack of mesenteric response
observed after challenge infection in both the pre-exposed and naive animals,
understanding the local hepatic response could be crucial for determining the
immune mechanisms operating in this study.
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7.7 Conclusions
This study has provided a unique insight into the early immune response and
in particular, the local lymph node responses, to F. hepatica infection in cattle. In
summary, this study has demonstrated that:
• Pre-exposure to 5-6 day old fluke by drug abbreviated infections results in a
reduction in liver damage, eosinophilia and in faecal egg counts during the early
patent period, upon secondary challenge, when compared to na'ive animals.
• The predominant immune response to whole fluke antigen and excretory-
secretory protein preparations 10-11 days following challenge infection is present
at the level of the liver and not the gut, in both 5-6 day pre-exposed and nai've
animals.
• A mixed IgGl/IgG2 antibody response was observed to the haem-containing high
molecular weight fraction during the first few weeks of infection. Hepatic lymph
node cells also showed a strong proliferative reaction to culture with this fraction
at 10 days post-infection. Antibody and cellular immune responses to cathepsin-L
were less significant during the early infection period, with IgGl antibody
responses absent until the 5th week of infection.
• The early, peripheral and local IgGl antibody response to infection is directed
against a variety of proteins present in adult fluke preparations of 96-82, 72-68
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Recipes for solutions and culture media
All chemicals were obtained from Sigma or BDH, unless stated otherwise.
A.l Solutions used for protein preparation, SDS PAGE and Western blots





Distilled water to 1000 mis
A.l.2 PBS-T
0.5 ml of Tween 20 per 1000 ml of PBS.
A.l.3 Sample loading buffer (non-reducing and reducing)
0.5M Tris-HCl pH 6.8 1.2 ml
Glycerol 1.0 ml
10%w/vSDS 2.0 ml
0.1% w/v Bromophenol blue 0.5 ml
Distilled water 4.8 ml
For a reducing buffer, 25 pi of P-mercaptoethanol was added to 475 pi aliquots of
the above sample buffer and used within 2 weeks (stored at 4°C).
A.l.4 SDS-PAGE running buffer (IX)
Tris 9g
Glycine 43.2g
SDS (Lauryl sulphate) 3g
Distilled water to 1000 mis








Distilled water to 1000 mis
A.1.6 Tris buffered saline, TBS, pH 7.6 (IX)
Tris 3.15g
8gNaCl
Distilled water to 1000 mis
A.1.7TBS-T
1 ml of Tween 20 per 1000 ml of TBS.
A.2 Solutions and media used in tissue culture procedures (* indicates material
obtained from Life Technologies)
A.2.1 PBS, pH 7.4 for all cell culture techniques was prepared from tablets (Sigma
P-4417) and sterilised by autoclaving.
A.2.2 Acid citrate dextrose anticoagulant
2.5% w/v D-glucose
2.05% w/v Di-sodium hydrogen citrate
in distilled water; sterilised through a 0.22 pm filter.
A.2.3 Tissue culture complete media
RPMI 1640 (Sigma R-7388)
L-glutamine*
2-mercaptoethanol*, 50 mM







A.2.4. Lymph node media
HBSSa





Heparin (Sigma H-3149) to a final concentration of 10 IU/1
a
= Hank's Buffered Saline Solution without Ca2+ and Mg2+ (Sigma H-6648)
A.2.5 0.83% ammonium chloride red cell lysis solution
Buffer A
pH 7.65, to 1000ml with distilled water
Buffer B
0.83% w/v NH4CI in distilled water
Buffers A and B were sterilised by autoclaving. The working solution was prepared
immediately prior to use by mixing 1 ml of buffer A with 9 ml of buffer B.
Tris 20.6g
APPENDIX B
Bl: Longitudinal profile of group mean serum levels of the enzyme gamma glutamyl
transferase (y-GT) over the entire period of study, for groups A, B, C and D (Experiment
A), in international units per litre (IU/1). Error bars show the standard error of the mean.
Equivalent to Figure 3.4, page 58.
A b - - c - -x- - D
B2: Longitudinal profile of group mean serum levels of the enzyme glutamate
dehydrogenase (GLDH) over the entire period of study, for groups A, B, C and D
(Experiment A), in international units per litre (IU/1). Error bars show the standard error
of the mean. Equivalent to Figure 3.5, page 59.
B3: Longitudinal IgGl antibody response to the high molecular weight fraction over the
period days 0-98. Group mean optical density values for groups A, B, C and D
(Experiment A) are shown, with error bars representing the standard error of the mean.
Equivalent to Figure 5.3, page 130.
B4: Longitudinal IgGl antibody response to the cathepsin-L pool fraction over the period
days 0-112. Group mean optical density values for groups A, B, C and D (Experiment A)
are shown, with error bars representing the standard error of the mean. Equivalent to
Figure 5.5, page 133.
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